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Summary 
Milk production is generally lower, but lactation persistency higher in primiparous (PP) than 
multiparous (MP) ruminants. This may be related to differences in development and 
maintenance of mammary gland function, but the underlying mechanisms are not well 
understood. Furthermore, milk production in MP ruminants is determined not only by the 
genetic capacity of the animal but also by management factors such as duration of the dry 
period in between successive lactations. The dry period appears to be essential for MP dairy 
animals to ensure that the mammary epithelial cell (MEC) population can be effectively 
renewed as one lactation comes to an end and prior to onset of the next lactation. Generally, 
the level of milk production and the changes in milk yield over the course of lactation depend 
on three main factors: 1) the number of MEC, which in turn is affected by the balance 
between the rate of epithelial cell proliferation and apoptosis; 2) the secretory activity of these 
cells, which in turn is affected by their differentiation; and 3) the provision of nutrients and 
removal of metabolic waste products via the blood. The present thesis aimed to address the 
hypotheses that 1) differences between PP and MP animals with respect to milk production 
and lactation persistency may be related to differences in mammary growth and remodelling 
also during lactation, 2) the factors responsible for interfering with mammary remodelling in 
continuous lactation throughout the dry period into the subsequent lactation, are the same 
factors involved also in determination of lactation persistency and performance differences 
between PP and MP animals, 3) milk protein synthesis in the lactating mammary gland will 
be less sensitive towards variations in nutrient supply in late compared to early lactation, 4) 
minor deficiencies in dietary provision of protein can be compensated by provision of energy 
(ATP) yielding substrates to sustain milk (protein) synthesis. 
The hypotheses were addressed in four papers based on three experiments with dairy goats. In 
Experiments 1 and 2, mammary remodelling was compared in PP and MP goats during 
lactation. In multiparous goats, the importance of the dry period for mammary remodelling 
was further assessed by unilateral drying off of one gland appr. 9 weeks prior to parturition 
followed by a normal lactation (NL), whilst omitting the dry period and thus subjecting the 
other gland to a continuous lactation (CL). In Experiment 3, the importance of nutrient supply 
in regulation of milk (protein) synthesis was assessed. This was done by providing extra 
nutrients through intravascular isoosmotic infusion of nutrients (essential amino acids, acetate 
or glucose) and determining the impact on milk yield and mammary nutrient uptake. The 
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goats were fed a basal diet providing appr. 90 and 80% of requirements for net energy and 
amino acids absorbable from the small intestine, respectively. This was done in early (EL) 
and late lactation (LL) to assess the changes in mammary sensitivity towards variations in 
nutrient supply with advancing lactation, and hence to evaluate whether there might be a 
physiological foundation for development of graded protein recommendations for ruminants. 
Mammary biopsies were obtained in Experiments 1 and 2 from both mammary glands and 
blood samples were obtained in all experiments for determination of arterio-venous 
concentration differences across each of the mammary glands at different stages of gestation-
lactation. Gene transcription relating to MEC turnover, lactogenesis, angiogenesis and 
vascular function was quantified by real time RT-PCR, mammary morphology characterized 
(quantitative histology), and cell turnover determined (TUNEL and Ki-67). Whole blood was 
analysed for acid-base parameters and plasma for contents of key metabolites and hormones.  
The experimental results demonstrated that initiation of lactation in the PP mammary gland is 
associated with development and growth of the gland in early lactation, which continues for a 
longer period of time compared to MP glands. Evidence has been provided that the set of 
genes regulating the orchestrated changes in mammary epithelial cell and vascular function 
during lactation, are also basically the same set of genes explaining different patterns of 
development between PP and MP goats. Both vascular and mammary epithelial cell 
development are thus determinants of lactation performance and can explain the reported 
higher lactation persistency in PP goats compared to MP. But the underlying reason why 
mammary development in PP animals have a different trajectory compared to MP remains to 
be established. No specific genomic factor(s) could account for the differences in mammary 
(re)development and MEC survival between PP and MP glands.  
We confirmed that omitting the dry period is possible although with some difficulty in goats, 
and without major impact on milk yield in the subsequent lactation, which is in contrast to the 
cow. MEC renewal was suppressed in CL glands, which resulted in a smaller MEC 
population in the subsequent lactation. At the time of parturition (and throughout lactation), 
the mammary glands subjected to CL had smaller alveoli, more fully differentiated MEC and 
a substantially larger capillary fraction compared with NL glands, and CL gland thus 
resembled a normally lactating gland in a more advanced stage of lactation. None of the 
studied genomic factors could account for the differences in mammary (re)development and 
MEC survival between NL and CL glands. Efficiency of mammary nutrient extraction was 
unaffected by CL, and the more MECs in a more fully differentiated state are therefore not 
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necessarily more metabolically active. The explanation why milk yield in dairy goats is 
relatively unaffected by CL (in contrast to dairy cows) remains to be established.  
In conclusion, mammary development and remodelling prior to parturition and during 
lactation in goats are dependent on parity as well as late gestation management (dry period). 
Redevelopment of the mammary microvascular system is closely coordinated with that of the 
mammary epithelial cell population, and crucial for overall integrity of mammary gland 
function, which explains higher lactation persistency in PP compared to MP animals. 
Omitting the late gestation dry period in dairy goats did not depress milk production in the 
following lactation (in contrast to dairy cows) despite interference with peri-partum mammary 
(re)development, and mammary nutrient extraction was not improved. The reason for this 
species difference is interesting, but as yet unknown. Furthermore, the cellular events 
explaining the differential developmental patterns 1) in PP versus MP animals and 2) in 
mammary glands allowed a pre-partum dry period versus mammary glands continuously 
milked throughout late gestation still need to be resolved.  
The decreasing mammary metabolic activity with progressing lactation appears to alter the 
sensitivity of the mammary gland towards variations in nutrient supply. Milk protein 
synthesis requires presence in the MEC of building blocks in the form of amino acids as well 
as energy in the form of ATP. An insufficient supply of amino acids to the mammary gland of 
dairy goats can be compensated in EL but perhaps not LL by increased mammary supply of 
energy, provided that this increased energy supply is in the form of nutrients like acetate, 
which is metabolized predominantly in pathways resulting in generation of ATP. The 
mammary gland may thus be relatively less sensitive towards variations in amino acid supply 
in EL compared to LL, but the underlying reason for this altered sensitivity during lactation 
remains to be established. This indicates that there could be scope for development of 
differential protein recommendations for ruminants in early and late lactation, and this issues 
should be pursued in future studies. 
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Sammendrag (Summary in Danish) 
Mælkeproduktionen er generelt lav, men det er set at laktation persistensen er højere hos 
primiparous (PP) end hos multiparous (MP) drøvtyggere. Dette kan være relateret til forskelle 
i udvikling og opretholdelse af mælkekirtlernes funktion i yveret, dog er de underliggende 
mekanismer for dette er ikke klarlagt. Endvidere er mælkeproduktionen hos MP drøvtyggere 
ikke kun bestemt af dyrets genetiske ydeevne, men også af management strategier for 
varigheden af goldperioden og perioden omkring ny laktation. Goldperioden synes at være 
afgørende for MP lakterende drøvtyggere, idet antallet af mælkekirtlens epitelceller (MEC) 
effektivt kan udskiftes efterhånden som en laktation ophører, og være forudgående for 
opstarten af den næste laktation. Generelt set afhænger mælkeproduktion og ændringer i 
mælkeydelsen under laktationen af tre hovedfaktorer så som 1) antallet af MEC, som er 
påvirket af forholdet mellem celleproliferation og apoptose, 2) den sekretoriske aktivitet af 
disse celler, som er påvirket af deres differentiering, og 3) tilførsel af næringsstoffer og 
fjernelse af metaboliske affaldsprodukter via blodet. Formålet med dette PhD projekt var at 
undersøge følgende hypoteser at 1) forskelle mellem PP og MP dyr i forbindelse med 
mælkeproduktion og laktation persistens kan være relateret til forskelle i vækst af 
mælkekirtlen og dens remodellering under laktation, 2) faktorer, der er ansvarlige for 
intervenerer mælkekirtelens remodellering i en sammenhængende laktation, som inkluderer 
goldperioden til den efterfølgende laktation, er de samme faktorer, der også er involveret i 
bestemmelse af laktation persistens og forskelle i ydeevne mellem PP og MP dyr, 3) 
mælkeproteinsyntesen i den lakterende mælkekirtel vil være mindre sensitive overfor 
variationer af næringsstofforsyning i sen laktation sammenlignet med tidlig laktation, 4) et 
mindre underskud i proteinindholdet i diæten kan kompenseres ved tilførsel af 
energisubstrater (ATP) til at fastholde mælke(protein)syntesen. 
Hypoteserne er adresseret i fire artikler baseret på tre forsøg udført i malkegeder. I forsøg 1 og 
2, blev mælkekirtelens remodellering sammenlignet mellem PP og MP geder under laktation. 
I multiparous geder, var betydningen af goldperioden for mælkekirtelens remodellering 
yderligere bestemt ved en ensidig kirtel goldning ca. 9 uger før læmning, efterfulgt af en 
normal laktation (NL), samtidig med undladelse af goldperioden, hvorved den anden kirtel 
blev udsat for en forsat laktation (CL). I forsøg 3, blev betydningen af næringsstofforsyning 
for regulering af mælke(protein)syntese bestemt. Det blev gjort ved at tilføre ekstra 
næringsstoffer gennem intravaskulær iso-osmotic infusion af næringstoffer (essentielle 
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aminosyrer, acetat eller glukose) for at klarlægge effekten på mælkeydelse og optagelse af 
næringsstoffer i mælkekirtlen. Gederne blev fodret med en basal diæt, som henholdsvis 
dækkede ca. 90 % og 80 % af behovet for nettoenergi og absorberbare aminosyrer fra 
tyndtarmen. 
Dette blev udført i tidlig (EL) og sen laktation (LL) for at bestemme ændringerne i 
mælkekirtlens sensitivitet overfor variationer i næringsstofforsyning med fremskreden 
laktation, og dermed kunne bestemme om et fysiologisk grundlag til udvikling af en særlig 
anbefaling af proteintildeling hos drøvtyggere. Mælkekirtelbiopsier blev udtaget i forsøg 1 og 
2 fra begge mælkekirtler, og blodprøver blev udtaget i alle forsøg til bestemmelse af forskelle 
i arteriovenøse koncentration forskelle for hver mælkekirtel på forskellige stadier af 
drægtighed og laktation. Gentransskription i forbindelse med MEC turnover, lactogenesis, 
angiogenese og den vaskulære funktion blev målt via real time RT-PCR, karakterisering af 
mælkekirtelens morfologi (kvantitativ histologi), og celle turnover blev ydermere bestemt 
(TUNEL og Ki-67). Fuldblod blev analyseret for syre-base parametre, og plasma blev 
analyseret for indhold af væsentlige metabolitter og hormoner. 
Forsøgsresultaterne viste, at indledningen af laktation i PP mælkekirtlen er forbundet med 
kirtlens udvikling og vækst i tidlig laktation, som fortsætter i en længere tidsperiode i forhold 
til MP mælkekirtler. Det er blevet vist, at gener regulerende for de dirigerede ændringer i 
mælkekirtelens epitelceller og den vaskulær funktion under laktation, stort set er det samme 
sæt gener, der forklarer forskellige udviklingsmønstre mellem PP og MP geder. Udviklingen 
af både vaskulær og mælkekirtlens epitelceller er afgørende for mælkeydelsen og kan forklare 
den højere rapporterede laktation persistens i PP geder i forhold til MP. Men den 
underliggende årsagsmekanisme til hvorfor udviklingen af mælkekirtlen hos PP dyr er en 
anden sammenlignet med MP, er endnu ikke blevet klarlagt. Der er på nuværende tidspunkt 
ingen specifik genom faktor(er), der kan forklare forskellene i mælkekirtlens udvikling og 
MEC overlevelse mellem NL og CL kirtler. 
Vi har vist, at udeladelse af goldperioden er muligt, om end det indeholdte nogle 
komplikationer hos gederne, og var uden væsentlig indflydelse på mælkeydelsen i den 
efterfølgende laktation, som i modsætning til koen. Udskiftning af MEC blev undertrykt i CL 
mælkekirtler, hvilket resulterede i et mindre antal MEC i den efterfølgende laktation. På 
tidspunktet for læmning (og under hele laktationen), havde mælkekirtlerne under CL mindre 
alveoler, mere fuldt differentieret MEC og en væsentlig større kapillær andel sammenlignet 
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med mælkekirtler under NL. Herved lignede CL kirtlen en normalt lakterende kirtel i et mere 
avanceret stadium af laktation. 
Ingen af de undersøgte genom faktorer kunne gøre rede for forskellene i mælkekirtlens 
udvikling og MEC overlevelse mellem NL og CL kirtler. Effektiviteten af mælkekirtlens 
udvinding af næringsstoffer var upåvirket af CL, og derfor vil flere MECs i en mere fuldt 
differentierede tilstand ikke nødvendigvis være mere metabolisk aktive. Forklaringen på 
hvorfor mælkeydelsen hos malkegeder er relativt upåvirket af CL (i modsætning til 
malkekøer) er endnu ikke klarlagt.  
Det kan hermed konkluderes, at udviklingen og remodellering af mælkekirtlen før læmning 
og under laktation hos malkegeder afhænger af paritet samt management under sendrægtighed 
(goldperiode). Videreudvikling (udvikling) af mælkekirtelens mikrovaskulærsystem er nøje 
reguleret af antallet af mælkekirtlens epitelceller, og afgørende for overordnet integritet af 
mælkekirtlens funktion, hvilket forklarer den højere laktation persistens hos PP sammenlignet 
med MP dyr.  
At undlade sendrægtighedens goldperiode hos malkegeder nedsætter ikke mælkeproduktionen 
i den efterfølgende laktation (i modsætning til malkekøer) på trods af interferens med 
mælkekirtel udvikling peri-partum, samt mælkekirtlens udvinding af næringsstoffer ikke var 
forbedret. Årsagen til denne artsforskel er interessant, men forsat ukendt. Det er forsat 
ønskeligt at identificere de cellulære forekomster, der kan forklare de forskellige 
udviklingsmæssige mønstre 1) hos PP versus MP dyr og 2) i mælkekirtlens tilladelse af en 
præ-læmning goldperiode versus mælkekirtlens forsat mælkeproduktion under den sene 
drægtighed. Mælkekirtlens nedsatte metaboliske aktivitet under progressiv laktation 
fremtræder, at kunne ændre mælkekirtlens sensitivitet overfor variationer i 
næringsstofforsyningen. Mælkeproteinsyntesen i MEC kræver tilstedeværelsen af byggesten i 
form af aminosyrer samt energi i form af ATP. En utilstrækkelig forsyning af aminosyrer til 
mælkekirtlen hos malkegeder kan kompenseres i EL, men måske ikke LL, ved øget 
energitilførsel til mælkekirtlen, forudsat at denne øgede energitilførsel er i form af 
næringsstoffer som acetat, der hovedsageligt omsættes til ATP. Mælkekirtlen må dermed 
være relativt mindre sensitive overfor variationer i aminosyretilførsel i EL forhold til LL, men 
den underliggende årsag til denne ændrede sensitivitet under laktation er endnu ikke klarlagt. 
Dette indikerer, at der kunne være mulighed for udvikling af forskellige proteinanbefalinger 
til drøvtyggere i tidlig og sen laktation, som er nærliggende at undersøge i fremtidige studier. 
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  (israF ni yrammuS)ﭼﮑﻴﺪﻩ 
زایﻤﺎن دوم ﺑﻪ )در ﻣﻘﺎیﺴﻪ ﺑﺎ ﺷﻴﺮدهﯽ هﺎﯼ ﺑﻌﺪﯼ ( ﺎنﻧﺨﺴﺘﻴﻦ زایﻤ)در ﻣﺠﻤﻮع، ﻧﺸﺨﻮارﮐﻨﻨﺪﮔﺎن در دورﻩ ﺷﻴﺮدهﯽ اّول 
ایﻦ ﻣﺴﺄﻟﻪ ﻣﯽ ﺕﻮاﻧﺪ ﻧﺸﺄت ﮔﺮﻓﺘﻪ از ﺕﻔﺎوﺕﻬﺎﯼ ﺁﻧﻬﺎ در ﺕﮑﺎﻣﻞ و . ، ﻣﻴﺰان ﺕﻮﻟﻴﺪ ﺷﻴﺮ ﮐﻤﺘﺮ وﻟﯽ ﺑﺎ ﺕﺪاوم ﺑﻴﺸﺘﺮﯼ دارﻧﺪ(ﺑﻌﺪ
ﺬﺷﺘﻪ، ﺕﻮﻟﻴﺪ از ایﻦ ﮔ. ﺱﺎﺥﺘﺎرهﺎﯼ زیﺮﺑﻨﺎیﯽ ﺁن ﺑﻪ درﺱﺘﯽ ﺷﻨﺎﺥﺘﻪ ﻧﺸﺪﻩ اﻧﺪ ﻧﮕﻬﺪارﯼ ﻋﻤﻠﮑﺮد ﻏﺪﻩ ﭘﺴﺘﺎﻧﯽ ﺑﺎﺷﺪ؛ هﺮ ﭼﻨﺪ،
ﺷﻴﺮ در ﺷﻴﺮدهﯽ دوم ﺑﻪ ﺑﻌﺪ ﻧﻪ ﺕﻨﻬﺎ ﺑﺎ ﻇﺮﻓﻴﺖ ﺕﮑﻮیﻨﯽ دام، ﺑﻠﮑﻪ ﺑﺎ ﻋﻮاﻣﻞ ﻣﺪیﺮیﺘﯽ ﻣﺎﻧﻨﺪ ﻃﻮل دورﻩ ﺥﺸﮑﯽ ﻣﺎ ﺑﻴﻦ دو 
ﺑﻪ ﻧﻈﺮ ﻣﯽ رﺱﺪ ﮐﻪ دورﻩ ﺥﺸﮑﯽ ﺑﺮاﯼ دوﺑﺎرﻩ ﻧﻮﺱﺎزﯼ ﻣﺆﺛﺮ ﺝﻤﻌﻴﺖ ﺱﻠﻮﻟﻬﺎﯼ . دورﻩ ﺷﻴﺮدهﯽ ﻣﺘﻮاﻟﯽ ﺱﻨﺠﻴﺪﻩ ﻣﯽ ﺷﻮد
در ﻣﺠﻤﻮع، ﻣﻴﺰان . ﻴﺶ از ﺁﻏﺎز دورﻩ ﺷﻴﺮدهﯽ ﺑﻌﺪﯼ، ﺿﺮورﯼ اﺱﺖﭘﻮﺷﺸﯽ ﭘﺴﺘﺎن در ﭘﺎیﺎن یﮏ دورﻩ ﺷﻴﺮدهﯽ و ﭘ
ﺕﻌﺪاد ﺱﻠﻮﻟﻬﺎﯼ ﭘﻮﺷﺸﯽ ( اﻟﻒ: ﺕﻮﻟﻴﺪ ﺷﻴﺮ و ﺕﻐﻴﻴﺮات ﺕﺮاوش ﺷﻴﺮ در دورﻩ ﺷﻴﺮدهﯽ ﺑﺴﺘﮕﯽ ﺑﻪ ﺱﻪ ﻋﺎﻣﻞ اﺻﻠﯽ دارد
ﻓﻌﺎﻟﻴﺖ ﺕﺮﺷﺤﯽ ﺁن ﺱﻠﻮﻟﻬﺎ، ﮐﻪ ﺕﺤﺖ ﺕﺄﺛﻴﺮ ( ﭘﺴﺘﺎن، ﮐﻪ ﻣﻨﺘﺞ از ﻣﻮازﻧﻪ ﻣﺎﺑﻴﻦ ﺱﺮﻋﺖ زایﺶ و ﻣﺮگ ﺁن ﺱﻠﻮﻟﻬﺎﺱﺖ؛ ب
ﻏﺬارﺱﺎﻧﯽ و ﺥﺎرج ﮐﺮدن ﻣﻮاد زاﺋﺪ ﻧﺎﺷﯽ از ﺱﻮﺥﺖ و ﺱﺎز از ﻃﺮیﻖ ﺝﺮیﺎن ( ﺝﻪ ﺕﻤﺎیﺰ ﺁن ﺱﻠﻮﻟﻬﺎ ﻣﯽ ﺑﺎﺷﺪ؛ و جدر
ﺕﻔﺎوﺕﻬﺎﯼ داﻣﻬﺎﯼ در دورﻩ اّول و ( اﻟﻒ: ﭘﺎیﺎن ﻧﺎﻣﻪ ﺡﺎﺿﺮ، ﺑﺮ ﺁن دارد ﺕﺎ ایﻦ ﻓﺮﺿﻴﻪ هﺎ را ﻣﻮرد ﺑﺮرﺱﯽ ﻗﺮار دهﺪ. ﺥﻮن
هﯽ، ﻣﻤﮑﻦ اﺱﺖ هﻤﭽﻨﻴﻦ ﻣﺮﺕﺒﻂ ﺑﺎ ﺕﻔﺎوﺕﻬﺎ در رﺷﺪ و ﺕﻐﻴﻴﺮات ﺷﻴﺮدهﯽ در ﺕﻮﻟﻴﺪ ﺷﻴﺮ و ﺕﺪاوم ﺷﻴﺮد( دوم ﺑﻪ ﺑﻌﺪ)ﭼﻨﺪم 
ﻋﻮاﻣﻞ ﻣﺴﺆول ﺕﺪاﺥﻞ ﺑﺎ ﺕﻐﻴﻴﺮات ﺱﺎﺥﺘﺎرﯼ ﭘﺴﺘﺎن در ﺷﻴﺮدوﺷﯽ ﻣﻤﺘﺪ ( ﺱﺎﺥﺘﺎرﯼ ﭘﺴﺘﺎن در ﻃﻮل دورﻩ ﺷﻴﺮدهﯽ ﺑﺎﺷﺪ؛ ب
 ، هﻤﺎن ﻋﻮاﻣﻠﯽ هﺴﺘﻨﺪ ﮐﻪ درﮔﻴﺮ در ﺕﻌﻴﻴﻦ ﺕﻔﺎوﺕﻬﺎﯼ ﻋﻤﻠﮑﺮدﯼ و ﺕﺪاوﻣﯽ(در ﻃﻮل دورﻩ ﺥﺸﮑﯽ ﺕﺎ دورﻩ ﺷﻴﺮدهﯽ ﺑﻌﺪﯼ)
ﺱﺎﺥﺖ ﭘﺮوﺕﺌﻴﻦ ﺷﻴﺮ در ﻏﺪﻩ ﭘﺴﺘﺎﻧﯽ در ( ﺷﻴﺮدهﯽ ﻣﯽ ﺑﺎﺷﻨﺪ؛ ج( دوم ﺑﻪ ﺑﻌﺪ)ﺷﻴﺮدهﯽ ﻣﺎﺑﻴﻦ داﻣﻬﺎﯼ در دورﻩ اّول و ﭼﻨﺪم 
( اﻧﺘﻬﺎﯼ دورﻩ ﺷﻴﺮدهﯽ در ﻣﻘﺎیﺴﻪ ﺑﺎ اﺑﺘﺪاﯼ دورﻩ ﺷﻴﺮدهﯽ، ﺡﺴﺎﺱﻴﺖ ﮐﻤﺘﺮﯼ در ﻗﺒﺎل ﺕﻨﻮع ﻣﻨﺎﺑﻊ ﻣﻐﺬﯼ ﺥﻮاهﺪ داﺷﺖ؛ د
ﭘﺮوﺕﺌﻴﻦ ﺑﻪ ﻣﻴﺰان ﮐﻢ در رژیﻢ ﻏﺬایﯽ ﻣﯽ ﺕﻮاﻧﺪ ﺑﺎ ﺕﺄﻣﻴﻦ ﻣﻐﺬﯼ هﺎﯼ  ﺷﻴﺮ، ﮐﻤﺒﻮدهﺎﯼ( ﭘﺮوﺕﺌﻴﻦ)ﺝﻬﺖ ﺛﺒﺎت ﻣﻴﺰان ﺕﻮﻟﻴﺪ 
  .ﺝﺒﺮان ﺷﻮد( PTA)ﺕﻮﻟﻴﺪﮐﻨﻨﺪﻩ اﻧﺮژﯼ 
در ﺁزﻣﺎیﺸﻬﺎﯼ اّول و دوم، . ایﻦ ﻓﺮﺿﻴﻪ هﺎ در ﭼﻬﺎر ﻣﻘﺎﻟﻪ ﺑﺮ اﺱﺎس ﺱﻪ ﺁزﻣﺎیﺶ ﺑﺮ روﯼ ﺑﺰهﺎﯼ ﺷﻴﺮﯼ ﮔﺰارش ﺷﺪﻩ اﻧﺪ
در . ر ﻃﻮل دورﻩ ﺷﻴﺮدهﯽ ﻣﻮرد ﻣﻘﺎیﺴﻪ ﻗﺮار ﮔﺮﻓﺘﻪ اﻧﺪﺕﻐﻴﻴﺮات ﭘﺴﺘﺎﻧﯽ در ﺑﺰهﺎﯼ ﺷﻴﺮدهﯽ اّول و ﺷﻴﺮدهﯽ دوم ﺑﻪ ﺑﻌﺪ د
ﺑﺰهﺎﯼ ﺷﻴﺮدهﯽ دوم ﺑﻪ ﺑﻌﺪ، اهﻤﻴﺖ دورﻩ ﺥﺸﮑﯽ ﺝﻬﺖ ﺕﻐﻴﻴﺮات ﭘﺴﺘﺎﻧﯽ ﻣﻮرد ﺑﺮرﺱﯽ ﻣﻀﺎﻋﻒ ﻗﺮار ﮔﺮﻓﺘﻪ اﺱﺖ؛ 
ﺑﻄﻮریﮑﻪ، ﺑﺎ اﺱﺘﻔﺎدﻩ از ﺥﺸﮏ ﮐﺮدن یﮏ ﻃﺮﻓﻪ یﮏ ﻏﺪﻩ ﺕﻘﺮیﺒًﺎ ﻧﻪ هﻔﺘﻪ ﭘﻴﺶ از زایﻤﺎن، اداﻣﻪ یﺎﻓﺘﻪ ﺑﺎ یﮏ دورﻩ ﺷﻴﺮدهﯽ 
در ﺁزﻣﺎیﺶ ﺱﻮم، اهﻤﻴﺖ ﻣﻮاد . درﺡﺎﻟﯽ ﮐﻪ، دورﻩ ﺷﻴﺮدهﯽ و ﺑﻪ ﺕﺒﻊ ﺁن ﺷﻴﺮدهﯽ ﻣﻤﺘﺪ ﺑﻪ ﻏﺪﻩ دیﮕﺮ ﺕﺜﺒﻴﺖ ﺷﺪﻩ ﺑﻮدﻋﺎدﯼ؛ 
ﺕﺄﻣﻴﻦ ﻣﻮاد ﻣﻐﺬﯼ از ﻃﺮیﻖ ﺕﺰریﻖ ﻣﻤﺘﺪ  ﺑﺎ[ ﻋﻤﻞ]ایﻦ . ﺷﻴﺮ ﻣﻮرد ﺑﺮرﺱﯽ ﻗﺮار ﮔﺮﻓﺘﻪ اﺱﺖ( ﭘﺮوﺕﺌﻴﻦ)ﻏﺬایﯽ در ﺱﺎﺥﺖ 
و ﺕﻌﻴﻴﻦ ﺕﺄﺛﻴﺮ ﺁﻧﻬﺎ در ﻣﻴﺰان ﺕﻮﻟﻴﺪ ﺷﻴﺮ و ( هﺎﯼ ﺁﻣﻴﻨﻪ ، اﺱﺘﺎت و ﮔﻠﻮﮐﺰاﺱﻴﺪ( )ایﺰواﺱﻤﺰ)داﺥﻞ وریﺪﯼ ﻣﺤﻠﻮﻟﻬﺎﯼ هﻢ ﺕﺮاوا 
ﺑﺰهﺎ ﺑﺎ یﮏ ﻏﺬاﯼ ﭘﺎیﻪ ﺕﺄﻣﻴﻦ ﮐﻨﻨﺪﻩ ﺕﻘﺮﺑﻴًﺎ ﻧﻮد و هﺸﺘﺎد درﺻﺪ . ﻣﻮاد ﻣﻐﺬﯼ، اﻧﺠﺎم ﺷﺪﻩ اﺱﺖ[ از]ﭘﺴﺘﺎن ( اﺱﺘﻔﺎدﻩ)ﺑﺮداﺷﺖ 
هﻢ در [ ﻋﻤﻞ]ایﻦ . ر ﮔﺮﻓﺘﻨﺪﻣﺎیﺤﺘﺎج ﺥﺎﻟﺺ ﺑﻪ ﺕﺮﺕﻴﺐ اﻧﺮژﯼ و اﺱﻴﺪﺁﻣﻴﻨﻪ ﻗﺎﺑﻞ ﺝﺬب از رودﻩ ﮐﻮﭼﮏ، ﻣﻮرد ﺕﻐﺬیﻪ ﻗﺮا
[ زﻣﺎﻧﯽ]اوایﻞ و هﻢ در اوﺁﺥﺮ دورﻩ ﺷﻴﺮدهﯽ ﺝﻬﺖ ﺑﺮرﺱﯽ ﺕﻐﻴﻴﺮات ﺡﺴﺎﺱﻴﺖ ﭘﺴﺘﺎن ﺑﻪ ﺕﻨﻮع ﻣﻮاد ﻣﻐﺬﯼ ﺑﺎ ﭘﻴﺸﺮﻓﺖ 
دورﻩ ﺷﻴﺮدهﯽ اﻧﺠﺎم ﮔﺮﻓﺘﻪ اﺱﺖ ، و ﭘﻴﺮو ﺁن ﺑﺮرﺱﯽ ایﻨﮑﻪ ﺁیﺎ ﭘﺎیﻪ هﺎﯼ ﻓﻴﺰیﻮﻟﻮژﯼ ﺝﻬﺖ ﺑﺴﻂ ﺕﻮﺻﻴﻪ هﺎﯼ درﺝﻪ ﺑﻨﺪﯼ 
 ﺑﻴﻮﭘﺴﯽ هﺎﯼ ﭘﺴﺘﺎﻧﯽ در ﺁزﻣﺎیﺶ اّول و دوم از هﺮ دو ﻏﺪﻩ ﭘﺴﺘﺎﻧﯽ،. ﮔﺎن، وﺝﻮد داردﭘﺮوﺋﻴﻦ ﺑﺮاﯼ ﺕﻐﺬیﻪ ﻧﺸﺨﻮارﮐﻨﻨﺪ
ﺱﻴﺎهﺮﮔﯽ در دو ﻃﺮف هﺮ ﻏﺪﻩ ﭘﺴﺘﺎﻧﯽ - و ﻧﻤﻮﻧﻪ هﺎﯼ ﺥﻮﻧﯽ در هﻤﻪ ﺁزﻣﺎیﺸﻬﺎ ﺝﻬﺖ ﺕﺸﺨﻴﺺ ﺕﻔﺎوﺕﻬﺎﯼ ﻏﻠﻈﺖ ﺱﺮﺥﺮﮔﯽ 
 ﻟﻬﺎﯼ ﭘﻮﺷﺸﯽروﻧﻮیﺴﯽ ژﻧﯽ ﻣﺮﺕﺒﻂ ﺑﺎ ﺕﻐﻴﻴﺮ و ﺕﺒﺪیﻞ ﺱﻠﻮ. ﺷﻴﺮدهﯽ اﻧﺠﺎم ﮔﺮﻓﺘﻪ اﺱﺖ- در ﻣﺮاﺡﻞ ﻣﺨﺘﻠﻒ ﺁﺑﺴﺘﻨﯽ
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. ﻣﻮرد ارزیﺎﺑﯽ ﻗﺮار ﮔﺮﻓﺘﻪ اﺱﺖ RCP-TR emit laerﭘﺴﺘﺎن، ﺷﻴﺮﺱﺎزﯼ، رگ ﺱﺎزﯼ و ﻓﻌﺎﻟﻴﺘﻬﺎﯼ ﻋﺮوﻗﯽ، ﺑﻪ وﺱﻴﻠﻪ  
ﻣﻮرد ( LENUTو  76-ikﺕﻮﺱﻂ )و ﺕﻐﻴﻴﺮ و ﺕﺒﺪیﻞ ﺱﻠﻮﻟﯽ ( ﺕﻮﺱﻂ ﺑﺎﻓﺖ ﺷﻨﺎﺱﯽ ﮐﻤﻴﺘﯽ)هﻤﭽﻨﻴﻦ ریﺨﺖ ﺑﺎﻓﺘﯽ ﭘﺴﺘﺎن 
ﺑﺎزﯼ، و ﭘﻼﺱﻤﺎﯼ ﺁن ﻣﻮرد ﺁﻧﺎﻟﻴﺰ ﻣﻘﺎدیﺮ ﻣﺘﺎﺑﻮﻟﻴﺘﻬﺎ و -اﺱﻴﺪﯼهﻤﻪ ﺥﻮن ﻣﻮرد ﺁﻧﺎﻟﻴﺰ ﭘﺎراﻣﺘﺮهﺎﯼ . ﺑﺮرﺱﯽ واﻗﻊ ﺷﺪﻩ اﺱﺖ
  .هﻮرﻣﻮﻧﻬﺎﯼ ﮐﻠﻴﺪﯼ ﻗﺮار ﮔﺮﻓﺘﻪ اﻧﺪ
ﻧﺘﺎیﺞ ﻧﺸﺎن ﻣﯽ دهﺪ ﮐﻪ ﺁﻏﺎز ﺷﻴﺮدهﯽ در ﭘﺴﺘﺎﻧﻬﺎﯼ دورﻩ ﺷﻴﺮدهﯽ اّول ﺑﺎ ﺕﮑﺎﻣﻞ و رﺷﺪ ﻏﺪﻩ در اوایﻞ دورﻩ ﺷﻴﺮدهﯽ 
ﺷﻮاهﺪﯼ اراﺋﻪ ﺷﺪﻩ . ﻧﯽ ﺕﺮﯼ اداﻣﻪ ﻣﯽ یﺎﺑﺪﻣﺮﺕﺒﻂ اﺱﺖ، ﮐﻪ در ﻣﻘﺎیﺴﻪ ﺑﺎ ﭘﺴﺘﺎﻧﻬﺎﯼ ﺷﻴﺮدهﯽ دوم ﺑﻪ ﺑﻌﺪ، ﺑﻪ ﻣﺪت ﻃﻮﻻ
اﺱﺖ ﮐﻪ ﻣﺠﻤﻮﻋﻪ ژﻧﻬﺎﯼ ﺕﻨﻈﻴﻢ ﮐﻨﻨﺪﻩ ایﻦ ﺕﻐﻴﻴﺮات ﻣﻮزون در ﺱﻠﻮﻟﻬﺎﯼ ﭘﻮﺷﺸﯽ و ﻓﻌﺎﻟﻴﺖ ﻋﺮوﻗﯽ ﭘﺴﺘﺎن در ﻃﻮل دورﻩ 
ﺷﻴﺮدهﯽ، ﺑﻪ ﻃﻮر اﺱﺎﺱﯽ هﻤﺎن ﻣﺠﻤﻮﻋﻪ ژﻧﻬﺎیﯽ هﺴﺘﻨﺪ ﮐﻪ ﺕﻔﺎوﺕﻬﺎﯼ ﺱﺎﺥﺘﺎرهﺎﯼ ﺕﮑﺎﻣﻠﯽ ﺑﻴﻦ دورﻩ ﺷﻴﺮدهﯽ اّول و دوم ﺑﻪ 
ﺑﻨﺎﺑﺮایﻦ، هﻢ ﻋﺮوق و هﻢ ﺱﻠﻮﻟﻬﺎﯼ ﭘﻮﺷﺸﯽ ﭘﺴﺘﺎن، هﺮ دو ﻣﺸﺨﺺ ﮐﻨﻨﺪﻩ ﮐﺎرﺁیﯽ ﺷﻴﺮدهﯽ و . ﺢ ﻣﯽ ﮐﻨﻨﺪﺑﻌﺪ را ﺕﺸﺮی
اّﻣﺎ ﻋﻠﺖ . هﻤﻴﻨﻄﻮر ﺑﺎﻻﺕﺮ ﺑﻮدن ﺕﺪاوم ﺷﻴﺮدهﯽ در ﺑﺰهﺎﯼ ﺷﻴﺮدهﯽ اّول در ﻣﻘﺎیﺴﻪ ﺑﺎ ﺑﺰهﺎﯼ ﺷﻴﺮدهﯽ دوم ﺑﻪ ﺑﻌﺪ هﺴﺘﻨﺪ
ﺑﺎ ﺷﻴﺮدهﯽ دوم ﺑﻪ ﺑﻌﺪ دارد، ﻧﻴﺎز ﺑﻪ ﺕﺤﻘﻴﻖ  اﺻﻠﯽ ﮐﻪ ﭼﺮا ﺕﮑﺎﻣﻞ ﭘﺴﺘﺎن در ﺷﻴﺮدهﯽ اّول ﻣﺴﻴﺮ ﻣﺘﻔﺎوﺕﯽ در ﻣﻘﺎیﺴﻪ
هﻴﭻ ﻋﺎﻣﻞ ژﻧﯽ ﺥﺎﺻﯽ ﮐﻪ ﺑﺘﻮاﻧﺪ ﺝﻬﺖ ﺕﻔﺎوﺕﻬﺎﯼ ﺕﮑﺎﻣﻠﯽ ﭘﺴﺘﺎن و ﻣﺎﻧﺪﮔﺎرﯼ ﺱﻠﻮﻟﻬﺎﯼ ﭘﻮﺷﺸﯽ ﭘﺴﺘﺎن ﻣﺎﺑﻴﻦ . ﺑﻴﺸﺘﺮﯼ دارد
  .دورﻩ ﺷﻴﺮدهﯽ اّول و دوم ﺑﻪ ﺑﻌﺪ ﺑﻪ ﺡﺴﺎب ﺁیﺪ، ﭘﻴﺪا ﻧﺸﺪ
ﺕﻐﻴﻴﺮ ﻋﻤﺪﻩ اﯼ ﺑﺮ ﺕﻮﻟﻴﺪ ﺷﻴﺮ در ﺑﺰ، در ﻣﻘﺎیﺴﻪ ﺑﺎ  ﻣﺎ ﺛﺎﺑﺖ ﮐﺮدیﻢ ﮐﻪ ﺡﺬف دورﻩ ﺥﺸﮑﯽ هﺮﭼﻨﺪ ﺑﺎ ﻣﻘﺪارﯼ ﻣﺸﮑﻞ، ﺑﺪون
ﻧﻮﺱﺎزﯼ ﺱﻠﻮﻟﻬﺎﯼ ﭘﻮﺷﺸﯽ ﭘﺴﺘﺎن در ﭘﺴﺘﺎﻧﻬﺎﯼ ﺑﻄﻮر ﻣﻤﺘﺪ ﺷﻴﺮدوﺷﯽ ﺷﺪﻩ، ﺱﺮﮐﻮب ﮔﺸﺘﻪ، ﮐﻪ . ﮔﺎو، اﻣﮑﺎن ﭘﺬیﺮ اﺱﺖ
و در )در زﻣﺎن زایﻤﺎن . ﺑﺎﻋﺚ ایﺠﺎد ﺝﻤﻌﻴﺖ ﮐﻮﭼﮑﺘﺮﯼ از ﺱﻠﻮﻟﻬﺎﯼ ﭘﻮﺷﺸﯽ ﭘﺴﺘﺎن در دورﻩ ﺷﻴﺮدهﯽ ﺑﻌﺪﯼ ﺷﺪﻩ اﺱﺖ
ﻏﺪﻩ ﭘﺴﺘﺎﻧﯽ ﺑﻄﻮر ﻣﻤﺘﺪ ﺷﻴﺮدوﺷﯽ ﺷﺪﻩ، ﺁﻟﻮﺋﻮﻟﻬﺎﯼ ﮐﻮﭼﺘﺮ، ﺱﻠﻮﻟﻬﺎﯼ ﭘﻮﺷﺸﯽ ﺑﻄﻮر ﮐﺎﻣﻞ ﺕﻤﺎیﺰیﺎﻓﺘﻪ  ،(ﻃﻮل ﺷﻴﺮدهﯽ
ﺑﻴﺸﺘﺮ و هﻤﻴﻨﻄﻮر ﺑﺨﺶ ﺑﺰرﮔﺘﺮﯼ از ﻣﻮیﺮﮔﻬﺎ در ﻣﻘﺎیﺴﻪ ﺑﺎ ﻏﺪﻩ هﺎﯼ ﺷﻴﺮدوﺷﯽ ﺷﺪﻩ ﺑﻄﻮر ﻋﺎدﯼ، داﺷﺘﻨﺪ؛ و ﺑﻨﺎﺑﺮایﻦ، 
اﺱﺖ ﮐﻪ در ﻣﺮﺡﻠﻪ ﭘﻴﺸﺮﻓﺘﻪ ﺕﺮﯼ از  ﻏﺪﻩ ﺑﻄﻮر ﻣﻤﺘﺪ ﺷﻴﺮدوﺷﯽ ﺷﺪﻩ ﻧﻤﺎیﺎﻧﮕﺮ یﮏ ﻏﺪﻩ ﺑﻄﻮر ﻋﺎدﯼ ﺷﻴﺮدوﺷﯽ ﺷﺪﻩ اﯼ
هﻴﭽﮑﺪام از ﻋﻮاﻣﻞ ژﻧﯽ ﻣﻮرد ﻣﻄﺎﻟﻌﻪ ﻗﺮارﮔﺮﻓﺘﻪ، ﻧﻤﺎیﺎﻧﮕﺮ ﺕﻔﺎوﺕﻬﺎﯼ ﺕﮑﺎﻣﻠﯽ ﭘﺴﺘﺎن و ﻣﺎﻧﺪﮔﺎرﯼ . ﺷﻴﺮدهﯽ ﻗﺮار دارد
راﻧﺪﻣﺎن ﭘﺴﺘﺎن در . ﺱﻠﻮﻟﻬﺎﯼ ﭘﻮﺷﺸﯽ ﭘﺴﺘﺎن ﻣﺎﺑﻴﻦ ﻏﺪﻩ ﺑﻄﻮر ﻣﻤﺘﺪ ﺷﻴﺮدوﺷﯽ و ﻏﺪﻩ ﺑﻄﻮر ﻋﺎدﯼ ﺷﻴﺮدوﺷﯽ ﺷﺪﻩ ﻧﺒﻮدﻧﺪ
ﺤﺖ ﺕﺄﺛﻴﺮ ﺷﻴﺮدوﺷﯽ ﻣﻤﺘﺪ ﻗﺮار ﻧﮕﺮﻓﺖ، و ﺑﻨﺎﺑﺮایﻦ، ﺕﻌﺪاد ﺑﻴﺸﺘﺮ ﺱﻠﻮﻟﻬﺎﯼ ﺑﻄﻮرﮐﺎﻣﻞ ﺕﻤﺎیﺰیﺎﻓﺘﻪ اﺱﺘﺨﺮاج ﻣﻮاد ﻣﻐﺬﯼ ﺕ
ﺕﻮﺿﻴﺢ ایﻨﮑﻪ ﭼﺮا ﺕﻮﻟﻴﺪ ﺷﻴﺮ در ﺑﺰهﺎﯼ ﺷﻴﺮﯼ ﺕﺤﺖ . ﭘﻮﺷﺸﯽ ﭘﺴﺘﺎن، ﻟﺰوﻣًﺎ ﻓﻌﺎﻟﻴﺖ ﺱﻮﺥﺖ و ﺱﺎزﯼ ﺑﺎﻻﺕﺮﯼ ﻧﺪارﻧﺪ
  .ﺑﻪ ﺕﺤﻘﻴﻖ ﺑﻴﺸﺘﺮﯼ دارد ﺕﺤﺖ ﺕﺄﺛﻴﺮ ﻗﺮار ﻧﮕﺮﻓﺘﻪ اﻧﺪ، ﻧﻴﺎز( در ﻣﻘﺎیﺴﻪ ﺑﺎ ﮔﺎوهﺎﯼ ﺷﻴﺮﯼ)ﺷﻴﺮدوﺷﯽ ﻣﻤﺘﺪ 
ﺑﻪ ﻋﻨﻮان ﻧﺘﻴﺠﻪ ﮔﻴﺮﯼ، ﺕﮑﺎﻣﻞ و ﺕﻐﻴﻴﺮ ﺱﺎﺥﺘﺎر ﭘﺴﺘﺎن ﻗﺒﻞ از زایﻤﺎن و در ﻃﻮل دورﻩ ﺷﻴﺮدهﯽ در ﺑﺰهﺎ، ﻣﺴﺘﻘﻞ از زایﻤﺎن 
ﺕﮑﺎﻣﻞ دوﺑﺎرﻩ ﺱﻴﺴﺘﻢ . ﻣﯽ ﺑﺎﺷﺪ( دورﻩ ﺥﺸﮑﯽ)و هﻤﻴﻨﻄﻮر ﻣﺪیﺮیﺖ اوﺁﺥﺮ دورﻩ ﺁﺑﺴﺘﻨﯽ ( دورﻩ ﺷﻴﺮدهﯽ ﭼﻨﺪم[ )ﭼﻨﺪم]
هﻤﺎهﻨﮓ اﺱﺖ ﺑﺎ ﺝﻤﻌﻴﺖ ﺱﻠﻮﻟﻬﺎﯼ ﭘﻮﺷﺸﯽ ﭘﺴﺘﺎن و ﻋﻤﻠﮑﺮد ﺑﯽ ﻋﻴﺐ ﻏﺪﻩ ﭘﺴﺘﺎﻧﯽ، ﮐﻪ ﻋﺮوﻗﯽ ﭘﺴﺘﺎن ﺑﻄﻮر ﻧﺰدیﮑﯽ 
ﺡﺬف دورﻩ . ﺕﻮﺿﻴﺤﯽ اﺱﺖ ﺑﺮاﯼ ﺕﺪاوم ﺷﻴﺮدهﯽ ﺑﻴﺸﺘﺮ در دورﻩ ﺷﻴﺮدهﯽ اّول در ﻣﻘﺎیﺴﻪ ﺑﺎ دورﻩ ﺷﻴﺮدهﯽ دوم ﺑﻪ ﺑﻌﺪ
ﺑﻌﺪﯼ را ﻋﻠﯽ رﻏﻢ  ، ﺕﻮﻟﻴﺪ ﺷﻴﺮ در دورﻩ ﺷﻴﺮدهﯽ(در ﻣﻘﺎیﺴﻪ ﺑﺎ ﮔﺎوهﺎﯼ ﺷﻴﺮﯼ)ﺥﺸﮑﯽ اوﺁﺥﺮ ﺁﺑﺴﺘﻨﯽ در ﺑﺰهﺎﯼ ﺷﻴﺮﯼ 
ﻋﻠﺖ ﺕﻔﺎوت ایﻦ دو ﮔﻮﻧﻪ ﺝﺎﻟﺐ ﺕﻮﺝﻪ، اّﻣﺎ ﻧﺎﺷﻨﺎﺥﺘﻪ . ﺕﺪاﺥﻞ ﺑﺎ ﺕﮑﺎﻣﻞ دوﺑﺎرﻩ ﭘﺴﺘﺎن در دورﻩ ﭘﻴﺶ از زایﻤﺎن، ﮐﻢ ﻧﮑﺮد
داﻣﻬﺎﯼ ﺷﻴﺮدهﯽ اّول و دوم ﺑﻪ ﺑﻌﺪ، و ( ﺑﻪ ﻋﻼوﻩ، اﺕﻔﺎﻗﺎت ﺱﻠﻮﻟﯽ ﺕﻮﺿﻴﺢ دهﻨﺪﻩ ﺕﻔﺎوﺕﻬﺎﯼ اﻟﮕﻮهﺎﯼ ﺕﮑﺎﻣﻠﯽ در اﻟﻒ. اﺱﺖ
ﺥﺸﮑﯽ ﭘﻴﺶ از زایﻤﺎن داﺷﺘﻨﺪ درﺑﺮاﺑﺮ ﻏﺪد ﭘﺴﺘﺎﻧﯽ ﮐﻪ ﺑﻄﻮر ﻣﻤﺘﺪ در ﻃﻮل ﺁﺑﺴﺘﻨﯽ  در ﻏﺪد ﭘﺴﺘﺎﻧﯽ ﮐﻪ دورﻩ( ب
  . ﺷﻴﺮدوﺷﯽ ﺷﺪﻩ اﻧﺪ، هﻨﻮز اﺡﺘﻴﺎج ﺑﻪ ﺡﻞ ﺷﺪن دارد
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ﺷﻴﺮدهﯽ، ﺡﺴﺎﺱﻴﺘﻬﺎﯼ ﻏﺪﻩ ﭘﺴﺘﺎن ﺑﻪ [ زﻣﺎﻧﯽ]ﺑﻪ ﻧﻈﺮ ﻣﯽ رﺱﺪ ﮐﻪ ﮐﺎهﺶ ﻓﻌﺎﻟﻴﺘﻬﺎﯼ ﺱﻮﺥﺖ و ﺱﺎزﯼ ﭘﺴﺘﺎن ﺑﺎ ﭘﻴﺸﺮﻓﺖ 
ﺮوﺕﺌﻴﻦ ﺷﻴﺮ اﺡﺘﻴﺎج ﺑﻪ ﺡﻀﻮر ﺑﻠﻮﮐﻬﺎﯼ ﺱﺎﺥﺘﻤﺎﻧﯽ ﺑﻪ ﺻﻮرت اﺱﻴﺪ ﺁﻣﻴﻨﻪ و ﺱﺎﺥﺖ ﭘ. ﺕﻨﻮع ﻣﻮاد ﻣﻐﺬﯼ را ﺕﻐﻴﻴﺮ ﻣﯽ دهﺪ
ﺕﺄﻣﻴﻦ ﻧﺎﮐﺎﻓﯽ اﺱﻴﺪهﺎﯼ ﺁﻣﻴﻨﻪ ﺑﻪ ﻏﺪﻩ ﭘﺴﺘﺎن ﺑﺰهﺎﯼ . در ﺱﻠﻮﻟﻬﺎﯼ ﭘﻮﺷﺸﯽ ﭘﺴﺘﺎن دارد PTAهﻤﻴﻨﻄﻮر اﻧﺮژﯼ از ﻧﻮع 
، ﺝﺒﺮان ﺷﻮد؛ ﺑﺎ ﺷﻴﺮﯼ، ﻣﯽ ﺕﻮاﻧﺪ ﺑﺎ اﻓﺰایﺶ ﺕﺄﻣﻴﻦ اﻧﺮژﯼ ﺑﻪ ﭘﺴﺘﺎن در اوایﻞ دورﻩ ﺷﻴﺮدهﯽ و ﻧﻪ در اوﺁﺥﺮ دورﻩ ﺷﻴﺮدهﯽ
ایﻦ ﺕﻀﻤﻴﻦ ﮐﻪ ایﻦ اﻓﺰایﺶ ﺕﺄﻣﻴﻦ اﻧﺮژﯼ ﺑﻪ ﺷﮑﻞ ﻣﻐﺬﯼ هﺎیﯽ ﻣﺜﻞ اﺱﺘﺎت ﺑﺎﺷﺪ، ﮐﻪ ﺑﻪ ﺻﻮرت ﻋﻤﺪﻩ در ﻣﺴﻴﺮهﺎیﯽ ﮐﻪ 
ﺑﻨﺎﺑﺮایﻦ، ﻏﺪﻩ ﭘﺴﺘﺎﻧﯽ ﻣﻤﮑﻦ اﺱﺖ ﺑﻪ ﺕﻨﻮع ﻣﻨﺎﺑﻊ ﺕﺄﻣﻴﻦ اﺱﻴﺪ ﺁﻣﻴﻨﻪ در اوایﻞ . اﺱﺖ، ﺱﻮﺥﺘﻪ ﻣﯽ ﺷﻮﻧﺪ PTAﻣﻨﺠﺮ ﺑﻪ ﺕﻮﻟﻴﺪ 
ورﻩ ﺷﻴﺮدهﯽ، ﺡﺴﺎﺱﻴﺖ ﮐﻤﺘﺮﯼ داﺷﺘﻪ ﺑﺎﺷﺪ؛ اّﻣﺎ، ﻋﻠﺖ ایﻦ ﺕﻐﻴﻴﺮ ﺡﺴﺎﺱﻴﺖ در ﻃﻮل دورﻩ ﺷﻴﺮدهﯽ در ﻣﻘﺎیﺴﻪ ﺑﺎ اوﺁﺥﺮ د
اﺱﺖ ﮐﻪ ﺑﺴﻂ ﺕﻮﺻﻴﻪ هﺎﯼ ﭘﺮوﺕﺌﻴﻨﯽ ﺑﺮاﯼ [ واﻗﻴﺖ]ایﻦ ﺑﻴﺎﻧﮕﺮ ﺁن . دارد[ ﺑﻴﺸﺘﺮ]دورﻩ ﺷﻴﺮدهﯽ ﻧﻴﺎز ﺑﻪ ﺕﺤﻘﻴﻖ 
ﻄﺎﻟﻌﺎت ﺁیﻨﺪﻩ ﻣﻮرد ﻧﺸﺨﻮارﮐﻨﻨﺪﮔﺎن در اوایﻞ و اوﺁﺥﺮ دورﻩ ﺷﻴﺮدهﯽ ﺝﺎﯼ ﮐﺎر ﺑﺴﻴﺎر دارد، و ایﻦ ﻣﻘﻮﻟﻪ ﻣﯽ ﺑﺎیﺴﺖ در ﻣ
  .ﭘﻴﮕﻴﺮﯼ ﻗﺮار ﮔﻴﺮد
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Introduction 
The level of milk production and the changes in milk yield over the course of lactation, 
depend on: A) the number of milk synthesizing mammary epithelial cells (MEC), which is 
affected by the balance between the rate of epithelial cell proliferation and apoptosis (Capuco 
et al., 2003), B) the secretory activity of these cells, which is affected by their degree of 
differentiation (Akers et al., 2006), and finally C) the provision of nutrients and removal of 
waste products via the vascular system essential for sustaining milk synthesis. These 
determining factors are, in general, affected by major factors like the genetic capacity of the 
animal, the parity number, management factors such as duration of the dry period in between 
successive lactations, and the amount and kind of nutrients supplied to the mammary gland.  
Mammary growth up until the first lactation has been studied quite extensively, whilst 
remodeling of the mammary gland during lactation and particularly in between successive 
lactations has received far less attention. Much remains to be known about how and by which 
mechanisms remodelling of the MEC and particularly the mammary microvasculature occurs 
in late gestation, and how it relates to lactational performance, MEC secretory activity and 
microvascular function in the subsequent lactation. The efficiency of mammary 
(re)modelling/development taking place pre-partum impact lactation performance post-partum 
and also lactation persistency. Understanding how this regulation takes place and identifying 
the key regulatory factors might therefore help to put such knowledge into use in future 
attempts to improve lactational performance and persistency in dairy animals. 
Generally, multiparous (MP) ruminants have a higher milk yield but lower lactation 
persistency compared to primiparous (PP) ones in their first lactation (Miller et al., 2006). 
This may be related to differences in development and maintenance of mammary gland 
function, and it has been reported that mammary growth continues longer post-partum into 
lactation in PP compared to MP goats (Anderson et al., 1981; Knight and Peaker, 1984) and 
cows (Miller et al., 2006). However, the underlying regulatory mechanisms for these 
differences in developmental patterns are not well understood. Metabolic status through the 
lactation period in an animal during its first lactation is different from that in subsequent 
lactation as the animal matures, since nutrients in PP animals are prioritized not only for 
lactation but also for the continued growth of the animal (Wathes et al., 2007). Therefore, 
comparing PP vs MP animals could improve our insight into the regulatory mechanisms that 
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determine mammary remodelling in late gestation and during lactation, and hence potentially 
identify important factors determining lactation performance and persistency.  
In MP dairy cows, renewal of the MEC population during the dry period in between 
successive lactations appears to be crucial to ensure optimal milk production in the following 
lactation (Capuco et al., 1997; Madsen et al., 2008; Remond et al., 1997; Swanson, 1965). 
Omitting the dry period and milking dairy cows continuously from one lactation into the next 
will interfere with MEC cell renewal (Annen et al., 2008; Capuco et al., 1997; Sorensen et al., 
2006) and has been reported to result in a substantial depression (up to 40%) of milk 
production in the next lactation. It remains to be established how and by which mechanisms 
continuous milking during late gestation can interfere with the MEC renewal, preventing the 
MEC population from fully expressing their production potential. The continuously lactating 
mammary gland does appear to be able to respond to systemic lactogenic signals initiating a 
new lactation with increased milk production around parturition (Caja et al., 2006; Madsen et 
al., 2008), and the MEC in the CL gland are capable of undergoing cell renewal (Annen et al., 
2007), and it remains to be established why a simple thing like continued removal of milk is 
interfering with restoration of mammary synthetic capacity in late gestation, when the 
processes involved in this restoration are apparently not inhibited. 
Despite the importance of the mammary microvascular system for sustenance of milk 
synthesis by providing the nutrients and oxygen to MEC and removing the metabolic waste 
products, remodelling of this mammary tissue compartment during the late gestation and 
following lactation period has received virtually no attention in normal mammary 
development of dairy animals (Akers, 2002; Djonov et al., 2001). An experimental animal 
model, with unilateral continuous milking (continuous lactation, CL) of one udder half in the 
late gestation period whilst drying off the other udder half (normal lactation, NL), would be 
useful to get improved insight into the local key regulatory factors involved in the 
remodelling of the mammary gland in the late gestation period and the relative importance of 
the MEC and microvascular compartments in determining lactation performance in the 
following lactation.  
Not only mammary remodelling (capacity of the mammary gland) is important for lactation 
performance, but also the extent to which this capacity can be exploited. Provision of 
nutrients to the mammary gland is an important factor in this respect. Synthetic capacity of 
the mammary gland and hence milk production change from early towards late lactation. 
There are indications suggesting that this is associated with an altered sensitivity of the 
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mammary gland towards variations in e.g. amino acid supply, since correlations between 
arterial concentrations and arterio-venous differences (efficiency of mammary uptake) for 
individual amino acids differed in early compared to late lactation in dairy goats fed different 
levels of lysine and methionine (Madsen et al., 2005).  
Protein synthesis in the mammary gland as in any other tissues relies on energy in the form of 
ATP, and both amino acid and energy supply to the mammary gland could thus limit milk 
protein synthesis. This may in part explain why increased supply of a number of specific 
amino acids have been found to have a positive effect on milk protein production in some 
situations (Hanigan et al., 2001; Rulquin et al., 1993; Weekes et al., 2006), but not always 
(Seymour et al., 1990), when supply of other energy yielding substrates were not increased. 
Acetate is utilized in oxidative phosphorylation of adenosine nucleosides, which results in the 
generation of ATP (Forsberg et al., 1984; Scott et al., 1976), whereas glucose is oxidized 
mainly through the pentose phosphate pathway to yield NADPH required for de novo fatty 
acid synthesis (lipogenesis) (Chaiyabutr et al., 1980; Chaiyabutr et al., 2008). If mammary 
energy supply is a main determinant for protein synthesis, it seems theoretically possible to be 
able to substitute amino acids to some extent in the diet with an energy yielding substrate to 
provide extra ATP in the mammary gland and improve utilisation of the amino acids 
available, but the extent to which this is possible may depend on the stage of lactation and the 
sensitivity of the mammary gland towards nutrient supply.  
Altogether it can be hypothesized that:  
1) differences between PP and MP animals with respect to milk production and lactation 
persistency may be related to differences in mammary growth and remodelling also during 
lactation, 
2) the factors responsible for interfering with mammary remodelling in CL are the same 
factors involved also in determination of lactation persistency and performance differences 
between PP and MP animals, 
3) milk protein synthesis in the lactating mammary gland will be less sensitive towards 
variations in nutrient supply in late compared to early lactation, 
4) minor deficiencies in dietary provision of protein can be compensated by provision of 
energy (ATP) yielding substrates to sustain milk (protein) synthesis. 
The aims of the experimental work in dairy goats were to: 
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I) determine if parity number (PP vs MP) and dry period (CL vs NL) impact mammary gland 
synthetic capacity exclusively through interference with turn over and function of the MEC, 
or if mammary remodelling of the micro-vascular system plays an equally important role, 
II) identify the essential regulatory mechanisms (factors) explaining the differences among 
those different models, 
III) if milk synthesis is more sensitive towards changes in nutrient provision in early lactation 
compared with late lactation, and 
IV) elucidate whether provision of energy (ATP) yielding substrates can compensate for an 
insufficient AA supply to the mammary gland and hence improve overall utilization of AA 
for milk protein synthesis, and if acetate is more efficient than glucose in that respect. 
Altogether, such comparative studies can provide evidence needed to find new avenues for 
the genetic selection and/or management of the dairy animals to increase the economical 
profitability in dairy production industry. In recent years, consumers’ increased demand for 
protein has promoted the value of milk protein production, and environmental concerns have 
placed increased focus on nitrogen utilization in farm animals. There might be a prospect for 
differentiating protein recommendations for ruminants across the lactation period, if milk 
protein production can indeed be sustained in certain stages of lactation through optimisation 
of the provision of energy yielding substrates relative to amino acids.  
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Background 
In order to improve the lactational performance of dairy animals in the future, it is important 
to know what factors limit the production potential of the animal during lactation. It is 
important in this respect to understand the mechanisms that impact on mammary gland 
synthetic capacity through interference with the turnover and function of the MEC and the 
mammary microvasculature during the gestation-lactation period. This section begins with a 
brief outline of the mammary gland and its development, focussing on epithelial cell turnover 
and micro-vascularisation, and on the remodelling of the mammary gland that takes place 
over the course of gestation-lactation. An effort is made to identify the crucial factors 
determining synthetic capacity and hence production potential and lactation persistency. In 
addition, the importance of the nutrient supply for milk synthesis and hence the utilisation of 
the synthetic capacity of the mammary gland, along with the sensitivity of the mammary 
gland towards changes in nutrient provision at different time points in lactation, will be 
discussed.  
 
The mammary gland 
The mammary gland is a secondary sexual organ and a part of the reproductive system 
(Sejrsen, 1994). It has the same overall structure in all ruminant species, with minor 
differences  (goats and sheep have two mammary glands in the udder, as opposed to four  in 
cows. The two udder halves are independent of each other).  
The mammary gland is composed of lobulo-alveolar clusters, emerging from  a branching 
network of ducts which are made by polarized single-layer epithelial cells (McManaman and 
Neville, 2003). Myoepithelial cells and a vascularized connective-tissue stroma containing 
adipocytes and fibroblasts cover the alveoli in the mammary gland.  Figure 1. gives a 
schematic illustration of the mammary alveolar system.  
MEC are the milk synthesizing units in the mammary gland, determining the quality and 
quantity of milk secretion (Akers, 2000). Milk yield is a function of the number of these cells 
as well as their activity. Their number depends on the stage at which the mammary gland has 
developed to, and hence, the previous rate of cell turnover in the gland. At the same time, the 
MEC’s productivity depends on their differentiation as well as their blood supply and on the 
efficiency of exchange of nutrients and waste products across the capillary-MEC barrier. In 
the section that follows the diagram, the key issues pertaining to the mammary gland - such as 
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its development, cell turnover, micro-vascularization, blood supply and metabolism - are 
briefly described. 
 
 
 
Figure 1- Schematic diagram of mammary duct and lobular-alveolar system: a) overall: b) 
cross-section; c) surface and internal anatomy of alveoli (Lawrence and Fowler, 2002). 
 
Development 
The development of the mammary gland may be described following its different stages, 
starting in fetal life, continuing over puberty, and subsequently during the gestation and 
lactation periods. In bovine biology, the growth of the mammary gland starts being isometric 
with other body organs and becomes allometric before puberty, with the first few oestrus 
cycles (Sejrsen, 1994; Sheffield, 1988). After puberty, its growth again becomes isometric, 
growing at a rate parallel to the rest of the body (Sinha and Tucker, 1969). Pubertal mammary 
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growth is important for the future development and ultimate milk-producing capacity of the 
mammary gland (Radcliff et al., 2000; Sejrsen, 1994), and any changes in this period are 
liable to affect the mammary gland potential for milk synthesis in the following lactation 
periods.  
In dairy heifers, parenchymal growth  doubles from day 260 of pregnancy to day 49 of 
lactation; however, the amount of DNA does not change (Keys et al., 1989). Norgaard et al. 
(2008a) have reported that in sheep the major phase of mammary redevelopment (growth and 
differentiation between successive lactations) takes place during late pregnancy, within the 
last 38 days pre-partum, during which period parenchyma in mammary tissue have an 
eightfold increase in weight and an MEC increase from 5 to 19 %. In general, the major 
element of mammary growth in ruminants (mammogenesis) occurs in late pregnancy and 
before the onset of lactation (pre-partum period, lactogenesis): it is then that the formation of 
its lobulo-alveolar structure is initiated (Akers, 2002; Erb, 1977; Tucker, 1987). It has been 
reported that in primiparous dairy goats (Anderson et al., 1981; Knight and Peaker, 1984) and 
cows (Miller et al., 2006), mammary growth also continues into the first early lactation, 
although with a lower speed than during gestation.  Mainly, this is a growth in parenchyma,  
coinciding with a decreased proportion of stroma (Akers et al., 2006; ELsayed et al., 2009). 
Compared to the mammary development in primiparous ruminants, mammary re-
development in  second gestation animals has been shown to have a faster growth of 
parenchymal volume, especially in late gestation  when the gland dries out and  prepares for 
the new lactation (Knight and Wilde, 1993). Within the mammary parenchyma, the 
differentiation of the MEC starts a few days pre-partum and continues till the subsequent peak 
lactation (Annen et al., 2007). When reaching parturition, this differentiation seems to be 
more pronounced in multiparous than in primiparous ruminants (Miller et al., 2006), so that 
less poorly differentiated MEC are evident in the mammary gland of multiparous cows at 
parturition compared to their primiparous counterparts  (Ellis and Capuco, 2002). 
Metabolic status during  the lactation period in the first lactating mammary gland  differs 
from that in the more mature ones, as the nutrients in primiparous (PP) animals are prioritized 
not only for lactation but also for the continued growth of the animal (Wathes et al., 2007). 
Furthermore, multiparous (MP) ruminants have a higher milk yield but lower lactation 
persistency compared to PP ones (Miller et al., 2006). This may be related to differences in 
the development and maintenance of the mammary gland function; as yet the underlying 
mechanisms are not well understood. The differential mammary remodelling in PP compared 
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to MP animals may be related not only to the MEC population but also to the vascular system 
required for nutrient supply and the removal of metabolic waste products. Angiogenesis -  the 
formation of new capillaries from pre-existing blood vessels - is a biological process known 
in other species to be associated with mammary remodelling (Matsumoto et al., 1992). Its 
function is to accommodate highly variable requirements for nutrients and oxygenation with 
respect to changes in mammary tissue composition and metabolic activity (Djonov et al., 
2001). The process has received virtually no attention in discussions of the normal mammary 
development of dairy animals (Akers, 2002), although the coordinated development of 
mammary vascular and epithelial cell function must be assumed to be of the utmost 
importance for normal mammary gland function and performance. Vascular function and 
remodelling may not be the same in PP and MP glands since the pre-partum development in 
either case could be different, since PP animals have not had a previous lactation with a fully 
developed mammary gland. So it is important to elucidate how and to what extent the 
differences in lactational performance between PP and MP mammary glands are related to the 
time-course of development and maintenance not only of the MEC population but also of the 
mammary vasculature which sustains synthetic activity. In addition, we need to identify the 
underlying regulatory factors or mechanisms responsible for such developmental differences 
between PP and MP mammary glands as exist. Knowledge about the mechanisms responsible 
for the regulation of MEC renewal as well as the remodelling of the mammary 
microvasculature can be of assistance in finding new ways to improve lactation persistency 
and overall lactational performance,  to the ultimate economic benefit of producers. 
In multiparous dairy herds, it has been shown that the mammary glands of cows continuously 
milked throughout the pre-parturient period have fewer secretory cells prior to calving, and  a 
more stable epithelia-to-lumen ratio,  than do cows that were dried off in that period, even 
though the total parenchymal mass was not affected by the pre-partum milking (Capuco et al., 
1997). In addition,  differentiation of MEC seems to be more important than  their number in 
early lactation; this is what causes the differences in productivity between dairy and beef 
animals (Akers et al., 2006). According to Wilde et al. (1986), the increase in milk yield 
observed after parturition in early lactation can be explained by a higher rate of cell 
differentiation resulting in a higher cell number and synthetic capacity in the gland. Likewise, 
it is suggested that the reduction in milk yield after peak of lactation can be accounted for by a 
decrease in MEC number rather than because of secretory activity per cell. So, depending on 
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the stage of lactation, MEC number and/or its secretory ability seem to be the main 
determinants of mammary gland synthetic capacity. 
In multiparous ruminants, the dry period is necessary for a full restoration of mammary 
synthetic capacity in the next lactation (Capuco et al., 1997; Remond and Bonnefoy, 1997; 
Swanson, 1965). According to previous studies (Akers, 2002; Bachman and Schairer, 2003; 
Capuco et al., 1997; Hurley, 1989; Smith and Todhunter, 1985), the dry period can be divided 
into three stages: 1) early dry period, when milk synthesis comes to an end and the gland 
status changes from lactating to non-lactating in the absence of the suckling/milking stimulus. 
At this stage, involution is dominant with regression of the MEC and gland structures,  
involving apoptosis and tissue remodelling; 2) mid dry period, when the involution process is 
complete and the non-lactating gland morphology remains relatively stable, and, 3) late dry 
period, when redevelopment of the mammary tissue and lactogenesis happen prior to and 
around parturition and initiation of the next lactation. The dry period appears to be essential 
for dairy animals to ensure that the MEC population can be effectively renewed at the end of 
one lactation and prior to onset of the next (Capuco et al., 1997);  it is crucial in ensuring 
optimal milk production in the following lactation in dairy cows (Madsen et al., 2008; 
Remond et al., 1997; Swanson, 1965). It has been shown that omitting the dry period while  
milking dairy cows continuously from one lactation into the next will interfere with MEC cell 
renewal (Annen et al., 2008; Capuco et al., 1997; Sorensen et al., 2006) and result in milk 
yield depressions of 20% or more in the following lactation (Madsen et al., 2008; Remond et 
al., 1997; Swanson, 1965).  Relatively few studies have been performed on continuous 
lactation (CL) in dairy goats, and the impact of omitting the dry period on milk production in 
the next lactation in this species appears to be less clear. Fowler et al. (1991) and Mackenzie 
(1967) report that CL has no negative effect on milk yield in subsequent lactations. However, 
the experimental design by Fowler et al (1991) included an unusually long dry period of 24 
weeks. In contrast to this, Caja et al. (2006) reported decreases in milk production of 29% in 
dairy goats in response to omitting the dry period. To our knowledge, there have been no 
previous studies showing how CL impacts on MEC turnover in the goat, and the impact of CL 
on the  remodelling of the microvascular system has not been studied in any species so far.  
 
Cell turnover 
Rather than the size of mammary gland, the best indicator of its synthetic capacity is the 
relative proportion of its secretory tissue, ie. MEC (Boutinaud et al., 2004; Capuco et al., 
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2003; Knight, 2000). The MEC population depends on an earlier balance between  cell 
proliferation and apoptosis, and different degrees of activity in these two events involved in 
cell turnover could issue in an equal number of cells (Capuco et al., 2001). Knight and Peaker 
(1984) have reported that each stage of gestation-lactation in dairy goats has its own 
characteristics with respect to changes in secretory cell number and productivity (fig. 2). As 
discussed above, the dry period appears to be essential for dairy animals to ensure that the 
MEC population can be effectively renewed as one lactation comes to the end and another one 
begins (Capuco et al., 1997). Pre-partum milking does not prevent cell turnover (renewal) in 
the late gestation period, but obviously limits the extent of such a renewal (Capuco et al., 
1997). The MEC is also capable of responding to lactogenic signals around the time of 
parturition;  it may initiate a new lactation, since parturition is associated with an increase in 
milk production resembling the pattern of change in milk production following a normal dry 
period (Madsen et al., 2008; Remond et al., 1997). It has as yet not been possible to establish 
through which key regulatory factors or processes CL interferes with mammary 
redevelopment, and why continued removal of milk throughout the late gestation period is 
incompatible with the re-establishment of full lactational capacity in the subsequent lactation 
(Caja et al., 2006; Madsen et al., 2008). Yet these underlying mechanisms and regulatory 
factors are obviously crucial for the remodelling of the mammary gland during late gestation 
in order to allow it to reach the optimum lactational performance.  
 
 
Figure 2- Diagram of lactation curve, mammary secretory cell number and milk yield per cell 
during lactation in dairy goats (Knight and Peaker, 1984). 
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In the following section the general concepts of cell proliferation and apoptosis are explained 
briefly, and key regulatory factors are identified that could potentially be affected by CL as 
well as being involved in the different developmental patterns observed in the mammary 
glands of PP vs MP animals. 
 
Proliferation concepts. Proliferation is a process by which a new cell is produced from a pre-
existing cell. The cell cycle of mitotic cells has two major phases (King et al., 1996; 
Vermeulen et al., 2003): 1) M (mitosis), the process of nuclear division, including prophase, 
metaphase, anaphase and telophase; and, 2) interphase, the process between two M phases, 
including G0 (resting), G1 (first gap), S (synthesis) and G2 (second gap).  
New cells resulting from mitosis either go directly to G1 or else enter G0. In G1, the cells grow 
in size, become resting or get prepared for DNA synthesis. After this they move into the G0 
phase and rest until the time when they are able to get back into the cycle, either returning 
back to the G1 phase again, or else continuing into the S phase where the DNA is duplicated. 
After the S phase, the cell enters G2 where it synthesises the needed proteins to progress to M 
phase. Control mechanisms for these phase transitions play an important role in cell 
proliferation (Norgaard, 2007). The mechanisms in question require a variety of proteins to be 
able to regulate the progress of cell cycle towards proliferation. 
 
Apoptosis. Apoptosis is a programmed process leading to the death of a cell. Its mechanisms 
work  to limit cell numbers, excluding unnecessary and aged cells, and eliminating potentially 
detrimental classes of cell (Strange et al., 1992). Some characteristics of apoptotic cells can be 
distinguished microscopically such as cellular shrinkage, cellular budding, condensed 
nuclei/chromatin/cytoplasm, fragmented nuclei, and unsettled plasma membrane including 
apoptotic bodies (cell organelles and/or nuclear material surrounded by an intact plasma 
membrane) which have been phagocytised by adjacent cells and macrophages (Van Cruchten 
and Van den Broeck, 2002). Furthermore, what makes apoptosis different from other cell 
death processes such as necrosis is that, in apoptosis, no inflammatory responses are visible, 
nor is membrane integrity lost (Proskuryakov et al., 2003; Van Cruchten and Van den Broeck, 
2002). Apoptosis uses two regulatory pathways (Norgaard, 2007): 1) extrinsic, by which the 
binding of extra-cellular proteins to death receptors on the cell surface activates the process 
(Maher et al., 2002); and, 2) intrinsic, where mitochondia plays a crucial function in cell 
survival and cytochrome c release (Waterhouse et al., 2002). In general, the initiation of 
[26] 
 
apoptosis involves particular stages of cell differentiation and thereby a limitation in  the 
factors required for cell viability  (Strange et al., 1992; Williams et al., 1990). 
 
In the following section, factors believed to be important determinants in cell turnover and 
differentiation in the MEC, are introduced. These could potentially be involved in 
determining differences in remodelling the mammary gland 1) subjected to CL or else 
allowed a dry period (NL) in late gestation and 2) between PP and MP animals. 
 
BCL2 and BAX. It seems clear that BCL2 and BAX  have independent functions as survival 
and death factors, respectively (Reed, 1998). The expression of the pro-apoptotic agent BAX 
and the anti-apoptotic agent BCL2 has been studied in the mammary gland of dairy cows 
(Norgaard et al., 2008b) and of goats (Wareski et al., 2001). In dairy goats, Wareski et al. 
(2001) reported the lowest expression of BAX during peak lactation and the correspondingly  
highest expression in late lactation and the dry period; at the same time, there was a gradual 
increase of BCL2  expression from early to late lactation and evidence of it remained high 
during the dry period. The BAX/BCL2 ratio in the mitochondrial membrane seems to 
determine whether a cell undergoes apoptosis or survives (Schultz and Harrington, 2003). It 
follows from this that their expressional changes might help account for the level of cell 
turnover in the mammary gland. 
Cyclin D1. Cyclin D1 (CCND1) has a role in the regulation/initiation of cell proliferation, and 
its expression is essential for cell cycle progression past the restriction point in G1 into the S 
phase. Its continuous synthesis is dependent on persistent growth factor stimulation (Norgaard 
et al., 2008a; Sherr, 1995). CCND1 has been studied in the mammary glands of dairy cows 
(Norgaard et al., 2008b) and of sheep (Norgaard et al., 2008a), where the results show a 
higher expression during gestation - specifically during the dry period - compared to lactation.  
IGF family. IGF1 plays an important role as an anti-apoptotic survival factor in cell turnover 
during mammary gland development and remodelling during involution (Allan et al., 2004).  
Its receptor impacts growth and inhibits apoptosis (Baumrucker and Erondu, 2000). In 
general, the interaction of IGF1 and its receptor promotes cell proliferation and survival (Sell 
et al., 1995). Sell et al. (1995) have demonstrated the role of IGF1R as an inhibitor of 
apoptosis, independent of its mitogenic actions. IGF binding protein 3 (IGFBP3), a multi-
functional protein, acts as a pro-apoptotic factor either independently from IGF1, or else 
serving as a transporter of IGF1, which in the mammary gland can be released from IGFBP3 
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in order to exert its action after binding of the IGF1-IGFBP3 complex to lactoferrin 
(Baumrucker et al., 2003; Butt and Williams, 2001; Grill and Cohick, 2000). Since it 
possesses  the ability to inhibit cell proliferation and IGF1 action, it is thought that IGFBP5 
may induce apoptosis in the mammary gland (Allan et al., 2004). In general, the IGF1 family 
members could play important roles in mammary remodelling, as their presence and actions 
are involved in related processes. 
TGFB family. TGFB1 is another anti-proliferative and apoptogenic factor for MEC (Wareski 
et al., 2001);  its two receptors, 1 and 2, mediate its effects (Akers, 2006). It seems that 
TGFB1 expression in goat mammary gland is low during early lactation, increases in late 
lactation and remains high during the dry period (Wareski et al., 2001); whereas in heifers its  
expression is low during lactation and  high during involution (Plath et al., 1997). It seems to 
follow from this that it might play an important role in the dry period when the main part of 
mammary involution occurs. 
Prolactin receptor. The prolactin receptor (PRLR) activates several pathways associated with 
proliferation, differentiation, and lactogenesis after binding with prolactin (Wall et al., 2006). 
While it has been suggested that the concentration of prolactin in plasma may be of less 
importance for development of mammary gland in cows, the level of its receptor in the 
mammary gland could well be of importance in mammary cell turnover and differentiation in 
ewes (Cassy et al., 2000) and in rodents (Neville et al., 2002).  
Alpha-lactalbumin. Alpha-lactalbumin (LALBA), a key enzyme in lactose synthesis, is a 
good indicator of lactogenesis as its expression increases sharply around the time of 
parturition when lactation is initiated (Forsyth and Neville, 2009; McFadden et al., 1987). The 
enzyme is also known to be a pro-apoptotic protein (Riley et al., 2008). 
Lactoferrin. Lactoferrin (LTF) is known to be involved in the immune system as well as 
helping govern the induction of cellular growth and differentiation (Ward et al., 2005).  It is 
highly expressed during late pregnancy, involution and infections (Baumrucker, 2005). 
Further, it has been shown to be a specific receptor for IGFBP3, while binding of the IGF1-
BP3 complex to lactoferrin will reduce the affinity of BP3 for IGF1(Baumrucker et al., 2003). 
In this way lactoferrin also plays a role in directing the action of systemic IGF1 towards the 
mammary gland. 
Leptin.  The inhibitory role of leptin on proliferation of mammary epithelial cells has been 
suggested by Silva et al. (2002). Leptin levels in milk have been reported to increase 
markedly two days after parturition in dairy goats and independently of changes in plasma 
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leptin (Chilliard et al., 2001; Rasmussen et al., 2008); this led to the suggestion that leptin and 
its receptor may play a role in mammary development and function in the early postpartum 
period in goats.   
 
Microvascularization 
Angiogenesis is a process whereby new capillaries are formed from pre-existing blood vessels 
(Djonov et al., 2001). As explained above, the process is important not only for mammary 
growth, but also for the maintenance and function of the mammary gland (Pepper et al., 
2000a). According to an unproved hypothesis put forward by Akers (2002) concerning  
ruminants, and as also indicated in studies about rodents (Nishinak, 1970; Soemarwoto and 
Bern, 1958), steroid hormones such as estrogen and progestrone may stimulate growth of the 
mammary microvasculature as well as the mammary parenchyma. In most organs the 
angiogenic potential is only triggered in response to injury, whereas in the mammary 
parenchyma, the microvasculature is persistently regulated (Djonov et al., 2001). Mammary 
microvasculature indirectly plays a very important role for milk synthesis by providing 
nutrients and oxygen to the MEC essential to sustain milk synthesis, and by removing 
metabolic waste products (Djonov et al., 2001). Based on studies in mice (Djonov et al., 2001; 
Matsumoto et al., 1992), it seems that regression of mammary microvasculature mainly 
occurs during involution in late gestation pre-partum, while angiogenesis, and the meandering 
of the capillaries surrounding the alveoli, occurs mainly during lactation. It has been 
suggested that this meandering of capillaries is advantageous in increasing the 
microvasculature contact with the alveoli, which is most extensive at the peak of lactation in 
mice (Matsumoto et al., 1992). Pepper et al. (2000a) proposed the MEC as the main source of 
angiogenic factors in the mammary gland, which ensures a coordinated development of the 
microvasculature according to development of the MEC population. Djonov et al. (2001) have 
suggested that prepartum regression of the endothelium in the mouse mammary gland could 
be related to, or even a consequence of, MEC involution. Whatever comes first, either 
vascular or alveolar degeneration, it seems evident that the function and integrity of the MEC 
is dependent on and closely coordinated with the vascular system responsible for the 
provision of nutrients and the removal of waste products, all of which are essential to sustain 
MEC metabolism. Yet despite the importance of mammary microvasculature surrounding 
alveoli, there is virtually no information available for dairy animals regarding the normal 
remodelling of the mammary microvasculature during the gestation-lactation period (Akers, 
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2002; Pepper et al., 2000a). Also as yet unknown are which kind of mechanisms are involved 
in remodelling of mammary microvasculature; what difference it makes in PP compared to 
MP dairy goats; and whether having a normal dry period or not during the late gestation 
period might interfere with this remodelling of the mammary microvasculature.  
 
In the following section, some of the factors that are believed to of crucial importance in the 
regulation of remodelling/angiogenesis and the function of  mammary microvasculature, and 
which could potentially be involved in determining differences between CL and NL as well as 
PP and MP animals, are introduced. 
 
VEGF family. Vascular endothelial growth factor, known to be the most potent factor in 
angiogenesis, possesses vascular permeability-inducing properties. Its receptor 1 regulates the 
mitogenic, and receptor 2 the permeabilizing, activity of VEGF, at the same time as receptor 1 
has negative regulatory effects on receptor 2 (Conway et al., 2001). It seems from this that 
they might play an important role in mammary microvasculature remodelling, especially pre-
partum, before initiation of a new lactation. 
Angiopoietin family. ANGPT1 is involved in maturation of blood vessels; it regulates the 
formation and stabilization of the blood vessel network. ANGPT2 destabilizes the vasculature 
and thereby initiates angiogenesis in the presence of VEGF (Conway et al., 2001). Both 
ANGPT1 and ANGPT2 compete for their tie2-receptor (RTK). They might play an important 
role not only in the initiation of angiogenesis especially around parturition time, but also have 
an impact on lactational performance by regulating the formation and stabilization of the 
mammary microvasculature. 
Prostanoids. Cyclooxygenase 1 and 2 are believed to have role in angiogenesis, regulating 
arterio-venous differentiation, and contributing to the production of prostaglandins and 
thromboxane (Claria, 2003),  potent vasoactive substances involved in local regulation of 
blood perfusion. Prostocylin I2 synthase (PTGIS) regulates the synthesis of PGI2, an arterial 
vasodilator; and thromboxane synthase regulates synthesis of TBXA, a venous 
vasoconstrictor that also affects vascular permeability (Claria, 2003). These two prostanoids 
might have role in regulation of mammary synthetic or secretory activity (Nielsen et al., 
2004b) in  addition to their role in regulation of vascular tone and blood perfusion.  
Carbonic anhydrase. CA4 is believed to be the endothelial isoform of carbonic anhydrase, 
which catalyses the reversible hydration of CO2 to HCO3- and H+. It is positively correlated 
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with mammary gland synthetic activity in goats (Cvek et al., 1998), which suggests it could  
play a role in the sustenance of mammary secretory activity. 
 
Milk synthesis 
Mammary remodelling (capacity of the mammary gland) is important for lactation 
performance; and so is the extent to which this capacity can be exploited. In this respect, one 
needs to look at the provision of nutrients to the mammary gland. Nutrient supply for the 
synthesis of milk may affect milk production differently in early and later lactation when the 
capacity of the mammary gland has changed, and the priority of the mammary gland in the 
provision of nutrients relative to other tissues has also changed (see previous discussion). 
Nutrients are supplied to the mammary gland by the blood, from which they are taken up by 
MEC and converted into the milk constituents:  lactose, fat and protein (fig. 3) (Madsen, 
2002). Hence MEC is  an important “biological factory”, second in importance only to 
photosynthesis in sustaining mammalian life (Bauman et al., 2006; Patton, 1969).  
 
In the following section, the processes involved in milk synthesis and the conversion of 
nutrients supplied to the gland into milk components, are discussed. The sensitivity of the 
mammary gland towards changes in nutrient provision during the course of lactation, is also 
considered. 
 
Lactose synthesis. Lactose is a disaccharide composed of one glucose and one galactose unit, 
and is the dominant sugar of ruminant milk. Lactose synthesis is regulated by factors 
controlling the mammary gland synthetic capacity and therefore follows the general shape of 
the lactation curve (Uden and Danfaer, 2008). Lactose is the major osmotic factor in milk, 
determining the milk yield by controlling its volume (Knight et al., 1994; Riley et al., 2008). 
The major part of glucose taken up by the mammary gland (60-85 %) is converted to lactose 
in MEC of dairy cows and goats (Bickerstaffe et al., 1974; Nielsen and Jakobsen, 1993). 
However, it has been reported that in dairy goats  mammary glucose uptake is  related neither 
to long term nor to acute changes in the supply of glucose to the mammary gland (Nielsen et 
al., 2001). Rather, according to Bauman and Davis (1974), Kuhn (1983) and Madsen (2002),  
the availability of glucose in MEC for lactose synthesis depends on glucose transportation 
into the cell, as well as on its distribution in different pathways such as 1) lactose synthesis 
representing the most important fate, 2) the pentose phosphate cycle, providing NADPH for 
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de novo fatty acid synthesis, 3) glycolysis, providing glycerol-3-phosphate (which contributes 
in TG formation) and pyruvate (which contributes in ATP production); and finally 4) 
tricarboxylic acid cycle, providing alpha-keto acids for the formation of amino acids. The 
final step in lactose synthesis is catalysed by the enzyme complex lactose synthase, which 
consists of the catalytic subunit galactose transferase plus a modifying unit, the milk whey 
protein α-lactalbumin, which alters substrate affinity of galactosyl transferase to become 
capable of transferring a galactosyl group to free glucose and hence to create lactose (Akers, 
2002). As previously mentioned, α-lactalbumin is up-regulated closely coordinated with the 
onset of lactation and is therefore a good marker of lactogenesis.  
 
Fat synthesis. The main part of milk fat consists of triglyceride (TG; >95%) droplets which 
are coated with a milk fat globule membrane containing smaller amounts of phospholipids 
and cholesterol. In ruminants, there are over 400 different fatty acids secreted in milk fat TG, 
and the fatty acid composition depends on both the dietary manipulation of the animal as well 
as on the stage of lactation. The fatty acids incorporated into milk TG come from two major 
sources in ruminants (Akers, 2002; Jenness, 1974; Lock and Bauman, 2004): 1) direct uptake 
from TG and NEFA supplied by the blood, consisting mainly of long chain fatty acids (C16 
and all ≥ 18 carbons),  2) de novo synthesis of short and medium chains (C4-C14) and part of 
16 carbon (C16) fatty acids within the mammary gland from acetate (C2) and BHB (C4) 
taken up from the blood. Glucose via acetyl-coenzyme A on the other hand does not 
contribute to any significant extent to de novo fatty acid synthesis in ruminants, but only to 
the synthesis of the glycerol backbone. Lipids absorbed either from the digestive tract or 
synthesised in the liver are provided to the mammary gland in the form of lipoproteins 
(chylomicrons and very low density lipoproteins, respectively). Fatty acids can be released 
from these lipoproteins and be taken up by the mammary gland upon hydrolyses of TG by the 
mammary capillary wall enzyme, lipoprotein lipase (LPL), which converts TG to glycerol and 
fatty acids; these in turn can be taken up by the MEC (Lock and Bauman, 2004). NEFA 
originating from the body fat reserves are taken up by the MEC directly by passive diffusion. 
Plasma NEFA content, and hence energy balance, is thus highly correlated to milk fat content 
in milk (Chilliard et al., 2003). This explains why after parturition and in early lactation, when 
the animal is generally in a negative energy balance, milk fat content is high with a high 
proportion of C18:0 and C18:1 (Chilliard et al., 2003).  When lactation peaks in dairy goats, 
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fat content drops (Chilliard et al., 1986; Mioc et al., 2008),  the animal’s feed intake increases, 
and the proportion of nutrients allocated for milk synthesis falls. 
 
Protein synthesis. Milk has two major protein fractions (Akers, 2002; Ambrosoli et al., 1988; 
Bequette et al., 1998; Law and Brown, 1994): 1) Casein (αs-, β-, κ- and γ-casein) (about 80% 
of milk proteins), a hydrophobic globular protein present in milk as a colloidal suspension, 
and 2) whey proteins or milk serum proteins (α-lactalbumin, β-lactoglobulin and proteose-
peptones). Milk proteins are synthesized from amino acids derived from the blood supply. 
The ratio of mammary uptake of amino acid nitrogen compared to output of amino acid 
nitrogen in milk protein is about 1:1 (Bequette et al., 1996; Bickerstaffe et al., 1974; Guinard 
and Rulquin, 1994a; Guinard and Rulquin, 1994b; Madsen, 2002; Mepham, 1982). There is 
still however an excess uptake of certain essential amino acids (EAA) which in the mammary 
gland are used to synthesize nonessential amino acids (NEAA) (Akers, 2002). This indicates 
the role of EAA as amino group donors in transamination reactions where NEAA are 
synthesised de novo (Bequette et al., 1998; Madsen et al., 2005; Mepham, 1982). Generally 
(Bequette et al., 1998; Madsen, 2002; Mepham, 1982; Rudolph et al., 2007), intracellular 
amino acids contribute by: 1) being polymerised on ribosomes attached to the endoplasmic 
reticulum in MEC to form the milk protein (the most important fate), 2) synthesing the 
structural proteins and enzymes, and 3) producing ATP, NADPH and glycerol-3-phosphate  
via deamination to α-keto acids and oxidation processes in the citric acid cycle. 
As previously described, when supply of other energy-yielding substrates is not increased,  an 
increased supply of specific amino acids has been found to have a positive effect on milk 
protein production -  in some situations (Hanigan et al., 2001; Rulquin et al., 1993; Weekes et 
al., 2006), but not all (Seymour et al., 1990). Milk protein synthesis in the mammary gland 
relies on energy in the form of ATP, and a shortage of nutrients to provide this energy supply 
may result in a poorer utilisation of amino acids supplied to the mammary gland. Acetate and 
glucose are the major energy suppliers to the mammary gland. Acetate is utilized in oxidative 
phosphorylation of adenosine nucleosides; this process generates predominantly ATP 
(Forsberg et al., 1984; Scott et al., 1976), in contrast to the situation where glucose is oxidized 
mainly through the pentose phosphate pathway to yield the NADPH required for de novo fatty 
acid synthesis (lipogenesis) (Chaiyabutr et al., 1980; Chaiyabutr et al., 2008). It is likely that 
supply to the mammary gland of energy in the form of ATP limits protein synthesis and hence 
the efficiency of the amino acids provided to the mammary gland. Conversely, it should be 
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theoretically possible to substitute amino acids in the diet to some extent and sustain milk 
protein synthesis by optimizing provision of energy-yielding substrates to provide extra ATP 
in the mammary gland, and at the same time improve the overall utilization of amino acids 
available to the animal. In an experiment with goats fed different levels of rumen-protected 
lysine and methionine, rather close correlations were observed between arterial concentrations 
for individual amino acids and the arterio-venous differences (AVD) across the mammary 
gland for these amino acids (Madsen et al., 2005). However, the magnitude of change in AVD 
over a given range of arterial concentrations was smaller in early as opposed to late lactation, 
indicating that the sensitivity of the mammary gland towards variations in amino acid supply 
may be different at different stages of the lactation process. Changes in mammary synthetic 
capacity during the course of lactation may determine to what extent amino acids may be 
substituted by energy-yielding (ATP) substrates without negative consequences for milk 
(protein) production. 
 
 
Figure 3- Simple diagram of conversion of nutrient uptake into milk components, modified 
from Cant et al. (2003; Madsen, 2002) 
 
In conclusion, it remains to be established:  
1) which factors are responsible for the changes in growth and remodelling of MEC and 
particularly the mammary microvasculature during gestation-lactation,  
2) the role of the mammary microvasculature in determining lactation performance and 
persistency, 
3) whether  the  factors which can account for different developmental patterns between PP 
and MP animals in early lactation, are also the factors responsible for the impaired mammary 
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(re)development in animals subjected to continued milking as opposed to animals allowed a 
normal dry period in late gestation, 
4) whether changes in mammary synthetic capacity during lactation influence the extent to 
which amino acid supply to the mammary gland can be compensated by provision of energy-
(ATP)-yielding substrates to sustain milk (protein) synthesis. 
 
Knowledge on all these issues is important for future attempts to find new ways to improve 
lactation persistency and the overall lactation performance of dairy animals. 
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Methodology 
It was aimed to: 1) determine the impact of parity number (PP vs MP) and dry period (CL vs 
NL) on mammary synthetic capacity through interference with cell turnover and function of 
MEC and microvasculature, and identify the involved regulatory factors, 2) Elucidate if milk 
(protein) synthesis is more sensitive towards variations in nutrient supply in the early 
compared to late lactating mammary gland, and whether provision of energy yielding 
substrates (acetate vs glucose) can compensate for an insufficient amino acid supply to the 
mammary gland and hence improve overall milk (protein) synthesis. These aims have been 
addressed in three experiments with dairy goats. The experiments were carried out at the 
experimental facilities either at Rørrendegård in Høje Taastrup or at Frederiksberg campus, 
Faculty of Life Sciences, University of Copenhagen, Denmark, and approved by the Danish 
Animal Experimentation Inspectorate, and complied with the Danish Ministry of Justice laws 
concerning animal experimentation and care for experimental animals. In the following after a 
short introduction of each experiment, the main methods and techniques used in those 
experiments are presented. 
 
Experiment 1. Omitting the dry period: effects on mammary remodelling and metabolic 
activity (papers 1 and 2)  
During years 2004-2006, nine dairy goats were used followed over one (5 goats) or two 
consecutive (4 goats) pregnancy-lactation periods. Goats were previously surgically prepared 
with exteriorized carotid arteries and milk veins. They were fed according to Danish 
requirements and milked manually (at 09:00 and 15:30) and fed twice a day (at 07:30 and 
14:30), half the ration being given at each feeding. The experimental design was a 
randomized complete block design; the two udder halves in each animal were randomly 
assigned to two different treatments: one udder half was dried-off approximately 9 weeks pre-
partum (normal lactation; NL), and the other udder half of the same goat was milked 
continuously (continuous lactation; CL) until parturition. Samplings were performed at 
different time-points during gestation and lactation: just before the NL gland was dried off 
(before dry period); within the first 2 weeks after drying-off (only NL glands); in the mid-dry 
period; within the last 2 weeks prior to parturition (late dry period); and at days 1 (day of 
parturition); 3; 10; 60; and 180 of lactation. At each sampling time, two blood samples were 
obtained from the exteriorized carotid artery and each of the milk veins after the afternoon 
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and following morning milkings, and mammary biopsies were obtained from each udder half 
after the morning milking. Half udder milk yields were recorded. 
 
Experiment 2. Parity number: effects on mammary remodelling (paper 3) 
The experiment was conducted during years 2004-2006. Mammary biopsies were obtained 
from both mammary glands of 3 primiparous (PP) and 6 multiparous (MP) (≥2 parity) dairy 
goats at parturition (d1), days 10, 60, and 180 of lactation. The 3 PP goats were followed in 
their subsequent 2nd lactation in the second year of the experiment. Feeding and milking was 
done as described for  experiment 1. 
 
Experiment 3. Continuous intravenous infusion of nutrient substrates: effects on mammary 
metabolic activity in early and late lactating dairy goats (paper 4) 
This experiment was conducted in autumn 2007- early spring 2008 when goats were in late 
lactation (157±9 days postpartum) and in their following early lactation (21±1 days 
postpartum), respectively. At each stage, there was a pre-trial period of 4 weeks, where the 
goats became adapted to the less palatable parts of the diet, and to ensure equilibration of the 
rumen environment prior to initiation of the experimental treatments. The early and late 
lactating dairy goats were fed a basal diet deficient in energy (fulfilling 90% of requirements 
for NE) and protein (fulfilling 80% of requirements for Amino Acids Absorbable from the 
small intestine), according to the body weight and milk yields recorded in the last of the 4 pre-
trial weeks, and based on the Danish feeding standards (Strudsholm et al., 1999), which are 
consistent with the nutrient requirements of dairy goats, as reported by Sauvant and Morand-
Fehr (1989).  Goats were randomly allocated to 4 treatments in a balanced 4 x 4 Latin Square 
design. The goats were milked and fed the restricted basal diet in two daily meals (at 07:00 
and 17:00 h) during the first 3 days of each infusion period, and every 4 h for the last 24 h 
during the sampling period. The treatments consisted of 4 d (96 h) continuous intravenous 
infusions of isoosmotic solutions at pH 7.4 of saline as control, essential amino acids, sodium 
acetate and glucose with a 3 d rest period between each treatment. The essential amino acid, 
acetate and glucose infusions were designed to be isoenergetic calculated from the theoretical 
yield of ATP upon complete oxidation of the nutrients infused intravenously. Simultaneous 
arterio-venous blood samplings over each udder half (gland) were performed every 4 h during 
the last 24 h of infusion. Feed refusals from the last 24 hours of each infusion period were 
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collected. Milk yields were recorded at each milking, and proportionate milk samples were 
obtained from each milking during the last 24 h of each infusion period. 
 
For both experiments 1 and 2, mammary morphology was characterised in biopsies by 
quantitative histology, and cell turnover was determined immunohistochemically (TUNEL 
and Ki-67). Transcription of genes encoding for factors involved in mammary epithelial cell 
(MEC) turnover and vascular function was quantified by quantitative reverse transcription 
PCR. In experiments 2 and 3, immediate determination of acid-base parameters was done on 
whole blood, and plasma was analyzed for selected metabolites and hormones. In the 
following, the main used methods and their general concepts are discussed. 
 
Animal model 
All experiments were conducted on dairy goats. Goats have often been used as experimental 
models for dairy cows in lactation studies due to their low cost and their similar selection for 
high milk production as dairy cattle (Anderson et al., 1981), but dairy goats appear to differ 
from dairy cows for instance in their ability to sustain extended and continuous lactation 
(omission of the dry period) (Fowler et al., 1991; Mackenzie, 1967). Observations from dairy 
goats may therefore not be directly applicable to the dairy cow and vice versa. Species 
comparisons are however fruitful as they can contribute to elucidate general physiological 
mechanisms underlying mammary function for instance in relation to lactation persistency. 
 
Unilateral model. As suggested by Annen et al (2004), the udder halves within each animal 
can be used as individual experimental units. By such an approach, the animal can be used as 
its own control, since both udder halves within an animal have the same genetic heritage and 
are subjected to the same systemic regulatory factors such as nutrients and endocrine 
hormones, especially the circulating growth factors (Annen et al., 2004; Bachman and 
Schairer, 2003). Therefore, it makes it a reasonable approach to study local regulatory 
mechanisms within each udder half subjected to different treatments, and minimizes the 
number of experimental animals required compared to when the whole mammary gland 
between different animals are to be compared. It must, however, be considered that one udder 
half may have a certain impact on the function of the other (Annen et al., 2004; Capuco and 
Akers, 1999). Thus, when only one udder half is dried off, both milk yield (Hamann and 
Reichmuth, 1990; Henderson and Peaker, 1983), and growth (Capuco and Akers, 1990) 
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increases in a compensatory way in the lactating gland within the same udder, and the 
involution is partially inhibited in the gland which is not lactating (Akers and Heald, 1978; 
Akers and Keys, 1985). Pre-partum milking advances lactogenesis and milk production 
(Akers and Heald, 1978). While one gland is milked prepartum, this could possibly affect the 
nonlactating gland within the same udder, having a premature milk synthesis without 
removal, which might affect its subsequent lactation (Capuco and Akers, 1999). As Capuco 
and Akers suggested (1999), this could either result in a positive effect on the continuously 
milked gland or a negative effect on the dried gland within the same udder. However, the 
experimental approach with unilateral drying-off of one gland whilst continuously milking the 
other throughout the late gestation period, appears useful in the attempt to identify 
remodelling events responsible for determination of lactation performance in the subsequent 
lactation and identification of the potential key regulatory factors involved. 
 
Biopsy technique. There have been a number of studies in dairy cows (Capuco et al., 1997), 
goats (Fowler et al., 1991) and sheep (Norgaard et al., 2008a), where animals were sacrificed 
at different time points during the pregnancy-lactation cycle to determine characteristics of  
the mammary gland. This is obviously the most correct way of truly assessing the total 
composition of the gland. But the main disadvantage of such an approach is the large inter-
animal variation (Knight and Peaker, 1984), and the associated costs due to the need of high 
numbers of animals. Another disadvantage of this method is that the patterns of 
metabolic/cellular changes in the mammary gland can not be followed in the same animal 
over the course of time. Obtaining smaller biopsies of the mammary gland is an alternative 
approach, which has been used in several experiments with dairy cows (Miller et al., 2006), 
goats (Caja et al., 2006) and sheep (Norgaard et al., 2008a). This method (see appendix 1) 
allows samplings from the mammary gland of the same animal at different stages of 
pregnancy-lactation. Such a technique is preferred when changes within the mammary gland 
over the course of e.g. lactation are to be followed in the same animals, and the number of 
animals needed can be limited. The repeated biopsy sampling does apparently not affect milk 
production over a long-term period (Knight and Peaker, 1984). When obtaining small biopsies 
from a large organ like the ruminant udder, not all parts of the organs will have the same 
chance of being sampled, and therefore the biopsy samples may not be entirely representative 
of the whole organ. In experiments 1 and 2 we worked with adult goats which had 
experienced at least one parturition, and hence one complete period of mammary development 
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during pregnancy. The mammary gland in such animals can be assumed to be composed 
mainly of parenchymal tissue (Knight and Wilde, 1993), which was the main target of our 
study. Therefore, it should be possible by the biopsy procedure to get fairly representative 
samples of parenchymal tissue. The advantage of the mammary gland in general in this 
respect is that the tissue structures within the part of the gland that was sampled (see papers 1 
and 3) have a fairly random orientation by nature and is composed of sphere like alveoli 
surrounded by the other tissue components. Hence, tissue structure in mammary biopsies 
obtained by our approach can be assumed to be fairly isotropic (randomly distributed), which 
is a requirement in unbiased stereology (Gundersen et al., 1988; Howard and Reed, 2005).  
 
Histology 
To be able to look into qualitative as well as quantitative changes of mammary tissue 
components, histological studies were performed (table 1, see also appendices 2 and 3). An 
interval of at least 30 µm between studied successive tissue sections was ensured so that 
individual cells were not recounted. Furthermore, a randomized direction of the sections on 
the slides was considered to make the further evaluations as unbiased as possible. The 
individual tissue sections were not numbered when cut, which would have made it possible 
for us to calculate the height of the same targeted object between two slides. Therefore, we 
were not able to calculate 3D volume density of the components we had in our tissue slides. 
Different duration of the staining steps, as well as different duration of being exposed to a 
fixative like ethanol, can affect the rate of tissue shrinkage. Every precaution was taken to 
ensure that all the samples were treated in the exact same way. For qualitative morphology, 
two staining methods, H&E and PAS, were chosen (briefly explained in appendices 4 and 5). 
When counting the different tissue fractions, stereological procedures were followed, using an 
unbiased counting frame, designed according to Gundersen et al. (1988).  
 
Immunohistochemistry 
To get an estimation of the quantity of MEC in mammary tissue, measuring the DNA content 
could be recommended (Capuco et al., 1997; Miller et al., 2006), but to get estimates of the 
relative ratios of cell proliferation and apoptosis, more specific measurements are required. 
Quantification of cell proliferation and apoptosis were done on mammary biopsies (papers 1 
and 3) using well-known immunohistochemical labelling methods (Baldi et al., 2002; 
Fitzgerald et al., 2007; Norgaard et al., 2005) to identify cells undergoing cell proliferation 
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(labelling for Ki-67) and apoptosis (TUNEL method) (briefly explained in appendix 6). Slight 
modifications have been made in the protocols for Ki67 and TUNEL compared to procedures 
used in sheep and cow ((Norgaard et al., 2008a), which are mentioned in paper 3. In our 
caprine samples we observed a slightly stronger background colour and somehow even 
unspecific staining relative to bovine samples, especially with the TUNEL method, which can 
probably be ascribed to the chemical nature of bovine and caprine mammary tissue. 
In the following (table 1), a general overview of the analytical steps performed on the paraffin 
embedded biopsy samples taken from the studied goat mammary glands, for both histological 
and immunohistochemical processes, are shown. 
 
Table 1 - An overview of the processes performed on the paraffin embedded biopsy samples 
 
 
 
 
 
Paraffin 
embedded 
sample  
 
Purpose Staining 
method 
Sections Pictures taken  
/section 
Kind of 
grid 
 
Counting points 
/grid 
Counted points 
/sample 
 
Histology 
 
 
Immuno- 
histochemistry 
H&E 
 
PAS 
 
Ki-67 
TUNEL 
2-3 
 
2-3 
 
4 
4 
3 
 
3 
 
5 
5 
100% 
 
100% 
 
25% 
25% 
30 + Alveoli no. 
 
30 + Alveoli no. 
 
all MECs 
all MECs 
~ 200 + Alveoli no. 
 
~ 200 + Alveoli no. 
 
~ 700 
~ 700 
 
Quantification of gene expression 
Expression of genes was quantified in mammary biopsies for genes suggested to be important 
factors in regulation of apoptosis, cell proliferation, vascular function and remodelling in 
either the mammary gland or other tissues. This was done to study if these regulatory factors 
could account for the differences in mammary remodelling at the level of MEC and 
microvasculature in PP versus MP animals and between CL versus NL glands.  
The candidate genes potentially involved in vascular function and angiogenesis/remodeling of 
the microvascular bed were: cyclooxygenase I (COX1), cyclooxygenase II (COX2), 
prostacycline synthase (PTGIS), thromboxane A2 synthase (TBXAS), carbonic anhydrase IV 
(CA4), angiopoietin I (ANGPT1), angiopoietin II (ANGPT2), tyrosine kinase tie2 receptor 
(RTK), vascular endothelial growth factor (VEGF), vascular endothelial growth factor 
receptor 1 (VEGFR1) and vascular endothelial growth factor receptor 2 (VEGFR2). 
Candidate genes potentially involved in regulation of cell proliferation and apoptosis were: B-
cell CLL/Lymphoma-2 (BCL2), Bcl2-Associated X Protein (BAX), cyclin D1 (CCND1), 
insulin-like growth factor I (IGF1), insulin-like growth factor I receptor (IGF1R), insulin-like 
[41] 
 
growth factor binding protein III (IGFBP3), insulin-like growth factor binding protein V 
(IGFBP5), transforming growth factor beta I (TGFB1), transforming growth factor beta I 
receptor I (TGFB1R1), transforming growth factor beta I receptor II (TGFB1R2), prolactin 
receptor (PRLR), lactoferrin (LTF), leptin (LPT) and leptin receptor (LPTR). 
Alpha-lactalbumin (LALBA) was included as a candidate gene as an indicator of 
lactogenesis, as upregulation of LALBA synthesis is closely synchronized with the time of 
parturition and lactogenesis.  
Transcription of target genes was quantified by real time RT-PCR (appendix 7). The 
oligonucleotide sequences for the genes were designed using the Primer Express software, 
version 2.0 (Applied Biosystems Inc, CA, USA) or Beacon Designer Version 7.00 software 
(Premier Biosoft International, CA, USA). All of the primer pairs and probes used in either of 
SYBR® or TaqMan® assays were designed based on the sequences available for goat 
(VEGF, VEGFR1 and VEGFR2), cow (COX1, COX2, PTGIS, TBXAS, CA4, ANGPT1, 
ANGPT2, RTK, CCND1, IGFBP3, IGFBP5, TGFB1, TGFB1R1, TGFB1R2, PRLR AND 
LTF) or sheep (BAX, BCL2, IGF1, IGF1R, LALBA, LPT and LPTR). The accession 
numbers, amplicon location and length, range of threshold cycle (CT) values in samples, and 
slope of standard curve as well as primer and probe sequences of the analyzed genes are 
presented in paper 1, tables 2 and 3. 
 
Attempts were also made to look for changes in expression of the gene Relaxin receptor 1 
(LGR7, leucine-rich repeat-containing G protein-coupled receptor) in the mammary gland. In 
rodents it has been reported that relaxin, along with other hormonal stimuli of pregnancy 
(mamogenenic hormones such as prolactin, growth hormone, estrogen, progesterone, and 
relaxin) could be associated with mammary development, especially around the time of 
parturition (Anderson et al., 1981; Harness and Anderson, 1977; Tucker, 1981). We were 
however not successful in finding proper primers and probes for this factor or its receptor 1 
due to time limitation and the inadequacy of available primer sequences for goat.  
 
All gene expression studies reported in the literature so far have been conducted on mammary 
biopsies consisting of a mix of different tissues and cell types present in the mammary gland. 
There is a risk that gene expression changes occurring in one particular cell type may not be 
detectable in such a mixed sample as discussed in more detail in papers 1 and 3. To really get 
an understanding of the regulatory events at the level of individual cell types, it would 
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therefore be necessary to study these individual cell types within the mammary tissue. For this 
reason in future studies, the use of laser microdissection is recommended to be able to work at 
the level of individual cell types among different mammary tissue components. 
 
Blood sampling 
To facilitate blood sampling and making it less stressful for the animals, we exteriorized the 
carotid arteries under the skin, and also made skin loops around both milk veins prior to the 
animals inclusion in the experiment. Brief description of surgical procedures according to 
Nielsen et al. (1995b) and catheterizations of Vena Jugularis are given in appendixes 8 to 10. 
An important consideration when performing measurements of arterio-venous concentration 
differences (AVD) across the mammary gland is to obtain representative samples of arterial 
blood which supplies the mammary gland and of the venous blood draining this organ. The 
milk veins (subcutaneous abdominal veins) and pudic veins (vena pudenda externa) are the 
quantitatively important veins draining the udder, and the valves in these veins become 
incompetent during the course of 1st lactation in ruminants, i.e. can transport blood in either 
direction. During sampling of blood from the milk veins, it is therefore essential to clamp the 
pudic vein to avoid contamination of mammary blood with blood from non-mammary origin 
(Linzell, 1960). Except from superficial arteries supplying extremities, blood samples from 
any artery in the body can be regarded as representative with respect to nutrient composition. 
With the exception of blood gasses, the majority of nutrients have similar concentrations in 
the carotid artery as in the jugular vein, and jugular vein blood can therefore also be sampled 
instead of arterial blood when only concentrations of major nutrients are of interest. Arterial 
concentration (Miller et al., 1991) as well as rate of mammary blood flow (Madsen et al., 
2005; Madsen et al., 2008) could both affect mammary uptake and AVD for different 
nutrients.  
As described in papers 2 and 4, blood samples were collected in 1 ml LiHep coated syringes 
and immediately analyzed for acid-base parameters such as pH, HCO3-, O2 and CO2 content 
which are involved in vascular function and hence the function of the milk synthesizing cells. 
Other blood samples were collected in 10 ml vacutainers coated with EDTA, and stored on 
ice till centrifugation (3000 gav at 4 °C for 12 min). Plasma was transferred to labeled cryo-
tubes, and were analyzed for contents of metabolites involved in synthesis of the major milk 
components (glucose, acetate, beta-hydroxy-butyrate (BHB), non-esterified fatty acids 
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(NEFA), triglycerol (TG)), urea, and metabolic hormones (IGF1, insulin) using commercially 
available kits (described in further details in paper 4). 
Continuous intravenous infusions (see also appendix 10). In the continuous infusion trial, 
goats were fed a basal diet (see paper 4, table 2) designed to meet approximately 90% and 
80% of daily requirements for energy and amino acids absorbable from the small intestine, 
respectively, according to their body weights and milk production in the two stages of 
lactation, early and late. On top of the daily basal diet, goats were given continuous 
intravenous infusions of one of 4 isoosmotic solutions at pH 7.4 (960 ml/d for 4 days) 
containing either saline as control, glucose, sodium acetate, or a mixture of essential amino 
acids composed to match the relative proportion of essential amino acids (EAA) in milk 
protein determined in a previous experiment with this goat breed (Madsen et al., 2005). There 
is no simple relation between what is fed to a ruminant animal and the absorption of EAA and 
glucose (Danfaer et al., 1995; Seymour et al., 1990) due to rumen fermentation. To provide a 
certain and known amount of a given nutrient, it has to be provided after the level of the 
forestomach fermentation, and in this experimental approach providing nutrients via 
intravenous (systemic) infusions was preferred. The EAA infusion was designed so that the 
total supply of amino acids (absorbed + infused) reached 105% of requirements for amino 
acids absorbable from the small intestine, and glucose and acetate infusions were calculated to 
be isoenergetic with the EAA infusion based on the potential yield of ATP from oxidation of 
the infused nutrients in the body. Composition of the infusates are shown in paper 4, table 1. 
Each treatment period lasted one week, where the intravenous infusions were initiated at 
12:00 on day 1 (Monday) and concluded at 12:00 on day 5 (Friday), followed by a 3 day rest 
period in between. Samplings were performed during the last 24 hours of each infusion 
period. 
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Paper I & II:  
Continuous Lactation Effects on Mammary Remodelling and Mammary Extraction 
Rates of Nutrients during Late Gestation and Lactation in Dairy Goats 
 
Objectives 
In these two papers we aimed to: 1) elucidate whether continuous milking during late 
gestation in dairy goats negatively impacts mammary remodelling and hence milk production 
in the following lactation, 2) identify the regulatory factors responsible for changes in cell 
turnover and angiogenesis in the continuously lactating mammary gland, and 3) determine if 
continuous lactation in the dairy goat will increase the efficiency of nutrient extraction across 
the mammary gland in the following lactation. 
 
Material and methods 
Nine dairy goats were followed over one (5 goats) or two consecutive (4 goats) pregnancy-
lactation periods. Goats were previously surgically prepared with exteriorized carotid arteries 
and milk veins. They were milked manually (at 09:00 and 15:30) and fed twice a day (at 
07:30 and 14:30), half the ration being given at each feeding. The experimental design was a 
randomized complete block design; one udder half was dried-off approximately 9 weeks pre-
partum (normal lactation; NL), and the other udder half of the same goat was milked 
continuously (continuous lactation; CL) until parturition. After morning and afternoon 
milking, two blood samples were obtained from the exteriorized carotid artery and each of 
both milk veins, and mammary biopsies were obtained from each udder half just before the 
NL gland was dried off (BDP; before dry period), within the first 2 weeks after drying-off 
(EDP; early dry period), in the mid-dry period (MDP), within the last 2 weeks prior to 
parturition (LDP, late dry period), and at days 1 (the day of parturition), 3, 10, 60, and 180 of 
lactation. Mammary morphology was characterised in biopsies by quantitative histology, and 
cell turnover was determined by immunohistochemistry (TUNEL and Ki-67). Transcription 
of genes encoding factors involved in mammary epithelial cell (MEC) turnover and vascular 
function was quantified by quantitative reverse transcription PCR. Blood samples were taken 
for immediate determination of acid-base parameters, and plasma was analysed for glucose, 
non-esterified fatty acids (NEFA), acetate, beta-hydroxy-butyrate (BOHB), triglycerol (TG), 
and urea. Mammary extraction (E) rates of metabolites were calculated as mammary arterial-
milk vein concentration difference (AVD) divided by arterial concentration. 
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Main results 
? We experienced considerable problems in preventing the glands from drying off 
spontaneously in very late lactation.  
? Milk yield turned out to be virtually unaffected by CL in the glands that were capable of 
completing a continuous lactation. 
? CL glands had a 3-7% lower proportion of MEC in the subsequent mid-late lactation 
compared to NL glands, due to lower proliferation rate during MDP-LDP. 
? At the time of parturition (and throughout lactation), the mammary glands subjected to CL 
had smaller alveoli, more fully differentiated MEC and a substantially larger capillary 
fraction compared with NL glands. None of the studied genomic factors could account for 
these treatment differences. 
 
 
 
 
 
 
 
 
 
? MEC undergoing proliferation occurred predominantly in the intermediately differentiated 
rather than in the poorly and fully differentiated MEC (69%, 23% and 9%, respectively). 
We found no apoptotic cells among poorly differentiated MEC, but only in the 
intermediately or fully differentiated MEC.  
? The higher rate of apoptosis in CL glands at d3 coincided with a drop in the proportion of 
fully differentiated MEC, which was not observed in NL glands. 
? AVD and/or E differed for some metabolites (glucose, TG, LCFA and BHB) either 
significantly or numerically between the CL and NL glands during the late gestation 
period. This could reflect differences in extraction activity between the CL glands that 
remained lactating and the NL glands that were dried off prepartum.  
? There was no significant impact of the prepartum milking of the CL glands on efficiency 
of mammary nutrient extraction in the subsequent lactation 
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Conclusions and perspectives 
CL suppressed MEC renewal, due to suppression of pre-partum cell proliferation; however, 
the rate of apoptosis was unaffected. Continuously lactating mammary glands of goats 
therefore entered the subsequent lactation with a smaller MEC population, as known in dairy 
cows. CL glands throughout lactation had a larger micro-vessel proportion, lower proportion 
of MEC, but more fully differentiated and likely older population of MEC compared to NL 
glands. If fully differentiated MECs have higher secretory activity, this could in part explain 
why goats can lactate continuously without major negative impact on milk yield, in spite of 
the smaller population of MEC. But, the observation that extractions of nutrients were 
unaffected by CL do not lend immediate support to the hypothesis that these more fully 
differentiated MECs could have a more efficient nutrient extraction reflecting a higher 
metabolic activity in the subsequent lactation.  
We were not able to resolve why continued milking during the late gestation period interferes 
with MEC and vascular remodelling within the mammary gland, and what regulatory 
mechanisms are responsible. So two puzzling questions remain: Why is the full restoration of 
the MEC population and overall mammary remodelling inhibited just because of continuous 
milk removal from a mammary gland throughout gestation? And why is this associated with a 
marked depression in milk yield in dairy cows in the subsequent lactation, but apparently not 
in the dairy goat that (with some difficulty) manage to lactate continuously? 
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Paper III:  
Mammary Remodelling in Primiparous and Multiparous Dairy Goats During Lactation 
 
Objectives  
The overall aims of this study were to elucidate whether differences in lactational 
performance between primiparous (PP) and multiparous (MP) mammary glands are related to 
the time course of development and maintenance, not only of the MEC population but also of 
the mammary vasculature which sustains synthetic activity. We tried to identify the 
underlying regulatory factors or mechanisms responsible for developmental differences 
between PP and MP mammary glands. We aimed to address these issues in a study in dairy 
goats and to the extent possible make comparisons to what is known in the dairy cow. 
 
Material and methods 
In this study, mammary biopsies were obtained from both mammary glands of 3 PP and 6 MP 
(≥2 parity) dairy goats at parturition (d1), days 10, 60, and 180 of lactation. Performing real 
time RT-PCR, quantitative histology (PAS and H&E) and immunohistochemistry (TUNEL 
and Ki-67) on the biopsies, we determined MEC turnover and differentiation, changes in 
morphology of the micro-vascular system, and the changes in patterns of expression of the 
major factors responsible for regulation of mammary cell turn-over as well as vascular 
function and angiogenesis. 
 
Main results 
? Mammary glands of PP goats compared to of MP goats:  
- were less compositionally differentiated at parturition 
- had higher rates of MEC cell proliferation in early lactation 
- had similar high rates of apoptosis right after parturition, which decreased to almost zero 
in PP glands over the course of lactation and numerically lower than in MP glands in mid-
late lactation.  
- had higher MEC survival and differentiation throughout lactation 
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- had substantially lower MEC:lumen ratio (1.0:1 and 1.6:1, respectively) at the time of 
parturition, but by d 60 of lactation the ratio in PP glands (1.8:1) had increased to the same 
level as in MP glands (1.7:1). 
 
 
 
 
 
 
 
 
- showed lower expression of angiogenic factors (VEGFR1, VEGFR2, ANGPT1, ANGPT2 
and RTK) as well as PRLR and LALBA at the time of parturition, but this had reversed by 
d10, where highest expression levels were found in PP glands.  
- Had markedly higher micro-vessel to interstitial tissue ratio (71% and 41%, respectively) 
during the whole lactation period. This ratio decreased in parallel in PP and MP glands 
from early lactation and reached the lowest levels in late lactation in both PP and MP 
glands (59% and 31%, respectively). 
 
 
 
 
 
 
 
 
- had higher expression of number of genes (COX1, COX2, PTGIS and TBXAS) encoding 
factors regulating vascular tone and function, especially in late lactation.  
? Parity significantly impacted expression of the majority of genes involved in regulation of 
cell turnover and lactogenesis (BCL2, IGF1, IGFBP3, IGFBP5, TGFB1, TGFB1R2, 
PRLR, LALBA, LPT and LPTR), but not BAX, CCND1, IGF1R, TGFB1R1 and LTF.  
? Expression of the antiapoptotic factor BCL2 corresponded with the high rates of apoptosis 
at parturition and the higher apoptotic rates in PP compared to MP glands. 
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? expression of IGF1, LPT and LPTR were at similar levels in MP and PP glands at the time 
of parturition, but with progress of lactation, expression of these factors increased in PP 
glands, which was in contrast to MP glands where expression levels remained constant or 
even diminished. This coincided with the more pronounced shift from poorly over 
intermediate to fully differentiated MEC in PP compared to MP glands.  
? IGF1, LPT and LPTR exhibited the same pattern of expression changes as COX1, COX2, 
PTGIS and TBXAS. 
 
Conclusions and perspectives 
We have found that initiation of lactation and growth of the mammary gland continues further 
into early lactation in the PP compared to the MP dairy goats. This not only applies to MEC 
renewal, but also to development of vascular function (angiogenesis). This combined with 
improved MEC survival and maintenance of vascular competence, could explain the reported 
higher lactation persistency in PP compared to MP ruminants. There is an orchestrated change 
taking place to regulate the MEC and vascular function during normal lactation and to ensure 
coordination of function in these two important tissue components of the mammary gland. We 
have provided evidence that the set of genes regulating these orchestrated changes, are also 
basically the ones which can explain the different patterns of mammary development and 
performance during lactation between PP and MP animals, and hence the factors encoded for 
by these genes must be important determinants of lactational persistency. We therefore 
suggested that development and function of the mammary microvasculature may be just as 
essential for the overall integrity of the mammary gland and lactational persistency as the 
MEC. This issue should be addressed in future studies.  
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Paper IV:  
Intravenous Supplementation of Acetate, Glucose or Essential Amino Acids to an 
Energy and Protein Deficient Diet in Early and Late Lactating Dairy Goats: Effects on 
Milk Production and Mammary Nutrient Extraction 
 
Objectives 
The aims of the present project were to determine whether : 1) provision of energy (ATP) 
yielding substrates can compensate for an insufficient amino acid supply to the mammary 
gland and hence improve overall utilization of amino acids for milk protein synthesis, 2) 
acetate is more efficient than glucose in stimulating milk synthesis and particularly its milk 
protein content; and 3) milk synthesis is more sensitive towards changes in nutrient provision 
in early lactation (EL) compared with late lactation (LL). 
 
Material and methods 
Four dairy goats used in this study were previously surgically prepared with exteriorized 
carotid arteries and milk veins.  They were fed a basal diet deficient in energy (90% of 
requirements) and protein (80% of requirements), and were randomly allocated to 4 
treatments in a balanced 4 x 4 Latin Square design. The treatments consisted of 4-d 
continuous intravenous infusions of isoosmotic isoenergetic solutions of essential amino acids 
(EAA), sodium acetate (ACE) and glucose (GLU) with saline (SAL) as control. There was a 
3-d rest period between each treatment. Simultaneous arterio-venous blood samplings over 
each udder half (gland) were performed every 4 h during the last 24 h of infusion. Blood acid-
base parameters and plasma concentrations of glucose, non-esterified fatty acids, beta-
hydroxy-butyrate, triacylglycerol and urea were determined. Mammary extraction (E) rates of 
metabolites were calculated as mammary arterial-milk vein concentration difference (AVD) 
divided by arterial concentration. Milk production over the last 48 h of infusion was recorded, 
and milk fat and protein contents determined. 
 
Main results 
? Milk yield and energy corrected milk, milk fat and protein yields in g/last 48 hours were 
significantly higher in EL than LL.  
? Gross milk yield was significantly higher on GLU and EAA treatments in EL compared to 
the SAL control treatment, and yield of ECM was increased on ACE relative to SAL. In 
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LL, nutrient supplementations did not affect gross milk yield, but ECM was increased on 
EAA compared to other treatments.  
? Protein percentage was lowest on GLU compared to other treatments, and protein yields 
were increased on EAA and ACE, but not on GLU compared to SAL in EL. In LL, milk 
protein percentage was higher on EAA than GLU and milk protein yield was higher on 
EAA compared to ACE and GLU.  
? Fat percentages were decreased by GLU and EAA compared to ACE and SAL in EL, and 
highest fat yield in EL was observed on ACE. In LL, GLU also lowered milk fat 
percentages whereas EAA increased in contrary to the effect in EL. 
 
Conclusions and perspectives 
An insufficient amino acid supply to the mammary gland of dairy goats can be compensated 
in EL but perhaps not LL by increased mammary supply and uptake of an energy yielding 
substrates, which specifically contributes to ATP formation in MEC. The mammary gland 
may thus be relatively less sensitive towards variations in amino acid supply in EL compared 
to LL. This suggests there might be scope for development of differential protein 
recommendations for ruminants in early and late lactation, and this issue should be pursued in 
future studies. 
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Discussion 
Three experiments have been carried out with dairy goats to elucidate: 1) the impact of parity 
number (PP vs MP) and dry period (CL vs NL) on mammary synthetic capacity through 
interference with cell turnover and function of MEC and microvasculature, and identifying 
the regulatory factors; and 2) the sensitivity of the mammary gland in early compared to late 
lactation towards variations in nutrient supply, and whether provision of energy yielding 
substrates (acetate vs glucose) can compensate for an insufficient amino acid supply to the 
mammary gland and hence improve overall milk (protein) synthesis. 
 
Parity and omission of the dry period in late gestation impact lactation performance due to 
similar patterns of changes in mammary growth and remodelling 
PP vs MP. Our results confirmed recent studies in cow (Norgaard et al., 2005), sheep 
(Norgaard et al., 2008a) and goat (Caja et al., 2006) that mammary (re)development in MP 
goats takes place predominantly in late pregnancy with only little occurring after parturition. 
In contrast, a continued growth into lactation in PP mammary glands has been seen in our 
studies as also reported by other dairy goats (Anderson et al., 1981; Knight and Peaker, 1984) 
and dairy cows (Miller et al., 2006). Our results indicate that PP glands are less 
compositionally differentiated at parturition compared to MP-NL glands. Thus it seems that 
MEC proliferation as well as differentiation continues further into lactation in PP compared to 
MP goats, and the first hypothesis raised in the “Introduction” could thus be confirmed. 
Our results on the proportional changes of poorly, intermediately and fully differentiated 
MEC during gestation-lactation period and previous reports in Holstein cows (Akers et al., 
2006) make it reasonable to suggest that the poorly differentiated MEC are the newly formed 
cells in the mammary gland, that need to differentiate further to acquire full lactational ability. 
In our studies, the proportion of intermediately differentiated MEC decreased over the course 
of lactation in PP glands, whilst the proportion of fully differentiated MEC increased, 
especially from d10 and onwards. These changes most likely reflect that intermediately 
differentiated MEC progressively become differentiated into fully differentiated MEC in PP 
glands. As a consequence of lower rate of apoptosis from d10 and onwards in PP compared to 
MP glands, this would overall indicate that the MEC population in PP glands in addition to 
having new cells added during lactation, also were more persistent and hence capable of 
remaining lactating for a longer period of time. 
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The micro-vessel to interstitial tissue ratio in MP changed in parallel but at a lower level in PP 
glands over the course of lactation, which presumably reflects microvasculature regression, 
consistent with the changes observed over the course of lactation in rats (Yasugi et al., 1989). 
It has been suggested in mouse, that microvascular regression either follows the alveolar 
degeneration (Matsumoto et al., 1992) or could be correlated to, or even be a consequence of, 
MEC involution (Djonov et al., 2001). It has not been definitively proven what comes first, 
but it appears evident that the function and integrity of the MEC is dependent on and  closely 
coordinated with the vascular system responsible for provision of nutrients and removal of 
waste products, essential to sustain MEC metabolism. 
NL vs CL in multiparous goats. Despite the negative impact of CL on MEC renewal in MP 
goats, milk yield turned out to be virtually unaffected by CL in the glands that were capable 
of completing a continuous lactation. CL glands had a higher proportion of more fully 
differentiated MECs. But there was no significant impact of the pre-partum milking of the CL 
glands on efficiency of mammary nutrient extraction in the subsequent lactation, which does 
not lend immediate support to the hypothesis that the more fully differentiated MECs in the 
CL compared to NL glands would have a more efficient nutrient extraction reflecting a higher 
metabolic activity. It would therefore be relevant to find out how regulation of mammary 
remodelling differs between cows and goats and thus find the explanation why the milk yield 
in the subsequent lactation in goats subjected to CL is not negatively affected to the extent 
observed in dairy cows. The CL mammary gland in both species (Capuco and Akers, 1999; 
and Paper 1) apparently possesses MEC in a stage of differentiation capable of undergoing 
both cell proliferation and responding to endocrine factors initiating lactogenesis just as in NL 
glands. We can speculate that the MEC in goats may survive longer than in cows, but it 
remains to be established if it is so. 
CL resulted in a larger ratio of capillaries-to-alveoli during lactation compared to NL glands,, 
which could be indicative of a greater blood supply to the MEC and favour exchange of 
nutrients and waste products across the capillary-MEC barrier in those glands. This could be 
another explanation why milk yield in goats is unaffected by CL, despite the negative impact 
of CL on pre-partum cell renewal. The capillary-to-alveolar ratio will normally be at its 
lowest in early lactation and increase as lactation progresses, reflecting a high number of very 
small capillaries surrounding large alveoli in the beginning of lactation, and increasingly 
larger and fewer capillaries surrounding alveoli as lactation progresses (Nielsen MO et al., 
unpublished data, and present study). This ratio is thus inversely related to mammary blood 
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flow changes (Nielsen et al., 1990) and efficiency of nutrient extraction in the mammary 
gland during lactation (Nielsen et al., 2001), very small capillaries would favour a more 
efficient nutrient exchange across the capillary – MEC barrier due to smaller diffusion 
distances, and extraction rates were in fact higher in EL compared to LL (Madsen et al., 2008; 
Nielsen et al., 2001 and paper 4). In our study, there seemed to be an increased contact 
between microvasculature and alveoli with progressing lactation, which could be a 
consequence of either the enlargement of capillaries (Nielsen MO et. al., unpublished data) or 
more meandering (Djonov et al., 2001; Matsumoto et al., 1992). This was more evident in CL 
than NL glands. Our findings therefore indicate that CL glands enter the new lactation with an 
older population of MEC surrounded by a similarly older (and possibly more developed) 
capillary network. As a result, nutrient exchange across the capillary-MEC barrier would 
occur less efficiently, but the decrease in vascular resistance (larger capillary diameter) could 
possibly allow for a compensatory increase in mammary blood flow. Future studies will need 
to be conducted to reveal if milk yield in this way could be maintained relatively unaffected 
by CL in the goat due to a higher mammary blood perfusion per unit of milk synthesized. 
Altogether, similar to the effects of parity, it is also evident that CL would affect mammary 
remodelling not only by influencing MEC turnover and differentiation, but also MEC activity 
which appears to be in close coordination with the surrounding microvasculature, and thereby 
the overall mammary gland function. Improving our understanding of these remodelling 
events in the mammary gland in future studies are required to be able to optimise mammary 
gland performance and hence production capabilities of dairy animals. 
 
Omission of the dry period in late gestation interferes with mammary remodelling through 
regulatory factors that are not identical to the factors responsible for differential mammary 
development in PP versus MP goats  
Mammary epithelial cells. Initiation of lactation in MP ruminants is associated with up-
regulation of the PRLR in MEC (Wall et al., 2006), and initiation of copious milk secretion 
including the whey protein LALBA (Forsyth and Neville, 2009; McFadden et al., 1987). In 
this study expression of these factors was therefore at its highest at the time of parturition in 
MP goats. However, in PP goats both PRLR and LALBA expression increased from 
parturition to peak at d10, which is yet another indication that initiation of lactation and 
growth in the PP mammary gland continues further into early lactation than in MP, and that 
initiation of lactation possibly is a delayed or prolonged process in the PP dairy goat. Theil et 
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al. (2006) showed that expression of PRLR in mammary glands of sows is crucial in order to 
ensure continued growth of the mammary gland at parturition and to initiate lactation. The 
PRLR could therefore be one of the overall factors involved in coordinating mammary 
growth, function and angiogenesis in the PP dairy goat, and the delayed lactogenesis and 
continued development of the PP mammary gland into lactation could be a result of sustained 
expression of the PRLR. The underlying reason for this differential expression pattern in PP 
and MP goats’ mammary glands is not known. 
We were unable to relate differences in rates of apoptosis during the lactation period or 
between PP and MP glands to expression of BAX, which is an apoptotic factor (Reed, 1998). 
Our results suggest that the antiapoptotic factor BCL2 plays a greater role than BAX in 
regulation of apoptosis from parturition and during lactation. It can, however, not be ruled out 
that more cell specific gene expression studies could reveal that BAX may be involved in this 
regulation of MEC turnover as well.  
Insulin-like growth factor 1 has been reported to stimulate MEC growth, proliferation and cell 
survival (Knight, 2000), and LPT has been reported to be involved in regulation of MEC 
proliferation and/or differentiation prior to parturition (Chilliard et al., 2001). We found that 
expression of IGF1, LPT and LPTR were at similar levels in the MP and PP mammary gland 
at the time of parturition, but with progressing lactation, expression of these factors increased 
in PP glands, whereas expression levels remained constant or even diminished in the MP 
mammary glands. This coincided with the more pronounced shift from poorly over 
intermediately to fully differentiated MEC in PP compared to MP glands. It is therefore 
tempting to speculate that IGF-1 and LPT are important factors involved in regulating 
differentiation and cell survival during lactation in general, and also contributing to explain 
the different developmental patterns between PP and MP glands over the course of lactation. 
The regulatory factors determining development and differentiation of MEC during the 
normal lactation in the mammary gland of MP goats thus seem to be the same set of factors 
responsible for the differential pattern of development in the PP ones. It would be valuable to 
gain insight into the underlying reason for the impact of parity on expression of this whole 
range of MEC genes, as this is a key to understanding aspects of cell survival, metabolic 
activity and hence lactation persistency. 
We were not able to demonstrate any significant effects of CL on expression of any of the 
genes encoding for factors with reported effects on cell turnover and differentiation. 
Therefore, the factors or mechanisms explaining the impact of CL in late gestation on cell 
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renewal and differentiation still remain to be identified, and may apparently be different from 
the factors involved in the normal regulation of mammary remodelling during gestation and 
lactation. However, we can not rule out that our failure to link the cell turnover events to 
changes in gene transcription in MEC in our mammary biopsies could have been “masked” by 
the presence of several other cell types. Obviously the impact of continued milking in late 
gestation on cell renewal and mammary remodelling must be mediated by local mechanisms 
in the gland subjected to CL, since it is possible to continuously milk one udder half in the 
animal whilst drying-off the other. 
Mammary micro-vasculature. This is the first report of quantitative gene expression analysis 
for factors involved in angiogenesis and vascular remodelling (VEGF, VEGFR1, VEGFR2, 
ANGPT1, ANGPT2 and RTK) in the mammary gland of ruminants to our knowledge, and 
only few studies in rodents have looked into the mammary vasculature and regulation of its 
remodelling (Djonov et al., 2001; Pepper et al., 2000b). Parity appeared to influence the 
whole range of studied genes associated with vascular function and angiogenesis in our dairy 
goats. VEGFR1, VEGFR2, ANGPT1, ANGPT2 and RTK are all angiogenic factors (Shibuya, 
2001; Thurston, 2003), and these genes as well as PRLR and LALBA were generally higher 
expressed in MP compared to PP at parturition, but this had reversed by d10, where highest 
expression levels were found in PP glands. It has been suggested that the MEC is the main 
source of angiogenic factors in the mammary gland suggested by Pepper et al. (2000b), and as 
such it appears logical that expression of angiogenic factors would follow the developmental 
pattern of MEC described above during lactation and in mammary glands of different parity. 
Primiparous glands thus continue to develop also their vascular system post-partum to a 
greater extent than in MP goats. Furthermore, we observed that a number of other genes 
(COX1, COX2, PTGIS and TBXAS) encoding for factors regulating vascular tone and 
function (Nielsen et al., 1995a) were higher expressed in PP than MP glands, especially in late 
lactation. These factors are synthesized within the capillary endothelial cells in addition to 
MEC. Cyclooxygenase (COX1 and COX2) are key enzymes involved in synthesis of a 
number of vasoactive substances (Simmons et al., 2004), and the enzyme PTGIS specifically 
regulates the synthesis of prostacyclin (PGI2), which has been reported to be a potent 
vasodilator in the mammary gland (Nielsen et al., 2004a). Higher expression of genes 
encoding for potent vasodilators could likely be associated with improved blood perfusion in 
PP glands in more advanced stages of lactation, and would thus contribute to explain why 
lactation persistency may be higher in PP goats. The reason for higher expression of these 
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genes encoding for factors with vasoactive action is not known.  It is noteworthy that IGF1, 
LPT and LPTR exhibited the same pattern of expression changes as the vasoactive factors 
COX1, COX2, PTGIS and TBXAS. This could suggest that the differential expression of the 
vascular function genes was linked to the differential development of the MEC in PP 
compared to MP glands, and in this way coupled to differential development also of the 
mammary vascular system. An important message thus seems to be that the changes in 
vascular and MEC function appear to be regulated in a coordinated manner. Our studies give 
rise to the question whether the vascular system may be involved in determining lactation 
persistency, and this issue deserves to receive more attention in the future, as so little work 
has been carried out in this area so far. 
As mentioned above, CL did not affect expression of any of the genes encoding for MEC 
turnover, but CL did affect expression during gestation and at the day of parturition for some 
of the genes encoding for factors regulating vascular function. The higher gene expression of 
CA4 (P<0.06) particularly in the pre-partum period and of VEGFR1 during the first part of 
the dry period in CL glands may be ascribed to the fact that those glands had a MEC 
population that was prevented from involution, and thus maintained in lactation. 
Consequently a functional capillary network was sustained as well. Statistically or 
numerically higher expressions of ANGPT1, VEGF, VEGFR1, VEGFR2 and COX2 in CL 
glands at d1, suggest that the CL glands experiences a higher rate of vascular growth than the 
NL glands around parturition, probably renewing part of the ageing vascular system at this 
time, which, in the NL gland would have happened prior to parturition in parallel to the 
renewal of the MEC population.  
Altogether, the same regulatory factors appear to be involved in vascular remodelling 
irrespective of whether this is a result of parity or induced by CL, whereas CL will affect 
MEC turnover by different mechanisms than the ones that regulate MEC turnover during the 
normal course of lactation in PP and MP animals. The second hypothesis could therefore only 
partly be confirmed. Identification of such mechanisms in future studies may lead to a better 
understanding of how lactation performance and persistency can be favoured in dairy animals. 
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Milk protein synthesis in the lactating mammary gland is less sensitive towards variations 
in amino acid supply in early compared to late lactation provided the energy supply is 
adequate 
It is commonly believed that nutrient supply to the mammary gland is the main limiting factor 
for milk production in EL, whereas synthetic capacity becomes limiting in LL, as MEC die 
and feed intake increases to the extent where nutrient supply no longer limits nutrient uptake 
in the mammary gland (Madsen et al., 2005; Wilde and Knight, 1989). In LL, the population 
of transporters in the MEC for both glucose (Shennan and Peaker, 2000) and amino acids 
(Sharma and Kansal, 2000) decrease compared to EL. The same has been reported for activity 
of the capillary enzyme lipoprotein lipase involved in mammary uptake of plasma TG 
(Neville and Picciano, 1997). Hence more nutrients provided by the blood will escape 
mammary uptake. Consequently AVD and E were significantly lower in LL compared to EL, 
reflecting the decreased synthetic capacity and metabolic activity in the organ, with a 
decreasing capability to extract nutrients from whatever volume of blood that flows through 
it. Even for nutrients where concentration gradients are believed to be the driving force for 
mammary uptake (acetate, BOHB and NEFA), efficiency of mammary uptake decreased as 
lactation progressed, showing that extraction of such nutrients is determined not only by 
arterial concentrations, but probably also by the intracellular concentration and hence 
metabolic activity in the mammary epithelial cells. With progressing lactation, it therefore 
appears logical to assume that milk synthesis within the mammary gland should become less 
sensitive to changes in supply of nutrients. In LL, additional supply of acetate and glucose did 
indeed fail to drive up milk synthesis, although AVD for acetate increased on ACE compared 
to all other treatments. This indicates that mammary gland synthetic capacity was the main 
limiting factor for milk synthesis at this stage of lactation and not substrate supply. However, 
in contrast to ACE and GLU, supplementation of additional EAA to the basal energy and 
protein deficient diet could drive up synthesis of ECM, milk protein as well as fat in LL.  
In a previous goat experiment we showed that AVD for lysine and methionine across the 
mammary gland increased linearly with A in both EL and LL in response to increased dietary 
supply. But it required higher arterial concentrations to drive a given uptake (AVD) in LL 
(Madsen et al., 2005). It has been shown by Sharma and Kansal (2000) in the rabbit that the 
relative abundance of different amino acid transporters in the mammary epithelial cell 
membrane changes during lactation. This observation along with our results, suggest that in 
contrast to our third hypothesis, the mammary gland in EL may in fact be more robust 
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towards changes in amino acid supply, capable of maintaining amino acid uptake even at 
rather low arterial concentrations. And this may explain why an insufficient amino acid 
supply in EL could be compensated by a larger energy (ATP) supply, whereas this was not 
possible in LL. 
 
Deficiencies in dietary provision of protein can be compensated in EL but not LL by 
provision of energy (ATP) yielding substrates to sustain milk (protein) synthesis 
In agreement with a study done on dairy cows by Cant et al. (2002), we experienced a milk 
protein reduction with GLU infusion. This negative impact on protein and also fat percentages 
in both EL and LL observed on GLU treatment in our study, could be probably be ascribed to 
a dilution effect explained by increased lactose synthesis in response to the provision of 
glucose (Cant et al., 2002; Rook, 1979). There was a significant increase in total milk yield 
and a numerical increase in ECM in EL but not in LL in response to GLU infusion. This 
would be in agreement with the mammary gland being capable of increasing glucose uptake 
to some extent in EL in response to increased supply, but not as efficiently in LL where the 
synthetic capacity of the mammary gland is presumed to be the most limiting factor for 
glucose uptake (Nielsen et al., 2001).  
Compared to the SAL control group, milk protein yield was increased by provision of EAA 
and an energy yielding substrate in the form of ACE in EL, but in LL, insufficient mammary 
EAA supply could apparently not be compensated as efficiently by provision of more energy-
yielding substrates. Acetate and glucose are both substrates contributing to oxidative 
metabolism in the MEC. Acetate and glucose are the main source of energy in the mammary 
gland of lactating cows and goats, but acetate contributes to the oxidative metabolism more 
significantly than glucose in both dairy goats and cows (Bickerstaffe et al., 1974). Acetate is 
utilized in oxidative phosphorylation of adenosine nucleosides, which results in the generation 
of ATP (Forsberg et al., 1984; Scott et al., 1976), whereas glucose is oxidized mainly through 
the pentose phosphate pathway to yield NADPH required for de novo fatty acid synthesis 
(lipogenesis) (Chaiyabutr et al., 1980; Chaiyabutr et al., 2008). Milk protein synthesis is a 
highly energy consuming process, and 5 ATP are consumed for every peptide bond formed 
(Hanigan and Baldwin, 1994; Lobley, 1990). Our results confirmed the fourth hypothesis that 
it is possible in EL to sustain milk protein synthesis whilst substituting amino acid supply to 
the mammary gland with a substrate, acetate, providing energy predominantly in the form of 
ATP. But when the energy is given in the form of glucose, protein synthesis and milk protein 
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content cannot be sustained. This underlines the importance of energy (ATP) supply for milk 
protein synthesis particularly in EL. The present study thus indicate there could be scope for 
development of differential protein recommendations for ruminants in early and late lactation, 
and this issue should be pursued in future studies.  
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Conclusions and perspectives 
Not only MEC renewal, but also development of vascular function, initiation of lactation and 
growth of the mammary gland continues further into early lactation in the PP compared to the 
MP dairy goats. This combined with improved MEC survival and maintenance of vascular 
competence, could explain the reported higher lactation persistency in PP compared to MP 
goats. We suggest that development and function of the microvasculature may be just as 
essential for the overall integrity of the mammary gland and lactation persistency as the MEC 
population. The set of genes regulating these orchestrated changes in MEC and microvascular 
remodelling, are also basically the ones which can explain the different patterns of mammary 
development and performance during lactation between PP and MP goats. The factors 
encoded for by these genes are therefore likely to be important determinants of lactation 
persistency. The underlying reasons for the differential expression in PP compared to MP 
goats of genes responsible for regulation of MEC and vascular development remain to be 
established. Mammary development and remodelling prior to parturition and during lactation 
in goats are dependent on parity as well as late gestation management (dry period). But, we 
were not able to resolve why CL during the late gestation period interferes with MEC and 
vascular remodelling within the mammary gland, and what regulatory mechanisms are 
responsible. It remains to be elucidated why the full restoration of the MEC population and 
overall mammary remodelling is inhibited just because of CL, and why this is associated with 
a marked depression in milk yield in dairy cows in the subsequent lactation, but apparently 
not in the dairy goat that (with some difficulty) manage to lactate continuously.  
In our studies on gene expression we could not identify any specific regulatory factors that 
would account for the differences in MEC turnover between mammary glands allowed a dry 
period in late gestation compared to mammary glands milked continuously throughout the late 
gestation period. However, all gene expression studies so far have been conducted on biopsies 
of mammary tissue consisting of the variety of different tissues and cell types present in the 
mammary gland. And this may mask gene expression changes occurring in a particular cell 
type. To understand the regulation accounting for differences in cell turnover and hence 
lactation performance in dairy goats subjected to different lactation strategies, it is therefore 
necessary to study the individual cell types within a given tissue structure in the mammary 
tissue to be able to obtain a more detailed understanding. For this reason in future studies, 
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using laser microdissection is recommended to be able to work at the level of individual cell 
types among different mammary tissue components. 
In a tissue structure like an alveoli, it is possible to find apoptotic and some proliferative cells. 
Laser microdissection makes it possible to go into the individual cells and study their specific 
characteristics; why was it for example induced to go into apoptosis or proliferation compared 
to the other cells in that very same tissue structure. This new approach can improve our 
understanding of what determines the status of a particular cell, where the interactions 
between different cells could be studied specifically. In this way we could acquire new 
knowledge about the mechanisms responsible for the regulation of MEC as well as mammary 
microvasculature remodelling. If we could either synchronize angiogenesis with prepartum 
MEC proliferation or avoid early lactation apoptosis by knowing those mechanisms, we 
would have a powerful instrument to improve lactation persistency and overall lactation 
performance of economical benefit to the producers. 
Utilisation of the synthetic capacity present in the mammary gland at any given time point in 
lactation relies on supply of nutrients by the blood to sustain milk synthesis. We confirmed 
that the mammary gland synthetic capacity generally appears to be the main limiting factor 
for milk yield in LL, whereas milk production in EL is more likely to be limited by mammary 
nutrient supply. Both amino acids and energy in the form of ATP can limit milk protein 
synthesis and content in EL, and an insufficient supply of amino acids to the mammary gland 
of dairy goats could in fact be compensated in EL but apparently not LL by increased energy 
supply to the mammary gland, provided that this increased energy supply was in the form of 
nutrients like acetate, which are metabolized predominantly in pathways resulting in 
generation of ATP. In contrast to our initial hypothesis, the mammary gland in EL may thus 
in fact be more robust towards changes in amino acid supply, capable of maintaining amino 
acid uptake even at rather low arterial concentrations, whereas higher arterial plasma 
concentrations of amino acids may be required to sustain an adequate mammary uptake later 
in lactation. This should be verified in larger scale studies since it is something that 
potentially could open up for improvements of nitrogen utilization in dairy production 
through implementation of differential protein recommendations during lactation. 
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Appendixes 
 
Appendix 1 
 
Biopsy sampling 
Before taking biopsies using a fine needle biopsy gun (BIOPTY, Radiplast AB, Uppsala, 
Sweden, 14G x 10 cm biopsy needle, length of sample notch approximately 1.9 cm), we 
washed the target area by a scrub-brush containing anti-microbial skin cleaner, shaving, 
disinfecting  with iodine, marking the insertion point, making local anaesthesia (0.5 ml 
Lidocain 20 mg/ml for each side), and penetrating skin by using a large gauge needle (18G). 
To avoid insertion of biopsy needle in major blood vessels (basement and midline of the 
udder) and ductal area (nipples dorsal part), we were pulling the nipples in ventral and then 
cranial direction, and pushing it towards the sampler (caudally) by pressing the cranial part. 
After sampling, if there was no bleeding, we were using Penicillin powder and then Wound 
Plast to make a cover on the wound. The animal was milked, both before (to avoid milk in the 
biopsy) and after sampling (to remove any blood clots in the udder). 
 
Note:  
• It was tried to take samples from the same site of the gland at each sampling, by 
recording its position compared to the base- and midline of the udder. Of course, the 
size of the gland varies at different stages of gestation-lactation and doing so, was 
most helpful when the times of  samplings were for stages close to each other, 
especially around the parturition time. 
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Appendix 2 
 
Tissue preparation 
 
The mammary tissue samples were fixed in 4% para-formaldehyde (PFA) solution (see 
appendix 2) for one day, then dehydrated in graded series of ethanol (70%, 80%, 95% and 
100%) (2 × 60 min each), cleared in xylene (3 × 60 min), infiltrated with paraffin wax (56-58 
ºC) (2 × 90 min), and embedded in paraffin (Histokinet, Shandon Citadel 2000, UK). Samples 
were further sectioned in sections of 4 µm thickness (Microtome, Jung, Germany). Slides 
were dried in 37°C oven over two nights before being stained or stored. 
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Appendix 3 
 
Preparation of 4% PFA 
 
- Solution 1 
NaH2PO4  5,52 g     (NaH2PO4, H2O = 6,35g) 
Milli-Q water 200 ml 
 
- Solution 2 
Na2HPO4  28,83 g 
Milli-Q water 810 ml 
 
- Prepare 2L 0.1M PO4-buffer pH7,4 
Adjust Solution 2 to pH 7.4 with solution 1 
Dilute solution 2 (pH=7.4) with water 1:2 (1 liter Solution 2 (pH=7,4) + 1 liter Milli-Q water) 
 
- Prepare 4% paraformaldehyd in 0.1M PO4-buffer pH 7,4. (=4%PFA) 
Paraformaldehyd 20 g 
0.1M PO4-buffer pH 7.4 500 ml 
Place it on a heater with magnet (3-4 hours) until the solution is clear. 
Before use, place the 4%PFA in the refrigerator. 
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Appendix 4 
 
Mayer’s Haematoxylin-Eosin (H&E) method  
(Procedure for goat mammary samples) 
This is a combination of hematoxylin and eosin (H&E). Hematoxylin stains the acidic 
structures of the cell, including the (chromatin within) nucleus and the parts of cytoplasm 
which are rich in RNA, in a blue colour (Janqueira et al., 1995).  In contrast, eosin stains the 
cytoplasm in red and collagen in pink. H&E is one of the most commonly used methods in 
histology (Lun., 1968), giving details of various components in the tissue. In our studies 
(papers 1 and 3), various components such as alveoli and its lumen in general and MEC and 
its grade of differentiation in particular have been quantified or qualified using H&E slides. 
But, H&E stains glycogens weakly, if at all. That’s why another staining method, PAS has 
been tried (explained below), to be able to distinguish micro-vessels more clearly in the 
slides. 
 
 
 
Notes: 
• Steps 1-3, 4-6, 18-20 and 21-23, each in 3 separate jars. 
• Steps *8,*15- The same work. 
• Step 10- Mayers, BIE&B: LAB 12735. – Filtering every day, Use only 5 times! 
• Step 13- The running tap water should flow in a moderate stream, neither too much 
nor too little. 
• Step 16- Filtering every day! 
Step Procedure Time (min.) 
1 Xylene I 5 
2 Xylene II 5 
3 Xylene III 5 
4 Absolute alcohol I 5 
5 Absolute alcohol II 5 
6 Absolute alcohol III 5 
7 96% Alcohol 2 
8* 70% Alcohol 5 
9 Distilled water 5 
10 Staining in haematoxylin 30 
11 Washing with running tap water 5 
12 Differentiation in Acid-Alcohol 2-4 times (dip) 
13 Washing with running tap water 5-10 
14 Distilled water 2 
15* Dehydration in 70% alcohol 2 
16 Counterstaining in eosin 1% 5 
17 Dehydration in 96% alcohol 5 times (wash) 
18 Dehydration in absolute alcohol I  2 
19 Dehydration in absolute alcohol II 5 
20 Dehydration in absolute alcohol III 5 
21 Cleared in xylene I  5 
22 Cleared in xylene II 5 
23 Cleared in xylene III 5-… 
24 Mounting with xylene based medium (Covering)  
[80] 
 
• Step 24- BIE&BERNSTEN A-S, DPX Mountant, BDH, Prod 360294H – 500 ml. 
• Step 24- The mounting at the end should be done in the fume cupboard, taking care 
the mounting solution does not enter the rubber tip as this dissolves over time as it 
contains xylene (i.e do not press the tip too hard when the pipette is in the bottle). 
• Step 24- Make sure there are no air bubbles between the mounting glass and the tissue, 
eventual bubbles can be ‘squeezed’ out pressing on the mounting glass. 
• Step 24- Leave the mounted slides 2 days in the fume cupboard before use. 
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Appendix 5 
 
Periodic Acid-Schiff Reaction (PAS) 
(Procedure for goat mammary samples) 
 
Periodic acid-schiff (PAS) reaction demonstrates glycogen, a ubiquitous polysaccharide in the 
body, not bound to a protein or lipid. The PAS reaction, based on the oxidative action of 
periodic acid (HIO4) on 1, 2-glycol groups present in the glucose residues (carbohydrates), 
gives rise to aldehyde groups that react with Schiffs reagent, providing a new complex 
compound with a purple or magenta colour (Janqueira et al., 1995). That is why PAS is a 
staining method preliminary used to identify the tissue structures like vessel walls to which 
the carbohydrates are attached. 
 
Step Procedure# Time (min.) 
1 Xylene I  5 
2 Xylene II 5 
3 Xylene III 5 
4 Absolute Alcohol I  5 
5 Absolute Alcohol II 5 
6 Absolute Alcohol III 5 
7 96% Alcohol 2 
*8 70% Alcohol 5 
9 Distilled Water 5 
10 Oxidization in periodic acid 0.5% 5 
11 Washing in running tap water 5 
12 Rinsing in distilled water Once 
13 Schiff Solution 20 
14 Washing in running tap water 5 
15 Rinsing in distilled water Once 
16 Counterstaining Mayer’s haematoxylin 3 
17 Washing in running tap water 5 
18 Differentiation in 1% Acid-Alcohol 3 (Dip) 
19 Washing in running tap water 10 
20 Rinsing in distilled water Once 
*21 Dehydration in 70% alcohol 2 
22 Dehydration in 96% alcohol 2 
23 Dehydration in absolute alcohol I 2 
24 Dehydration in absolute alcohol II 5 
25 Dehydration in absolute alcohol III 5 
26 Cleared in xylene I 5 
27 Cleared in xylene II 5 
28 Cleared in xylene III 5-… 
29 Mounting with xylene based medium (Covering) … 
 
 Notes: 
• 1-3, 4-6, 23-25 and 26-28, each in 3 separate jars 
• *8,*21- The same work. 
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• 10- Merck: 100524 – 25 g – H5106 , 0,75 g + 150 ml H2O every day. 
• 13- Merck: 109033 – 500 ml. 
• 16- Mayers, BIE&B: LAB 12735. 
• 18- HCl - 96% or 70% Ethanol (880 ml 70% Eth. + 24 ml HCl (concentrated)). 
• 29- BIE&BERNSTEN A-S, DPX Mountant, BDH, Prod 360294H – 500 ml. 
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Appendix 6 
 
Immunohistochemistry methods Ki-67 and TUNEL 
 
Ki-67. All cells are able to express Ki-67 protein during different phases of the cell cycle 
except in phase G0 (Gerdes et al., 1991). Therefore, labelling of this protein is considered a 
good marker of cell proliferation. 5-bromodeoxyuridine (BrdU) is another way of labelling 
the proliferation in the cell, which binds to the single strand DNA in S phase, and therefore, 
gives a narrower result compare to Ki-67 which could be localized from G1, S, G2 and M 
phases. But, the problem with BrdU is its toxicity and mutagenic effects (Littlefield and 
Gould, 1960), and it has to be given to the animal in vivo, which gives one chance of 
sampling and ends in sacrifying the animal (Capuco et al., 2001). This was not possible in 
studies like ours with a unilateral design following the experimental units (udder halves) over 
the course of time (repeated measurements). Another point to be considered with regards to 
such techniques, is the duration of the cell cycle which is different in various cell types (Smith 
and Martin, 1973), and about 24 hours for mammary epithelial cells (Norgaard, 2007). 
 
TUNEL. The duration of apoptosis in a cell is about three hours (Bursch et al., 1990; Capuco 
et al., 2001). The TUNEL assay is based on labelling of the 180-200 nucleotide DNA 
fragments, which are characteristic for apoptotic cell (Bortner et al., 1995; Norgaard, 2007). 
Short duration (3 hours) of apoptosis compared to substantially longer duration of 
proliferation (24 hours) is the reason why a direct comparison between the outcomes of the 
two staining methods in tissue sections can not be made. 
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Appendix 7 
 
Real time RT-PCR  
Reverse transcription (RT) followed by a polymerase chain reaction (PCR) is the best known 
technology for detection of the amounts (relative quantification) of mRNA (Lockey et al., 
1998) (see figure 1). When there is a small amount of tissue (for example, biopsy sample) and 
with low abundant transcripts and low RNA concentrations, qRT-PCR is known as the most 
sensitive and most reliable method, because of its high sensitivity and potential for 
quantitative applications (Bustin, 2000; Freeman et al., 1999; Schmittgen et al., 2000). As 
shown in figure 1, it is a multi-step process; single strand RNA extraction from the tissue 
sample, and then, its conversion to a double-stranded complementary DNA (cDNA, which is 
more resistant to degradation than RNA), and then followed by its exponential amplification 
in a series of PCR reactions, called real-time PCR replicating the cDNA (of typically 120-200 
nucleotides) for e.g. 40 times. 
 
Figure 1- Different steps of real-time RT-PCR process (Tevfik Dorak, 2007). 
 
Sample     extraction     RNA    reverse transcription     cDNA     real-time PCR      Result 
 
To do our analyses, two systems for real-time RT-PCR method have been used (Bustin, 
2000): 1) SYBR® Green, a fluorescent dye binds to cDNA and becomes fluorescent. and 2) 
TaqMan® , which is based on binding of a specific fluorescent probe to the template between 
the two primers. Extension of primers displaces and cleaves the probe. When cleaved, the 
probe becomes fluorescent. The second method results in a high PCR specificity and provides 
strong assays even with poor quality samples. As much as possible, the TaqMan® method 
was prioritized to be used. Respect to shortages at the time (in year 2006), such as availability 
of designing software as well as time and economical limitations, the other method, SYBR® 
Green was chosen. 
Being built on continuous amplification of the target gene, the main positive point for real-
time RT-PCR method is its high sensitivity to low expressed genes. In general, real-time RT-
PCR as a fairly fast and cheap method, made it possible and realistic to look for many 
biological patterns in our study.  
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Appendix 8  
 
Techniques for subcutaneous replacement of the carotid artery (Fleet and Mepham, 1983) 
• Cut the skin dorsally and parallel to the direction of the jugular vein. 
• Loosen the skin from the 
facia if the facia is not cut 
through along the incision. 
• Using non-traumatic 
dissection, find the artery 
behind the jugular vein 
and between the muscles. 
It runs in the tunica 
together with vagus nerve. 
• Loosen the tunica with 
both artery and nerve from 
the underlying tissue 
• Using a rubber band, lift 
both carotid artery and the 
nerve (figure above). 
• Free the artery from the 
nerve. 
• Leaving the nerve in its 
original place, reclose the 
facia with absorbable 
sutures underneath the 
freed artery (figure in 
front). 
• Using 2-3 single 
interrupted sutures (4-0 
absorbable suture and and 
a non-traumatic needle), fix the artery to the subcutaneous layer in an arch above the 
incision 
• Close the incision using first a 
subcutaneous continuous absorbable 
suture in the subcutaneous to fixate 
the wound and then single 
interrupted monofilament sutures in 
the skin. 
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Appendix 9 
 
Techniques for making skin-loop around the milk vein (Fleet and Mepham, 1983) 
• Make two parallel incisions (about 7.5 cm each) with a distance of about 4.5 cm both 
dorsal and ventral parts around the vein (figure below). 
 
 
 
• Dissect the skin from the underlying tissue and the vein. 
• Using 1-2 rubber band(s), elevate the skin (figure below). 
• Dissect the vein from the underlying tissue.  
• Using 1-2 rubber band(s), elevate the vein (figure below). 
 
 
 
• Use two vertical U-sutures (0 monofilament suture) to draw the abdominal skin edges 
towards one another. It makes it easier to do the final suturing. 
• Suture the loop and the abdominal skin (3-0 monofilament suture). 
• Using just one assembling suture on each end, close the wound edges of the loop-skin 
and wound edges of the neck-skin (figure below) 
[87] 
 
 
 
• Suture (single interrupted) the abdominal skin (figure below). 
 
 
 
• Suture (single interrupted) the the loop-skin around the vein. 
 
 
 
 
 
 
 
[88] 
 
Appendix 10 
 
Catheterisations (for continuous infusion) 
 
In the continuous infusion project, temporary home-made catheters (Portex translurent PVC, 
0.63 ID, 1.40 OD, Smiths SIMS Portex limited, UK) were inserted in one Vena Jugularis 
prior to the start of infusing the solutions. To prepare the catheter, the material was cut in 
pieces to a length of 40 cm and marks were made with a speed marker 10, 15 and 20 cm from 
the one end. They were placed in a hibitane-ethanol solution (70% ethanol) for disinfection. 
The animal was prepared on the neck by shaving, washing and disinfecting with iodine. The 
place of insertion, on top of Vena Jugularis was marked with a speed marker and 1 ml 
lidocain (local anaesthesia) was applied under the skin. After a few minutes, a 3 inches 14G 
needle was introduced into the vein and the catheter was pushed through the needle, which 
was then removed. The depth of the catheter was adjusted according to the marks, fitted with 
a rubber band at the exit point from the skin, which was then sutured to the skin. The catheter 
was placed in a pouch and the animal was fitted with a protecting collar. Temporary pre-made 
catheters were inserted in Vena Jugularis (Secalon® T ,18 G, Ohmeda, Swindon, UK) and 
into an exteriorised milk vein (v. Caudalis Superficialis Epigastrica) (Venflon®, 20G, 
Ohmeda, Swindon, UK). The place of insertion, on top on Vena Jugularis was marked with a 
speed marker, and 1 ml lidocain (20mg/ml; local anaesthesia) was applied subcutaneously. A 
small incision was made through the skin and the underlying fascia, and thereafter the 
catheter was introduced. The needle was removed and the Vena  Jugularis catheter was 
sutured to the skin, whilst the milk vein catheter was fitted with sleek around the milk vein 
loop. The function of the catheter was checked, and the catheter was rinsed with 5 ml isotonic 
NaCl solution containing 100 IU /ml heparin to avoid clotting of blood in the catheter in 
between samplings. The catheter was placed in a protecting collar of Danagrip and Co-Plus® 
(BSNmedical Ltd, BB9 5NJ, USA) around the neck and body of the animal. Catheters were 
flushed with a heparin solution (100 IU/ml in saline) after each sampling to avoid clotting of 
blood in the catheter. Stronger solutions (e.g. 500 IU/ml) were used when the catheter was not 
used for longer time intervals (usually not more than two weeks).  
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ABSTRACT 
 
The present study aimed to 1) elucidate whether continuous milking during late gestation in 
dairy goats negatively impacts mammary remodelling and hence milk production in the 
following lactation, and 2) identify the regulatory factors responsible for changes in cell 
turnover and angiogenesis in the continuously lactating mammary gland. 
Nine multiparous dairy goats were used. One udder half was dried-off approximately 9 weeks 
pre-partum (normal lactation; NL), and the other udder half of the same goat was milked 
continuously (continuous lactation; CL) until parturition, or until the half-udder milk yields 
had dropped to below 50 g/d. Mammary biopsies were obtained from each udder half just 
before the NL gland was dried off (BDP; before dry period), within the first 2 weeks after 
drying-off (EDP; early dry period, samples available only for NL glands), in the mid-dry 
period (MDP), within the last 2 weeks prior to parturition (LDP, late dry period), and at days 
1 (the day of parturition), 3, 10, 60, and 180 of lactation. Mammary morphology was 
characterised in biopsies by quantitative histology, and cell turnover was determined by 
immunohistochemistry (TUNEL and Ki-67). Transcription of genes encoding factors 
involved in mammary epithelial cell (MEC) turnover and vascular function was quantified by 
quantitative reverse transcription PCR. Results demonstrated that omitting the dry period was 
possible in goats, but not as easy as claimed before. MEC renewal was suppressed in CL 
glands, which results in a smaller MEC population in the subsequent lactation. At the time of 
parturition (and throughout lactation), the mammary glands subjected to CL had smaller 
alveoli, more fully differentiated MEC and a substantially larger capillary fraction compared 
with NL glands. The continuously lactating gland thus resembled a normally lactating gland 
in an advanced stage of lactation. None of the studied genomic factors could account for these 
treatment differences. The described characteristics in CL glands compared to NL glands 
indicated a gland maintained in lactation for a longer period of time.  
Key words: continued milking, cell turnover, angiogenesis, dry off 
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INTRODUCTION 
 
Milk production in ruminants is determined not only by the genetic capacity of the animal but 
also by management factors such as duration of the dry period in between successive 
lactations. The dry period appears to be essential for dairy animals to ensure that the 
mammary epithelial cell (MEC) population can be effectively renewed as one lactation comes 
to the end and prior to onset of the next lactation (Capuco et al., 1997). The MEC population 
renewal is reported to be crucial to ensure optimal milk production in the following lactation 
in dairy cows (Madsen et al., 2008; Remond et al., 1997; Swanson, 1965). Only few studies 
have been performed on continuous lactation (CL) in dairy goats, and the impact of omitting 
the dry period on milk production in the next lactation in this species appears to be less clear. 
Fowler et al. (1991) and Mackenzie (1967) reported that CL had no negative effect on milk 
yield in the subsequent lactation. However, the experimental design by Fowler et al (1991) 
included an unusually long dry period of 24 weeks. In contrast to this, Caja et al. (2006) 
reported decreases in milk production of 29% in dairy goats in response to omitting the dry 
period.  
The level of milk production and the changes in milk yield over the course of lactation,  
depend on three main factors: 1) the number of MEC, which in turn is affected by the balance 
between the rate of epithelial cell proliferation and apoptosis (Capuco et al., 2003; Knight, 
2000); 2) the secretory activity of these cells, which in turn is affected by their differentiation 
(Akers et al., 2006); and 3) the provision of nutrients and removal of metabolic waste 
products via the blood.  
It has been reported previously in the dairy cow that omitting the dry period and milking of 
dairy cows continuously from one lactation into the next will interfere with MEC cell renewal 
(Annen et al., 2008; Capuco et al., 1997; Sorensen et al., 2006). This is likely to provide some 
of the explanation for the negative impact of CL on milk production in the next lactation. It 
remains to be established how and by which mechanisms continuous milking during late 
gestation can interfere with the regulation of MEC renewal. 
Angiogenesis is the process by which new capillaries are formed from pre-existing blood 
vessels; a process known in other species to be associated with mammary remodelling 
(Matsumoto et al., 1992). The mammary microvasculature indirectly plays a very important 
role for milk synthesis by providing the nutrients and oxygen to the MEC and removing the 
metabolic waste products, which is essential to sustain milk synthesis (Djonov et al., 2001). 
However, there is a scarcity of information available for dairy animals regarding the normal 
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remodelling of the mammary microvasculature during the dry period in preparation for the 
next lactation (Akers, 2002). It is unknown whether continued milking during the late 
gestation period will interfere with this remodelling of the mammary microvasculature.  
We hypothesized that omission of the dry period can interfere not only with key regulatory 
mechanisms responsible for renewal and differentiation of the MEC population (cell turnover 
and lactogenesis), but also with mammary vascular function and angiogenesis, which prevents 
the MEC population from fully expressing their production potential. We further 
hypothesized that dairy goats would be similar to dairy cows in this respect. 
The objectives of the present study on the dairy goats were therefore to: 
1) determine if the negative impact of CL on mammary synthetic capacity in the following 
lactation can be ascribed to interference exclusively with mammary cell turn-over and 
differentiation, or whether angiogenesis and hence tissue structures supporting metabolic 
activity are also affected. 
2) identify through which regulatory mechanisms CL interferes with mammary cell turn-over 
(apoptosis and cell proliferation), vascular function and angiogenesis. 
 
MATERIALS AND METHODS 
 
Experimental Animals 
Nine Danish crossbred Landrace-Saanen dairy goats (parity ≥ 2) were used over one (5 goats) 
or two consecutive (4 goats) lactation periods. They were fed a diet consisting of hay ad 
libitum, supplemented with barley, concentrate, and molasses, according to their 
requirements. Animals had free access to fresh water and a vitamin/mineral supplement. They 
were milked manually at 0900 and 1530 h and fed twice a day at 0730 and 1430 h,  half the 
ration being given at each feeding. The experiment was carried out at the experimental 
facilities at the Faculty of Life Sciences, University of Copenhagen, Denmark, and approved 
by the Danish Animal Experimentation Inspectorate, and complied with the Danish Ministry 
of Justice laws concerning animal experimentation and care for experimental animals. 
 
Experimental Design 
The experimental design was a randomized complete block design with two treatments in 18 
blocks. The two udder halves in each animal were randomly subjected to two different 
treatments, thus using the animal as its own control: one udder half was dried-off 
approximately 9 weeks prior to expected kidding followed by a normal lactation (NL), 
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whereas the other udder half was milked continuously throughout pregnancy and into the next 
lactation (CL). Omission of the dry period was not done in the same gland two consecutive 
years. Milk yield of individual udder halves was recorded daily during the first 10 days of 
lactation, and twice per week during the rest of the experiment.  
 
Mammary Gland Biopsies 
Mammary biopsies were obtained from both mammary glands at different time points during 
gestation and lactation: just before drying-off of the NL gland (before dry period; BDP), 
within the first 2 weeks after drying-off (early dry period; EDP) (samples available only for 
NL glands), in the mid-dry period (MDP), within the last 2 weeks prior to parturition (LDP, 
late dry period), and at d 1 (day of parturition), 3, 10, 60, and 180 of lactation (Figure 1). 
From each mammary gland, two biopsies were sampled according to the procedure described 
by Cvek et al. (1998).  
Histology and immunohistochemistry. Mammary biopsies were fixed in 4% 
paraformadelhyde (PFA), embedded into paraffin blocks, sliced and prepared to be stained 
for detection of cell apoptosis (TUNEL) and proliferation (Ki67), and histomorphological 
studies (H&E and PAS), as described by Norgaard et al. (2008a). Random micrographs were 
taken at primary magnification 400x at a light microscope (Leica DMR, Leica microsystems, 
Germany) with a camera (Leica DPC 490, Leica microsystems, Germany) connected to 
computer. Using ImageJ software (Abramoff et al., 2004), a 30 points transparent grid was 
put on each micrograph. Proportions refer to the number of point hits on a given cell or tissue 
structure compared to the total number of hits, and numbers refer to the total number of that 
structure observed in the whole picture. When a point was hitting a mammary epithelial cell 
(MEC), it was classified into poorly, intermediate or fully differentiated epithelial cell 
according to its secretory activity as described by Akers et al. (2006). Briefly, a fully 
differentiated polarized MEC has a basally located and rounded nucleus, a high cytoplasm to 
nucleus ratio, and many vacuoles including large apical lipid droplets. Intermediately 
differentiated MEC have fewer vacuoles, more irregularly shaped nuclei, and a smaller 
cytoplasm to nuclei ratio compared with fully differentiated cells. Poorly differentiated MEC 
have very few if any vacuoles, large or randomly positioned lipid droplets, very little 
cytoplasm, and an oval (flattened) nucleus (Figure 2). The counting of coinciding points with 
the mentioned desired structures allowed the unbiased estimation (Gundersen et al., 1988) of 
volume fractions for each animal. 
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Real Time Reverse Transcription-PCR. Genes were chosen to be analyzed based on their 
suggested roles in mammary growth, remodelling and function (Table 1). As shown in tables 
1-3, target genes were divided in two groups: 1) Genes related to vascular function: 
cyclooxygenase I (COX1), cyclooxygenase II (COX2), prostocylcine synthase (PTGIS), 
thromboxane A2 synthase (TBXAS) and carbonic anhydrase IV (CA4), and angiogenesis: 
angiopoietin I (ANGPT1), angiopoietin II (ANGPT2), tyrosine kinase tie2 receptor (RTK), 
vascular endothelial growth factor (VEGF), vascular endothelial growth factor receptor 1 
(VEGFR1) and vascular endothelial growth factor receptor 2 (VEGFR2), and 2) Genes 
related to cell turnover and lactogenesis: B-cell CLL/Lymphoma- 2 (BCL2), Bcl2-Associated 
X Protein (BAX), cyclin D1 (CCND1), insulin-like growth factor I (IGF1), insulin-like 
growth factor I receptor (IGF1R), insulin-like growth factor binding protein III (IGFBP3), 
insulin-like growth factor binding protein V (IGFBP5), transforming growth factor beta I 
(TGFB1), transforming growth factor beta I receptor I (TGFB1R1), transforming growth 
factor beta I receptor II (TGFB1R2), prolactin receptor (PRLR), alpha-lactalbumin 
(LALBA), lactoferrin (LTF), leptin (LPT) and leptin receptor (LPTR). Transcription of 
target genes was quantified by real time RT-PCR. Approximately 10 mg of mammary tissue 
was homogenized in 350 µL of RNeasy lysis buffer and diluted (1:1) with 70% ethanol. The 
RNA was purified using the RNeasy mini kit (Qiagen, Albertslund, Denmark) and reverse-
transcribed with oligo-dT and Superscript II RNAse H reverse transcription kit (Invitrogen, 
Taastrup, Denmark) according to the manufacturer’s protocol. Reverse-transcribed material (1 
µL) was amplified with TaqMan Universal PCR Master Mix (Applied Biosystems, 
Stockholm, Sweden) using gene-specific primers. Locked nucleic acid (LNA) probes from the 
human Universal ProbeLibrary (Roche Applied Science, Hvidovre, Denmark), labeled with 
FAM fluorophore were used for detecting amplified LPT, PRL-R, BAX, CCND1, IGF1R, 
LTF, ANGPT2 and COX2 genes.  Power SYBR-Green PCR Master Mix (Applied 
Biosystems, California, USA)  was used for detection of the remaining genes: LPT-R, BCL2, 
IGF1, IGFBP3, IGFBP5, LALBA, VEGF, VEGF-R1, VEGF-R2, CA4, TBXAS, TGFB1, 
TGFB1-R1, TGFB1-R2, RTK, ANGPT1, COX1 and PTGIS. Melting curves showed no more 
than a single amplified product. The PCR amplification signal was detected using an ABI 
PRISM 7900 detection system (Applied Biosystems). Transcription of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), 18S ribosomal RNA I (18S RNR1) and beta-actin 
(ACTB) were quantified and their appropriateness as house keeping gene (HKG) were 
evaluated against the total RNA content. Transcription of target genes were normalized by the 
mean transcription level of GAPDH as HKG, as suggested by Vandesompele et al. (2002) and 
[95] 
 
described by Theil et al. (2006). The oligonucleotide sequences for the genes were designed 
using the Primer Express software, version 2.0 (Applied Biosystems Inc, CA, USA) or 
Beacon Designer Version 7.00 software (Premier Biosoft International, CA, USA). No 
amplification was found in ribonuclease free water and in samples of genomic bovine DNA. 
For qRT-PCR, 40 cycles were used at 95°C for 15 s, and 60°C for 60 s. The response was 
quantified as the number of PCR cycles required to reach a certain threshold, and samples 
were analyzed in duplicates. The oligonucleotide sequences of forward primers, LNA probes 
(when used), and reverse primers for the genes are shown in table 3.  
Gene expression data were obtained as Ct values (the cycle number at which PCR cycles 
logarithmic plots cross a calculated threshold line) to evaluate mRNA quantities according to 
the manufacturer’s guidelines, and used to determine ∆Ct values: 
∆Ct = [Ct of the target gene] – [Ct of the reference gene (GAPDH)] 
Least square means of ∆Ct values of target genes were normalized to the level observed at 
BDP of NL glands, by calculating the ∆∆Ct values: 
∆∆Ct = [∆Ct observed at a given stage for CL or NL] – [∆Ct observed at BDP for NL] 
The relative mRNA quantity was calculated as Q
-∆∆Ct
, where Q is 1 + PCR efficiency as 
determined by 10
-1/slope of standard curve
 -1 (Rasmussen, 2000). In cases with 100% PCR 
efficiency, this formula was simplified to the following:  
Relative mRNA quantity (100% efficiency) = 2
-∆∆Ct
 
All statistics were performed at the ∆Ct level (Theil et al., 2006) to exclude potential bias 
because of averaging data that had been transformed through the equation 2
-∆∆Ct (Pfaffl, 
2001). Expression of both 18S rRNA and ACTB but not GAPDH were affected by parity. 
Therefore, GAPDH was selected to be used as housekeeping gene (HKG) for data 
normalization. 
 
Statistical Analysis and Calculations 
Statistical evaluation of all data was performed using the Mixed procedures in SAS (SAS 
Institute, 2003). Variables in the statistical models included the experimental year, treatment 
(CL or NL), experiment day at which the biopsy sample has been taken and its interaction 
with treatment as fixed effects, and the factors goat, goat within experimental year, and gland 
within goat at each experiment day as random effects, as shown in the following model:  
 Y = µ + αi + βj + γk + βγjk + ρl + τil + υklm  + εijklm, where 
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Y= the dependent variables, µ= the overall means, αi= experimental year (i=1,2), βj= 
lactation regimen (j= CL and NL), γk= experiment day (k= BDP, MDP, EDP, D1, D3, D10, 
D60 and D180), βγjk = interaction between lactation regimen and experiment day, ρl= 
random effect of goat (l=1, 2,..,9), τil = random effect of goat within a year, υklm  = random 
effect of udder half within a goat within a year (m= left, right), εijklm= random variation 
which was assumed to be normally distributed with a variance σ2 and a mean of zero. For 
analysis of milk yield, week of lactation was included as fixed effect instead of experimental 
day. Before performing the final statistical analyses, data were checked for outliers based on 
residual plots. The data from poorly differentiated MEC as well as cell proliferation and 
apoptosis were arc-sinus transformed to meet statistical assumptions for normal distribution. 
However, the back-transformed data are presented in figures. Presented results are expressed 
as least squares means with standard error of mean. The PDIFF option in SAS was used to 
generate comparisons between treatment means. The level of significance was set at P < 0.05.  
 
RESULTS 
 
Milk Yield  
In experimental year 1, 6 glands (6 goats, and one of each) were attempted to be milked 
continuously during the late gestation period, but only 2 glands completed a CL with a milk 
production above 50 g/d  until the day of parturition, In experimental year 2, out of 7 glands 
(7 goats, and one of each) assigned to the CL treatment, only 4 glands remained lactating 
throughout the entire gestation period. Thus, a total of 6 glands completed a CL out of 13 
attempts over the 2 years. 
Half-udder milk yield data were available only for the first 2 weeks of lactation and again 
from lactation day 60 and onwards due to unfortunate erroneous recordings in the period in 
between. However, based on these milk yield data, it was evident that out of the total number 
of 6 glands which completed a CL, milk production was numerically suppressed in 2, it was 
unaffected in 2 and was numerically increased in 2 compared with the milk production in the 
contra-lateral NL gland, and overall CL thus had no significant impact on milk yield (data are 
not shown). 
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Mammary morphology 
Gross morphological changes. In mammary sections, the highest number of alveoli per 
picture (5.6), the lowest proportion of MEC (34%), lowest proportion of lumen (17%), the 
highest proportion of interstitial tissue (49%) and the peak in micro-vessel proportion (19%) 
were observed in the middle of the dry period (MDP) (Figure 2), compared to other 
developmental stages examined. In general, no statistical differences were observed between 
the CL and NL glands. Closer to parturition in period LDP, the proportion of micro-vessels 
(17%) remained high, alveoli proportion (66%) as well as alveoli lumen (30%) and MEC 
fractions (37%) increased in both CL and NL glands compared to MDP, whereas the 
proportion of interstitial tissue (34%) and alveoli numbers per picture (3.6) decreased. At 
parturition, the proportion of MEC had increased even further (44%), while lumen and 
interstitial tissue (30%) remained at the same high level (25%) as in LDP, and the micro-
vessel proportion was decreased (12%). Overall, this resulted in peak values in alveoli 
proportion in sections at D1 and D10 (71 and 73%, respectively), but distributed on a lower 
number of alveoli. NL glands tended (P=0.08) to have a lower number of alveoli (2.8) 
compared to CL (3.8) glands at the day of parturition ( D1). 
Alveolar lumen and interstitial tissue areas remained relatively constant during early to mid-
lactation, but the alveoli and MEC fractions gradually decreased. MEC decreased the most in 
CL glands and were similar in NL glands in mid (38 vs. 44%, respectively) and late lactation 
(37 vs. 41%, respectively). The micro-vessel proportion did not change in early-mid lactation 
in the NL glands, but increased during this period and became significantly highest from D10 
and onwards in the CL glands. Concurrently, alveoli number remained at the same level in NL 
glands during lactation; but gradually declined in CL glands to lower levels than observed in 
the NL glands.  
The lowest values during lactation for epithelial (39%), lumen (23%) and alveoli fractions 
(63%) were observed during late lactation. The decreases from early to mid-lactation were 
numerically more pronounced in the NL glands than in the CL glands, and alveoli number 
remained similar to CL (2.2) compared to NL glands (3.0) (P=0.18). The opposite was 
observed for interstitial tissue, where the highest values during lactation were observed in late 
lactation (38%), and the micro-vessel fraction was substantially higher in CL compared to NL 
glands (20% and 11%, respectively) at this time point. 
Differentiation of MEC. As shown in Figure 2, intermediate differentiated MEC proportion 
was high (83%), while the poorly differentiated MEC was low (11%) in both kinds of glands 
in period BDP (before drying off the NL gland). At MDP, the proportion of intermediate 
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differentiated MEC declined to its lowest level (31%), while poorly differentiated MEC 
peaked (68%) at this time-point. Although poorly differentiated MEC were significantly 
higher in NL than CL glands at MDP (68% and 48%, respectively, P=0.01) and LDP (41% 
and 15%, respectively, P=0.004), the proportion of poorly differentiated MEC reached the 
same low level in both glands at parturition (4%) and during the following lactation. On the 
other hand, the proportion of intermediate differentiated MEC rose in both glands to reach a 
plateau (79%) a few days after parturition (D3) and remained at this level during the rest of 
lactation. Fully differentiated MEC proportion was low in both glands in BDP (14%), rose at 
LDP where it tended (P=0.10) to be higher in  CL (36%) than NL glands (20%), and it 
remained higher in CL compared to NL glands throughout lactation, either numerically or 
statistically. Across the whole gestation-lactation period, CL glands thus had significantly 
higher (P=0.004) proportion of fully differentiated MEC (24%) than NL glands (15%); but a 
lower proportion of poorly differentiated MEC compared with NL glands (16% vs. 21%, 
P=0.003).  
 
Immunohistochemistry  
As shown in figure 3, MEC proliferation happened predominantly in late gestation prior to 
parturition, and was high in MDP (3.1% in CL and 6.8% in NL glands) and peaked in LDP 
(5.0% in CL and 8.0% in NL glands). The fraction of apoptotic cells (cell staining positive in 
the TUNEL assay) peaked in both glands (0.4%) in the early stage of lactation (D10). The 
proportion of cell staining positive for apoptosis and proliferation remained low throughout 
the rest of the lactation period.  
In general, CL glands had lower rate of cells staining positive for proliferation than NL glands 
(P=0.03), particularly during gestation (MDP, P=0.001 and LDP, P=0.02). Postpartum, the 
CL glands tended to have higher rate of apoptosis a few days after parturition compared with 
the NL glands (D3, P=0.12), and hence generally lowered rates of cell renewal in the peri-
partum period. 
 
Gene Expression 
Genes related to Cell turnover and lactogenesis. In general, BCL2, CCND1, IGF1, IGFBP3 
and LPTR had a high level of expression in mid to late dry period, as shown in Figure 4-A. 
Their expression levels dropped at parturition and remained low or decreased during the 
remaining part of lactation. An opposite pattern was observed for LALBA which was very 
low prepartum and increased at parturition and remained high thereafter. Although the general 
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pattern of changes in gene expression was the same in the two experimental years, the 
expression of LALBA was for unknown reasons higher in the second experimental year than 
the first.  
CL glands had significanlty higher expression of LALBA (P=0.03) compared to NL glands, 
and this was due to higher expression in CL glands of LALBA in late gestation, where CL 
glands were lactating and NL glands dried off . Contrast analyses, performed at each sampling 
stage, showed that CL glands compared to NL glands had higher mRNA expression of LTF 
(P=0.01) in LDP, CCND1 (P=0.04) at parturition, and of BAX in late lactation (P=0.03). In 
addition, there was a tendency for higher expression of IGFBP5 (P=0.08) at parturition and of 
IGF1 in mid lactation (P=0.08). In late lactation, however, expression of LTF was found to be 
lower (P=0.01) in CL compared to NL glands. There were no significant changes in 
expression of IGF1R, TGFB1, TGFB1R1, TGFB1R2, PRLR and LPT (data not shown) 
during the course of gestation-lactation in neither CL nor NL glands and no impact of CL on 
expression of these genes. 
Genes related to vascular function and angiogenesis. As shown in Figure 4-B, expression 
levels of CA4 and VEGF were low in LDP, increased at parturition and peaked a few days 
after (D10), and thereafter remained the same in CL than NL glands. Expression of ANGPT1 
and COX2 was high during the dry period, especially at MDP in NL glands and at parturition 
day in CL glands. ANGPT1 decreased to a lower level a few days after parturition (D3) and 
remained constant until late lactation. With a little delay, COX2 started to gradually decrease 
from D10 of lactation and reached its lowest level in mid-late lactation. For the rest of the 
studied genes (COX1, PTGIS, TBXAS and RTK), expression levels were fairly constant 
throughout the course of gestation-lactation (data not shown). The general pattern of changes 
in gene expression was the same in the two experimental years, but expression of ANGPT2 
was higher in the second year. 
In general, CA4 (P=0.06) tended to be higher in CL than NL glands. CL glands had higher 
expressions compared to NL glands of ANGPT1 (P=0.002) and VEGFR2 (P=0.007) at 
parturition, and tended to have higher expressions also of CA4 (P=0.08) at D10. However, 
expressions were lowest for VEGFR1 (P=0.02) at D3 and tended to be lowest also for 
ANGPT2 (P=0.07) at D180 compared to NL glands. 
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DISCUSSION 
 
Continuous Milking and Milk Production  in Dairy Goats 
Although earlier reports (Fowler et al., 1991; Mackenzie, 1967) have claimed that goats are 
more capable of maintaining milk production throughout gestation when being continuously 
milked compared to cows, we, similar to Caja et al. (2006) experienced considerable 
problems in preventing the glands from drying off spontaneously in very late lactation. We 
therefore believe that goats and cows are more similar than it has been postulated in earlier 
studies (Fowler et al., 1991; Mackenzie, 1967) with respect to their ability to maintain milk 
production throughout the very late gestation period. In the glands that managed to lactate 
continuously throughout late gestation, the consequences for milk production in the next 
lactation, however, appeared to be far less severe than reported for dairy cows (Annen et al., 
2008; Madsen et al., 2008; Swanson, 1965), and thus in most goats milk yield may not be 
negatively affected at all. Irrespective of any impact on subsequent milk production, CL 
clearly does not prevent lactogenesis. This has been demonstrated in several other studies in 
cows as well as in dairy goats by the increase in milk yield right after parturition (Annen et 
al., 2008; Caja et al., 2006; Fowler et al., 1991), and further documented in this study by the 
clear and similar increase in expression of LALBA in CL and NL glands.  
 
Impact of CL on Mammary Epithelial Cell Remodelling 
Consistent with other studies in cow (Norgaard et al., 2005), sheep (Norgaard et al., 2008a) 
and goat (Caja et al., 2006), our results confirmed that the major part of mammary 
redevelopment takes place in late pregnancy. At parturition, the proportion of poorly 
differentiated MEC was decreased, whilst the proportion of particularly intermediate 
differentiated MEC was increased. It is reasonable to suggest that the poorly differentiated 
MEC are the newly formed cells in the mammary gland, that need to differentiate further to 
acquire lactational ability. CL glands had a 3-7% lower proportion of MEC in the subsequent 
mid-late lactation compared to NL glands, due to lower proliferation rate during MDP-LDP. 
Milk yield turned out to be virtually unaffected by CL in the glands that were capable of 
completing a continuous lactation, despite the negative impact of CL on MEC renewal. CL 
glands, however, had a higher proportion of more fully differentiated MEC throughout 
lactation, and this indicates that the fully differentiated, and presumably older, MEC 
possesses higher synthetic capacity compared to the intermediately differentiated MEC. It 
would be relevant to find out how regulation of mammary remodelling differs between cows 
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and goats and thus find the explanation for why the yield in the CL goats is not affected as it 
is in cows milked continuously. We suggest that the MEC in goats survive longer than in 
cows. 
In our histological samples, we observed that MEC undergoing proliferation occurred 
predominantly in the intermediately differentiated rather than in the poorly and fully 
differentiated MEC (69%, 23% and 9%, respectively). We found no apoptotic cells among 
poorly differentiated MEC, but only in the intermediately or fully differentiated MEC. 
However, due to the disappearance of cell borders in our TUNEL slides, it was difficult to 
make a clear distinction of the intermediately from the fully differentiated MEC. Moreover, 
there were no differences in these relative distributions between the CL and NL glands. It is 
therefore puzzling why CL glands cannot restore their MEC population in late gestation to the 
same extent as in the NL glands, when the CL glands apparently possess MEC in a stage of 
differentiation that are capable of undergoing both cell proliferation and initiation of 
lactogenesis (see below) just as in NL glands.  
 
Impact of CL on Vascular Remodelling 
Very few studies have addressed the changes in mammary vasculature during the normal 
course of gestation-lactation in ruminants, and to our knowledge no previous studies have 
looked into the impact of continued milking during late gestation on vascular remodeling. We 
found that in the goat mammary gland, the vessel fraction in histological slides peaked earlier 
in the NL glands (MDP) compared to the CL glands (LDP), and thereafter the vessel fraction 
decreased to the lowest levels in early lactation. This is consistent with the higher rate of 
formation of new cells in the NL glands throughout the dry period, resulting in the vasculature 
gradually occupying less and less space. Omission of the dry period resulted in an either 
numerically or statistically, higher proportion of micro-vessels in the following lactation. 
Thus, the results may indicate that the larger ratio of capillaries-to-alveoli in CL compared to 
NL glands is indicative of a greater blood supply to the MEC and more efficient exchange of 
nutrients and waste products across the capillary-MEC barrier in CL glands. This could partly 
explain why milk yield in CL glands in goats are unaffected by CL despite the negative 
impact of CL on pre-partum cell renewal. However, the capillaries-to-alveoli ratio will 
normally be at its lowest in early lactation and increase as lactation progresses (M. O. Nielsen, 
Faculty of Life Sciences, University of Copenhagen, Denmark; K. Dahlborn and K. Cvek, 
Department of Anatomy, Physiology and Biochemistry, The Swedish University of 
Agricultural Science, Sweden; present study). It is thus inversely related to mammary blood 
[102] 
 
flow changes (Nielsen et al., 1990) and efficiency of nutrient extraction in the mammary 
gland during lactation (Nielsen et al., 2001). In fact, the number of capillaries surrounding 
each alveolus is several fold higher in the early compared to the late lactation, but the 
capillary diameter is very small in early lactation and increases as lactation progresses (M. O. 
Nielsen, Faculty of Life Sciences, University of Copenhagen, Denmark; K. Dahlborn and K. 
Cvek, Department of Anatomy, Physiology and Biochemistry, The Swedish University of 
Agricultural Science, Sweden). Very small capillaries would favor a more efficient nutrient 
exchange across the capillary – MEC barrier due to smaller diffusion distances, and extraction 
rates for a number of nutrients have in fact been found to be higher in early compared to late 
lactation (Madsen et al., 2008; Nielsen et al., 2001). Our findings therefore indicate that CL 
glands enter the new lactation with an older population of MEC surrounded by a similarly 
older (and possibly more developed) capillary network. As a result, nutrient exchange across 
the capillary-MEC barrier would occur less efficiently, but the decrease in vascular resistance 
(larger peripheral resistance) could possibly allow for a compensatory increase in mammary 
blood flow. Future studies will need to be conducted to reveal if milk yield in this way could 
be maintained relatively unaffected by CL in the goat due to a higher mammary blood 
perfusion per unit of milk synthesized.  
 
Impact of CL on Key Regulatory Mechanisms Responsible for MEC Population 
We were not able to demonstrate any significant effects of CL on expression of any of the 
genes encoding for factors with reported effects on cell turnover and differentiation (Figure 
4A). Contrast analyses revealed differences in expression between CL and NL glands for a 
few genes at selected time points. CL glands had higher expressions in period LDP of LTF 
gene, and at parturition (D1) of CCND1 and IGFBP5 genes. LTF is an innate immune factor 
and reported to be increased during involution compared to lactation. LTF expression in 
general did not change during the lactation period, and the higher expression of this mitogenic 
factor (Baumrucker et al., 2006) in CL glands in LDP was not consistent with the fact that CL 
glands had much lower rates of cell proliferation in late gestation compared to NL glands. 
CCND1, BCL2, IGF-1 and leptin have all been reported to have mitogenic effects on MEC 
(Baumrucker and Erondu, 2000; Dlugosz et al., 2006; Sherr, 1995). Expression of CCND1, 
BCL2 and the LPTR increased across the pre-partum period, and decreased at parturition to 
reach the lowest levels during lactation. The same was reported in dairy cows (Annen et al., 
2007) and sheep (Norgaard et al., 2008a). These expression changes followed the general 
changes in MEC proliferation. However, CL did not affect expression of any of these factors 
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at any time point during gestation or lactation (except the higher expression for CCND1 at D1 
in CL glands) and could therefore not account for the negative effect of CL treatment on MEC 
renewal. 
BAX and IGFBP5 are potent apoptotic factors in the mammary gland (Sorensen et al., 2006; 
Wareski et al., 2001). BAX expression followed the same general pattern as observed for the 
mentioned mitogenic agents with highest expression pre-partum. As others before us 
(Norgaard et al., 2008b; Wareski et al., 2001), we have not been able to correlate BAX gene 
expression to the changes in apoptosis during the transition period from gestation to lactation 
and the peak observed in the early postpartum period (D3-D10). IGFBP5 was highly 
expressed at D1 in CL glands, and CL glands happened to have a close to significantly higher 
rate of apoptosis on D3 compared to NL glands. Upregulation of IGFBP5 around parturition 
may be a mechanism whereby cell death is induced in early lactation, whereby the oldest 
MEC remaining from the previous lactation can be renewed in CL glands. Another finding in 
support of this proposition was that the higher rate of apoptosis in CL glands at D3 indeed 
coincided at this exact time point with a drop in the proportion of fully differentiated MEC, 
which was not observed in NL glands. 
The factors or mechanisms explaining the impact of CL in late gestation on cell renewal and 
differentiation thus still remain to be identified. However, our failure to link the cell turnover 
events to changes in gene transcription could also be due the fact that these expression 
changes are cell specific. When performing expression studies on tissue samples consisting of 
several different cell types, as in mammary tissue, cell specific changes in gene expressions 
could have been masked, or might have been diluted at stages where the proportion of MEC 
was low. Obviously the impact of continued milking in late gestation on cell renewal and 
mammary remodelling must be mediated by local mechanisms in the gland subjected to CL, 
since it is possible to continuously milk one udder half in the animal whilst drying-off the 
other.  
 
Effect of CL on Key Regulatory Mechanisms Responsible for Vascular Function 
In contrast to the factors encoding for MEC turnover, CL did affect changes in expression 
during gestation and at the day of parturition for some of the genes encoding for factors 
regulating vascular function. Djonov et al. (2001) has suggested that regression of the 
capillary endothelium during mammary involution could be correlated to or be a consequence 
of MEC involution. Higher gene expression of CA4 (in general (P<0.06)and particularly in 
the pre-partum period) and VEGFR1 during the first part of the dry period in CL glands 
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maybe ascribed to the fact that those glands had a MEC population that was prevented from 
involution, and thus maintained into lactation. Consequently a functional capillary network 
was sustained as well. 
Statistically or numerically higher expressions of ANGPT1, VEGF, VEGFR1, VEGFR2 and 
COX2 in CL glands at d1, suggest that the CL glands experiences a higher rate of vascular 
growth than the NL glands, probably renewing part of the ageing vascular system at 
parturition, whereas this vascular renewal would have happened before parturition in the NL 
glands in parallel with the renewal of the MEC population. 
 
CONCLUSIONS 
 
CL suppressed MEC renewal, because of suppression of pre-partum cell proliferation; 
however, the rate of apoptosis was unaffected. Continuously lactating mammary glands of 
goats therefore entered the subsequent lactation with a smaller MEC population, as known in 
dairy cows. CL glands throughout lactation had a larger micro-vessel proportion, lower 
proportion of MEC, but more fully differentiated and likely older population of MEC 
compared to NL glands. If fully differentiated MECs have higher secretory activity, this could 
in part explain why goats can lactate continuously without major negative impact on milk 
yield, in spite of the smaller population of MEC. We were not able to resolve why continued 
milking during the late gestation period interferes with MEC and vascular remodelling within 
the mammary gland, and what regulatory mechanisms are responsible. So two puzzling 
questions remain: Why is the full restoration of the MEC population and overall mammary 
remodelling inhibited just because of continuous milk removal from a mammary gland 
throughout gestation? And why is this associated with a marked depression in milk yield in 
dairy cows in the subsequent lactation, but apparently not in the dairy goat that (with some 
difficulty) manage to lactate continuously? 
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Table 1- Roles of the analyzed genes. 
Gene* Suggested Role(s) 
Vascular Function and Angiogenesis: 
COX1 and COX2 involved in angiogenesis, regulating arterio-venous differentiation, and contributing in the production of 
prostaglandins and thromboxane (Claria, 2003). 
PTGIS catalyses the synthesis of prostacyclin I2 which is a potent arterial vasodilator (Claria, 2003). 
TBXAS catalyses the synthesis of thromboxane A2 which is a venous vasoconstrictor and affect vascular permeability (Claria, 
2003), and might also have a role in regulation of mammary cell proliferation or secretory activity (Nielsen et al., 
2004) 
CA4 catalyses the reversible hydration of CO2 to HCO3- and H+, positively correlated with the mammary gland synthetic 
activity (Cvek et al., 1998) 
ANGPT1 involved in maturation of blood vessels, regulates the formation and stabilization of the blood vessel network 
(Conway et al., 2001) 
ANGPT2 ANGPT1 antagonist; destabilizes the vasculature and initiates angiogenesis in the presence of VEGF (Conway et al., 
2001) 
RTK receptor for ANGPT1 ad ANGPT2 (Conway et al., 2001) 
VEGF potent angiogenic factor and possess vascular permeability-inducing properties (Conway et al., 2001)  
VEGFR1 negative regulator of VEGFR-2 (Conway et al., 2001) 
VEGFR2  VEGF receptor mediating the mitogenic and permeabilizing properties of VEGF (Conway et al., 2001) 
Cell turnover and Lactogenesis: 
BAX pro-apoptoticfactor  (Haughn et al., 2003) 
BCL2 anti-apoptotic factor (Haughn et al., 2003) 
CCND1 involved in regulation of cell proliferation (Sherr, 1995) 
IGF1 plays an important role as a survival factor during mammary gland development and remodelling during involution 
(Allan et al., 2004) 
IGF1R impacts mammary growth and inhibits apoptosis (Baumrucker and Erondu, 2000) 
IGFBP3 multifunctional protein, acts either as a growth facilitator or inhibitor (Grill and Cohick, 2000) 
IGFBP5 related to apoptosis of the mammary gland, and has the ability to inhibit cell proliferation (Allan et al., 2004) 
TGFB1 anti-proliferative and apoptogenic factor for MECs (Wareski et al., 2001) 
TGFB1-R1 and -R2 receptors for and mediating actions of TGFB1 (Akers, 2006) 
PRLR PRL receptor; upon binding to its receptor, PRL activates several pathways associated with MEC proliferation, 
differentiation, and lactogenesis (Wall et al., 2006) 
LALBA milk whey protein and a component of the enzyme complex regulating lactose synthesis and thus milk volume (Riley 
et al., 2008). Indicator of onset of copious milk secretion at lactogenesis 
LTF involved in local immune system, and induces cellular growth and differentiation (Ward et al., 2005) 
LPT and LPTR suggested inhibitor of proliferation of MEC (Silva et al., 2002). 
* Abbreviations used for the genes: COX1: Cyclooxygenase I; COX2: Cyclooxygenase II; PTGIS: Prostocylcine Synthase; TBXAS: 
Thromboxane A2 Synthase; CA4: Carbonic Anhydrase IV; ANGPT1: Angiopoietin I; ANGPT2: Angiopoietin II; RTK: Tyrosine Kinase 
Tie2 Receptor; VEGF: Vascular Endothelial Growth Factor; VEGFR1 (Flt1): Vascular Endothelial Growth Factor Receptor 1 (fms-like 
tyrosine kinase); VEGFR2 (Flk1): Vascular Endothelial Growth Factor Receptor 2 (Fetal liver kinase 1); BCL2: B-Cell CLL/Lymphoma 2; 
BAX: Bcl2-Associated X Protein; CCND1: Cyclin D1; IGF1: Insulin-like Growth Factor I; IGF1R: Insulin-like Growth Factor I Receptor; 
IGFBP3: Insulin-like Growth Factor Binding Protein III; IGFBP5: Insulin-like Growth Factor Binding Protein V; TGFB1: Transforming 
Growth Factor Beta I; TGFB1R1: Transforming Growth Factor Beta I Receptor I; TGFB1R2: Transforming Growth Factor Beta I Receptor 
II; PRLR: Prolactin Receptor; LALBA: Alpha-Lactalbumin; LTF: Lactoferrin (Lactotransferrin); LPT: Leptin; LPTR: Leptin Receptor. 
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Table 2- Accession numbers, amplicon location, range of threshold cycle (CT) values in 
samples, and slope of standard curve of the analyzed genes 
Gene symbol Accession no. Gene name Range of Ct 
in samples  
Standard 
Curve R2 
Standard 
curve slope 
  Housekeeping genes    
ACTB AY141970 Beta-Actin 22-32 0.998 -3.53 
GAPDH AF035421 GlycerAldehyde-3-Phosphate Dehydrogenase 28-37 0.999 -3.54 
18S RNR1 AY779625 18S Ribosomal RNA I 20-28 0.999 -4.30 
      
  Vascular function & Angiogenesis    
COX1 AF004943 Cyclooxygenase I 30-37 0.998 -3.38 
COX2 AF004944 Cyclooxygenase II 33-39 0.917 -3.54 
PTGIS NM_174444 Prostocylcine Synthase 33-39 0.990 -3.62 
TBXAS BC112647 Thromboxane A2 Synthase 31-39 0.999 -3.47 
CA4 NM_173897 Carbonic Anhydrase IV 28-39 0.996 -3.19 
ANGPT1 NM_001076797 Angiopoietin I 29-38 0.993 -3.50 
ANGPT2 AF094699 Angiopoietin II 31-39 0.996 -2.72 
RTK X71424 Tyrosine Kinase Tie2 Receptor 29-38 0.998 -3.72 
VEGF AY114353 Vascular Endothelial Growth Factor 24-35 0.998 -3.53 
VEGFR1 (Flt1) AY114355 Vascular Endothelial Growth Factor Receptor 1 
(fms-like tyrosine kinase) 
29-38 0.999 -3.23 
VEGFR2 (Flk1) AY114354 Vascular Endothelial Growth Factor Receptor 2 
(Fetal liver kinase 1) 
29-38 0.999 -3.83 
      
  Cell turnover & Lactogenesis    
BCL2 DQ152929 B-Cell CLL/Lymphoma 2 27-37 0.992 -3.66 
BAX AF163774 Bcl2-Associated X Protein 29-35 0.996 -4.26 
CCND1 XM_870776 Cyclin D1 28-39 0.994 -3.66 
IGF1 NM_001009774 Insulin-like Growth Factor I 29-38 0.989 -3.70 
IGF1R AF025303 Insulin-like Growth Factor I Receptor 30-38 0.987 -3.71 
IGFBP3 M76478 Insulin-like Growth Factor Binding Protein III 26-35 0.994 -3.23 
IGFBP5 S52657 Insulin-like Growth Factor Binding Protein V 25-36 0.992 -3.35 
TGFB1 M36271 Transforming Growth Factor Beta I 31-39 0.991 -3.77 
TGFB1R1 NM_174621 Transforming Growth Factor Beta I Receptor I 29-39 0.976 -3.74 
TGFB1R2 NM_615445 Transforming Growth Factor Beta I Receptor II 27-37 0.993 -3.29 
PRLR NM_001039726 Prolactin Receptor 27-36   
LALBA X63317 Alpha-Lactalbumin 14-32 0.997 -3.81 
LTF L08604 Lactoferrin (Lactotransferrin) 25-39 0.991 -3.70 
LPT OAU84247 Leptin 31-39 0.988 -5.18 
LPTR AY278244 Leptin Receptor 29-39 0.988 -3.71 
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Table 3- Gene names and primer and probe sequences in real-time RT-PCR 
Gene Forward primer, 5'→3' Probe, 5'→3' Reverse primer, 5'→3' 
HKG    
ACTB 5'-acccagatcatgttcgagacctt SYBR GREEN 5'-tcaccggagtccatcacgat 
GAPDH 5'-gtcggagtgaacggatttgg 5'-cgcctggtcaccagggctgct 5'-aacgatgtccactttgccagta 
18S RNR1 5'- gcaattattccccatgaacg SYBR GREEN 5'- agttcgaccgtcttctcagc 
    
Vascular Function & 
Angiogenesis: 
   
COX1 5'-cctcatcctcatcggggagac SYBR GREEN 5'-cggttgcggtactggaattgg 
COX2 5´-ctaagaagaaagttcattcctgatccc 5'-ttgcccag , LNA#61 5'-gaggatacatctctccattaatcatctg 
PTGIS 5'-gccgtcaacagcatcaaacaattc SYBR GREEN 5'-gcatcagcccaaagccatacc 
TBXAS 5'-gcctttggcaccgaagtg SYBR GREEN 5'-ttatggatggaaatgataagagtaaaacc 
CA4 5'-gacatccccagacccaatatgaac SYBR GREEN 5'-gagcgagcccaggtagcg 
ANGPT1 5'-ccataaccagtcagaggcagtac SYBR GREEN 5'-gtgtgacccttcaaatacaacctg 
ANGPT2 5'-cgaatgaagaactcaactacaggattc 5'-ccagccag , LNA#20 5'-gaaggaccacaggcatcaaacc 
RTK 5'-aactgtgacgacgaggtgtatg SYBR GREEN 5'-tccccgcgtaggtgaacttc 
VEGF 5'-gggctgctgtaatgacgaaag SYBR GREEN 5'-tgaggtttgatccgcataatctg 
VEGFR1 5'-tcaagccaatgtacaacaggatgg SYBR GREEN 5'-attaaacttgggagcagaaatatcttcc 
VEGFR2  5'-cactgtttatgtgtatgttcaagattac SYBR GREEN 5'-gatgtacacaacttcatgctggtc 
    
Cell turnover & 
Lactogenesis: 
   
BAX 5'-gagtggcggctgaaatgttt 5'-ctggggcc, LNA#57 5'-agggccttgagcaccagttt 
BCL2 5'-ggctgggatgcctttgtg SYBR GREEN 5'-agacagccaggagaaatcaaaca 
CCND1 5'-gccgagaagctgtgcatttac 5'-ctccatcc, LNA#58 5'-ccaggaccagctccatgtg 
IGF1 5'-tgtgatttcttgaagcaggtgaag SYBR GREEN 5'-gctgaaggcgagcaagca 
IGF1R 5'-tgcagaaggagcaggtgaca 5'-acctgggagccacggcctga 5'-cctccacttgggatccatatttt 
IGFBP3 5'-cagagcacagacacccagaa SYBR GREEN 5'-agggcccgtattctgtctc 
IGFBP5 5'-gaccgcaagggattctacaaga SYBR GREEN 5'-tccacgcaccagcagatg 
TGFB1 5'-tggagctgtaccagaaatatagcaa SYBR GREEN 5'-gccactgccgcacaactc 
TGFB1R1 5'-caatgggactagtattctgggaagtag SYBR GREEN 5'-tcaactgatggatcggaaggta 
TGFB1R2 5'-tccttcaagcagacggatgtc SYBR GREEN 5'-cccgaacggaggctcata 
PRLR 5'-catggatactggagtgagtgga 5'-ggatggag, LNA#58 5'-tgtccttcactgggaagtcat 
LALBA 5'-acaatggcagcacagaatatgg SYBR GREEN 5'-tgtcacaggagatgttacagatgttg 
LTF 5'-ggatggcaaggaagacttgatc 5'-caggaaga 5'-cgggtggagagccaaagag 
LPT 5'- gtgcccatccgcaaggt 5'-caccaggatcaatgac 5'- gacggactgcgtgtgtgaga 
LPTR 5'-acccaatgcaatccaatcac SYBR GREEN 5'-ggctgctcctatgatacctca 
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Figure legends 
Figure 1. The time schedule for sampling relative to drying-off of the gland with a normal 
lactation (NL) and day of parturition. 
CL: continuous lactation BDP, EDP, MDP and LDP: pre-partum sampling times related to the 
stage in the dry period of the NL gland, i.e. before drying-off, in the early, mid and late dry 
period, respectively. D: day of lactation. S: stage of gestation-lactation. 
Figure 2. Mammary epithelial cells (MEC) were characterized by being poorly differentiated 
(A), intermediate differentiated (B) or fully differentiated (C), respectively. The tissue 
samples shown have all been stained with PAS (x400 magnification).  
Figure 3. Number of alveoli per picture, and the proportions (%) in mammary sections of 
alveoli, MEC, lumen, interstitial tissue, micro-vessels, and poorly, intermediate and fully 
differentiated mammary epithelial cell (MEC). 
CL and NL: continuous and normal lactation, respectively. BDP, EDP, MDP and LDP: pre-
partum sampling times related to the stage in the dry period of the NL gland, ie. before 
drying-off, in the early, mid and late dry period, respectively. D: day of lactation.  
 P values for stage of gestation-lactation (S), CL treatment and their interaction are presented 
in the top or down right corner of each graph. 
Figure 4. Proportion of proliferative (Ki-67) and apoptotic (TUNEL) epithelial cells in 
mammary sections 
CL and NL: continuous and normal lactation, respectively. BDP, EDP, MDP and LDP: pre-
partum sampling times related to the stage in the dry period of the NL gland, ie. before 
drying-off, in the early, mid and late dry period, respectively. D: day of lactation.  
 P values for stage of gestation-lactation (S), CL treatment and their interaction are presented 
in the top or down right corner of each graph. 
Figure 5. Expression levels of genes related to A) cell turnover and lactogenesis, and B) 
vascular function and angiogenesis 
CL: continuous lactation. NL: normal lactation. BDP, EDP, MDP and LDP: pre-partum 
sampling times related to the stage in the dry period of the NL gland, ie. before drying-off, in 
the early, mid and late dry period, respectively. D: day of lactation. Values are least squares 
means relative to values obtained in the BDP stage of NL glands. P-values for stage of 
gestation-lactation (S), CL treatment and their interaction are presented in the top or down 
right corner of each graph. 
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Figure 3.  
   
   
   
   
  
S: <0.001 
CL: 0.97 
CL*S: 0.08 
S: <0.001 
CL: 0.85 
CL*S: 0.42 
S: 0.001 
CL: 0.48 
CL*S: 0.32
S: <0.001 
CL: 0.53 
CL*S: 0.91 
S: <0.001 
CL: 0.53 
CL*S: 0.70
S: 0.001 
CL: 0.02 
CL*S: 0.06
S: <0.001 
CL: 0.003 
CL*S: 0.04 
S: <0.001 
CL: 0.91 
CL*S: 0.89
S: 0.02 
CL: 0.004 
CL*S: 0.75 
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Figure 4.  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S: <0.001 
CL: 0.03 
CL*S: 0.08 
S: 0.06 
CL: 0.73 
CL*S: 0.77 
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Figure 5.  
A) 
   
   
   
  
 
 
 
 
 
 
S: 0.09 
CL: 0.58 
CL*S: 0.24 
S:  0.002 
CL: 0.659 
CL*S:  0.57 
S: < 0.001 
CL: 0.51 
CL*S: 0.24
S: < 0.001 
CL: 0.47 
CL*S:  0.54 
S:  0.002 
CL: 0.42 
CL*S:  0.80 
S: < 0.001 
CL: 0. 03 
CL*S:  0.01 
S: < 0.001 
CL: 0.26 
CL*S: 0.80
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B) 
     
   
    
S: 0.006 
CL: 0.36 
CL*S: 0.80 
S: 0.008 
CL: 0.06 
CL*S: 0.56 
S: < 0.001 
CL: 0.62 
CL*S: 0.68
S: 0.78 
CL: 0.36 
CL*S: 0.03
S: 0.40 
CL: 0.93 
CL*S: 0.07
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INTRODUCTION 
 
Having a dry period appears to be essential for dairy cows to ensure optimal milk production 
in the following lactation (Madsen et al., 2008). The situation in the dairy goat is less clear, as 
omission of the dry period (continuous lactation; CL) was reported to have no negative effect 
on subsequent milk yield in a study by Fowler et al. (1991), while Caja et al. (2006) reported 
a 29% decrease in milk yield in the subsequent lactation. We have found (unpublished data) 
that in the goat, mammary glands subjected to CL will enter the new lactation with a smaller 
mammary epithelial cell (MEC) population, but the MEC are more fully differentiated 
compared to in the normal lactating (NL) glands. If fully differentiated MEC are older and 
more secretory active, this could in part explain why goats can lactate continuously without 
major negative impact on milk yield despite a smaller MEC population. The aim of the 
present study was to determine if CL in the dairy goat will increase the efficiency of nutrient 
extraction across the mammary gland in the following lactation, which could reflect 
differences in MEC secretory activity. 
 
MATERIAL AND METHODS 
 
Nine dairy goats were used followed over one (5 goats) or two consecutive (4 goats) 
pregnancy-lactation periods. Goats were previously surgically prepared with exteriorized 
carotid arteries and milk veins. They were milked manually (at 09:00 and 15:30) and fed 
twice a day (at 07:30 and 14:30), half the ration being given at each feeding. The 
experimental design was a randomized complete block design; the two udder halves in each 
animal were randomly assigned to two different treatments, thus using the animal as its own 
control: One udder half was dried-off approximately 9 weeks pre-partum (NL), and the other 
udder half was milked continuously (CL) until parturition. After morning and afternoon 
milking, two blood samples were obtained from the exteriorized carotid artery and each of 
both milk veins, just before the time of drying-off of the NL gland (BDP), within the first two 
weeks after drying-off (early dry period; EDP), in the mid-dry period (MDP), within the last 
two weeks prior to parturition (late dry period; LDP), and at days 1 (day of parturition, D1), 3, 
10, 60, and 180 of lactation. Blood samples were taken for immediate determination of acid-
base parameters, and plasma was analysed for glucose, non-esterified fatty acids (NEFA), 
acetate, beta-hydroxy-butyrate (BOHB), triglycerol (TG), and urea. Mammary extraction (E) 
rates of metabolites were calculated as mammary arterial-milk vein concentration difference 
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(AVD) divided by arterial concentration. Statistical evaluation of all data was performed 
using the Proc Mixed procedures in SAS (2003). Variables in the statistical models included 
the experimental year, treatment (CL or NL), the sampling time (morning or afternoon), stage 
at which the sample was taken and its interaction with treatment as fixed effects, and the 
factors goat within experimental year, and milk vein side within goat at each stage as random 
effects. Pre- and postpartum values were analyzed separately. The PDIFF command in SAS 
was used to generate comparisons between treatment means. The level of significance was set 
at P < 0.05 and tendencies at P < 0.10. 
 
RESULTS 
 
There was not any indication of CL affecting the milk yield negatively in the goats in this 
study. There was no effect of treatment on acetate AVD and E prepartum, but for glucose and 
BHB, they were significantly higher in CL than NL glands. Postpartum AVD and E for 
glucose and BHB were higher compare to prepartum in both glands, but there was no 
difference between CL and NL glands during the post-partum period. NEFA AVD and E 
were negative prepartum, and became more negative across CL than NL glands in the LDP 
(P=0.01). Both peaked at the same positive level in both glands at parturition, due to a rise in 
arterial plasma concentration. They remained high in early lactation, but decreased to become 
negative again in mid-late lactation, thus following overall changes in arterial plasma 
concentration. AVD and E for TG were higher across CL than NL glands prepartum, 
decreased across the gestation period, and then increased after parturition to the same level in 
both CL and NL glands. The post-partum increase was numerically more marked in NL 
glands so that the AVD and E reached the same level as in CL glands during lactation. AVD 
for pO2 and pCO2 as well as AVD and E for TO2 and TCO2 were not affected by the 
treatment, neither pre- nor postpartum. Prepartum AVD tended to be higher for pH and lower 
for BE across CL compared with NL glands.  
 
CONCLUSION 
 
AVD and/or E differed for several metabolites either significantly or numerically between the 
CL and NL glands during the late gestation period. This could reflect differences in extraction 
activity between the CL glands that remained lactating and the NL glands that were dried off 
prepartum. However, there was no significant impact of the prepartum milking of the CL 
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glands on efficiency of mammary nutrient extraction in the subsequent lactation. Our previous 
findings have shown that the goat mammary gland subjected to CL have lower cell renewal in 
the subsequent lactation, but MEC on the other hand become more fully differentiated 
(unpublished data). The observation that extractions of nutrients were unaffected by CL do 
not lend immediate support to the hypothesis that these more fully differentiated MECs could 
have a more efficient nutrient extraction reflecting a higher metabolic activity in the 
subsequent lactation. The explanation why milk yield in dairy goats is relatively unaffected in 
CL (in contrast to dairy cows) thus remains to be established.  
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ABSTRACT 
Milk production is generally lower, but lactation persistency higher in primiparous (PP) than 
multiparous (MP) goats. This may be related to differences in development and maintenance 
of mammary gland function, but the underlying mechanisms are not well understood. The 
present study aimed to elucidate whether differences in lactational performance between PP 
and MP mammary glands are related to the time course of development and maintenance – 
not only of the mammary epithelial cell (MEC) population, but also of the mammary 
vasculature which sustains synthetic activity. Mammary biopsies were obtained from both 
mammary glands of 3 PP and 6 MP (≥2 parity) dairy goats at parturition (d1), days 10, 60, 
and 180 of lactation. Gene transcription relating to MEC turnover and vascular function was 
quantified by real time RT-PCR, mammary morphology characterised (quantitative 
histology), and cell turnover determined (TUNEL and Ki-67). Primiparous glands had higher 
expression for the genes involved in angiogenesis, namely vascular endothelial growth factor 
receptor 2, and angiopoietin 1 and 2 and their receptor, a few days after parturition (d10). 
Primiparous glands also had higher rates of MEC cell proliferation in early lactation. It 
therefore appears that initiation of lactation is associated with development and growth of the 
mammary gland into early lactation, which continues for a longer period of time in the PP 
compared to MP glands. In addition, MEC survival was found to be higher in PP glands 
throughout lactation, and MEC in PP glands underwent more extensive differentiation. This 
could well explain the reported flatter lactation curve and higher lactation persistency in PP 
glands. Although some of the genes included in this study were differentially expressed in PP 
and MP glands during the course of lactation, it was not possible to identify any specific 
genomic factor(s) that could account for the differences between PP and MP glands with 
respect to mammary development and MEC survival during lactation. Thus, why parity 
number impacts MEC and vascular development and survival during lactation, and 
particularly which regulatory mechanisms are involved, remain to be established.  
Key words: primiparous, multiparous, cell turnover, angiogenesis 
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INTRODUCTION 
The level of milk production and the changes in milk yield over the course of lactation, 
depend on: 1) the number of milk synthesizing epithelial cells, which is affected by the  
balance between the rate of epithelial cell proliferation and apoptosis (Capuco et al., 2003),  
and  2) the secretory activity of these cells, which is affected by their differentiation (Akers et 
al., 2006), and finally 3) the provision of nutrients and removal of waste products via the 
vascular system essential for sustaining milk synthesis.  
Metabolic status through the lactation period in the first lactation (primiparous, PP) mammary 
gland is different from that in the more mature ones (multiparous, MP), as the nutrients in PP 
animals are prioritized not only for lactation but also for the continued growth of the animal 
(Wathes et al., 2007). Generally, MP animals have a higher milk yield but lower lactation 
persistency compared to PP animals (Carnicella et al., 2008; Miller et al., 2006). This may be 
related to differences in development and maintenance of mammary gland function, but the 
underlying mechanisms are not well understood. We hypothesized that differences between 
PP and MP goats with respect to milk production and lactation persistency may be related to 
differences in mammary growth and remodelling also during lactation.  
The differential mammary remodelling in PP compared to MP goats may be related not only 
to the MEC population but also to the vascular system required for nutrient supply and 
removal of metabolic waste products. Angiogenesis, the formation of new blood vessels, is a 
biological process which occurs in order to accommodate highly variable requirements for 
nutrients and oxygenation with respect to changes in mammary tissue composition and 
metabolic activity (Djonov et al., 2001). This process has received virtually no attention in 
normal mammary development of dairy animals (Akers, 2002), although the coordinated 
development of mammary vascular and epithelial cell function must be assumed to be of 
utmost importance for normal mammary gland function and performance. Vascular function 
may not be the same in PP and MP glands because the pre-partum development could be 
different – PP animals not having had a previous lactation with a fully developed mammary 
gland.  
The overall aims of this study were therefore to elucidate whether differences in lactational 
performance between PP and MP mammary glands are related to the time course of 
development and maintenance, not only of the MEC population but also of the mammary 
vasculature which sustains synthetic activity. Furthermore, we aimed to identify the 
underlying regulatory factors or mechanisms responsible for these developmental differences 
between PP and MP mammary glands. We aimed to address these issues in a study in dairy 
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goats and to the extent possible make comparisons to what is known in the dairy cow. Goats 
have often been used as experimental models for dairy cows in lactation studies due to their 
low cost and their similar selection for high milk production as dairy cattle (Anderson et al., 
1981), but dairy goats appear to differ from dairy cows in their ability e.g. to sustain extended 
and continuous lactation (omission of the dry period) (Fowler et al., 1991; Mackenzie, 1967). 
Observations from dairy goats may therefore not be directly applicable to the dairy cow and 
vice versa. Species comparisons are however fruitful as they can contribute to elucidate 
general physiological mechanisms underlying mammary function in relation to lactation 
persistency.  
In our study, mammary biopsies were obtained from dairy goats, at parturition and at different 
time points during lactation. In the biopsies we determined MEC turnover and differentiation, 
changes in morphology of the micro-vascular system, and the changes in patterns of 
expression of the major factors responsible for regulation of mammary cell turn-over as well 
as vascular function and angiogenesis.  
 
MATERIALS AND METHODS 
Experimental Animals 
Nine Danish crossbred Landrace-Saanen dairy goats were used over two years of experiment: 
three PP + six MP (parity ≥ 2) goats in the first year, and seven MP goats in the second year 
(including the three PP + four of the MP goats from the first year). They were fed a diet 
consisting of hay ad libitum, supplemented with barley, concentrate, and molasses, according 
to their requirements. Animals had free access to fresh water and a vitamin/mineral 
supplement. They were milked manually at 0900 and 1530 h and fed twice a day at 0730 and 
1430 h, half the ration being given at each feeding. The experiment was carried out at the 
experimental facilities at the Faculty of Life Sciences, University of Copenhagen, Denmark, 
and approved by the Danish Animal Experimentation Inspectorate, and complied with the 
Danish Ministry of Justice laws concerning animal experimentation and care for experimental 
animals.  
 
Experimental Design 
Both glands in MP animals were dried off about approximately nine weeks before expected 
parturition. Two biopsies were sampled from each mammary gland on days 1 (day of 
parturition), 10, 60, and 180 related to actual kidding. At day 180, both PP and MP animals 
were in their first month of pregnancy. Biopsying was done according to the procedure 
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described by Cvek et al. (1998). Before taking biopsies, goats have been milked to be sure 
there is no milk left in their mammary glands while sampling. To keep the biopsy needle 
away from major blood vessels near dorsal aspect and midline of the udder and ductal area, 
the insertion point was marked about 1.5-2 centimeters away from the udder midline, and at 
the point where the udder protruded the most caudally. To avoid sampling from the same 
biopsy site and possible scar tissue from each udder half, the biopsy site was measured and 
noted down at each sampling. One sample was put in RNase-DNase-free tubes and 
immediately frozen in liquid nitrogen, and stored at -80°C pending analyses. The other biopsy 
was placed in embedding cassettes and fixed in 4% para-formaldehyde (PFA) solution as 
described below. Animals were milked both before (to avoid milk in the biopsy) and after (to 
remove any probable blood clots in the udder) sampling. 
 
Tissue Fixation 
Mammary biopsies were fixed in 4% PFA overnight at 4°C, transferred to 70% ethanol for 1-
3 days at 4°C, dehydrated using a series of ethanol solutions (70%, 80%, 95% and 100%) 
(2x60 min each), cleared in xylene (3x60 min), infiltrated with paraffin wax (56-58 ºC) (2x90 
min), and finally embedded into paraffin blocks (Histokinet, Shandon Citadel 2000, UK). 
Blocks were sectioned into 4µm slices (Microtome, Jung, Germany) with at least 30 µm 
intervals to insure that individual cells were not recounted on successive sections (Ellis and 
Capuco, 2002). Sections were placed on slides and dried at 37°C overnight for histology 
purposes and at 60°C for 30 minutes for immunohistochemistry. 
 
Immunohistochemistry 
For each sample, 4 sections were put onto each silanated slide (Super Frost Plus, Gerhard 
Menzel, Glasbearbeitungswerk GmbH & Co. KG, Braunschweig, Germany); one slide was 
made for Ki-67 antigen localization (Ki-67) and another for terminal deoxynucleotidyl 
transferase dUTP nick end labeling assay (TUNEL). Shandon Sequenza Slide Racks (Thermo 
Electron Corporation, Waltham, MA, USA) and Shandon Coverplates (Thermo Electron 
Corporation, Waltham, MA, USA) were used for both Ki-67 and TUNEL.  
Both Ki-67 and TUNEL have been done according to Nørgaard et. al. (2008b), except for a 
few modifications:  
Ki-67. Before the application of the primary antibody,  microwave antigen retrieval protocol 
was done by boiling sections with 10 mM warm citratbuffer (pH=6.0) in a microwave oven 
(EM-G4750, SANYO, UK) at 450W (3x5 min).  
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TUNEL. Slides were digested by proteinase K solution before staining process (Chemicon 
International Inc., Temecula, CA, USA) (15 min), incubated with equilibration buffer at 4°C 
for 10 min, and apoptotic cells were stained with diaminobenzidine (DAB) (Sigma-Aldrich 
Danmark A/S, DK-2605 Brøndby, Denmark) (5 min). 
Using the same techniques as for histology, 5 pictures from randomly selected fields of each 
section at 400x magnifications have been taken and analyzed by ImageJ software, with grid 
plug-in, to count the number of mammary gland epithelial cells which were positive for 
proliferation (Ki-67) or apoptosis (TUNEL), as well as total epithelial cell number. A 25% 
area grid was randomly fitted on pictures and about 700 epithelial cells spread on 20 pictures 
were counted for each biopsy sample. 
 
Histology 
As described by Nøregaard et al. (2008a), paraffin embedded sections were deparaffinized 
with xylene, rehydrated by serried of alcoholand washed with distilled water. Then, for each 
of Haematoxylin-Eosin (H&E) and Periodic Acid-Schiff (PAS) staining, 2-3 sections per 
sample were used to be processed in the routine lab methods.  
All the slides stained with H&E and PAS were studied by light microscopy by the same 
person, and each sample was assigned a code to mask its identity at the time of analysis to 
assure unbiased results. From each stained section, three random pictures were taken at 
primary magnification 400x at a light microscope (Leica DMR, Leica microsystems, 
Germany) with a camera (Leica DPC 490, Leica microsystems, Germany) connected to 
computer. Using ImageJ software (Abramoff et al., 2004), a 30 points transparent grid was 
put on each picture. The number of hits on epithelial cells, lumen, interstitial tissue and micro 
vessels (in PAS, either their lumen or endothelial cells) were counted. When a point was 
hitting a mammary epithelial cell (MEC), it was classified into poorly, intermediate or fully 
differentiated epithelial cell according to its secretory activity as previously described (Akers 
et al., 2006; Safayi et al., 2009). Furthermore, using an unbiased counting frame with the 
same size as the picture and having two forbidden lines to decrease the risk of a systematic 
overestimation, the number of alveoli per picture was counted to fulfill the quantitative 
measurements. The counting of coinciding points (more than 360 hits per sample) with the 
mentioned desired structures allowed the unbiased estimation (Gundersen et al., 1988) of 
volume fractions for each animal. 
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Real Time Reverse Transcription-PCR  
Genes were chosen to be analyzed based on their suggested roles in mammary growth, 
remodelling and function. Target genes were divided in two groups (see Safayi et al. (2009) 
for description of physiological function): 1) Genes related to vascular function: 
cyclooxygenase I (COX1), cyclooxygenase II (COX2), prostocylcine synthase (PTGIS), 
thromboxane A2 synthase (TBXAS) and carbonic anhydrase IV (CA4), and angiogenesis: 
angiopoietin I (ANGPT1), angiopoietin II (ANGPT2), tyrosine kinase tie2 receptor (RTK), 
vascular endothelial growth factor (VEGF), vascular endothelial growth factor receptor 1 
(VEGFR1) and vascular endothelial growth factor receptor 2 (VEGFR2), and 2) Genes 
related to cell turnover and lactogenesis: B-cell CLL/Lymphoma- 2 (BCL2), Bcl2-Associated 
X Protein (BAX), cyclin D1 (CCND1), insulin-like growth factor I (IGF1), insulin-like 
growth factor I receptor (IGF1R), insulin-like growth factor binding protein III (IGFBP3), 
insulin-like growth factor binding protein V (IGFBP5), transforming growth factor beta I 
(TGFB1), transforming growth factor beta I receptor I (TGFB1R1), transforming growth 
factor beta I receptor II (TGFB1R2), prolactin receptor (PRLR), alpha-lactalbumin 
(LALBA), lactoferrin (LTF), leptin (LPT) and leptin receptor (LPTR). transcription of target 
genes was quantified by real time RT-PCR. Approximately 10 mg of mammary tissue was 
homogenized in 350 µL of RNeasy lysis buffer and diluted (1:1) with 70% ethanol. The RNA 
was purified using the RNeasy mini kit (Qiagen, Albertslund, Denmark) and reverse-
transcribed with oligo-dT and Superscript II RNAse H reverse transcription kit (Invitrogen, 
Taastrup, Denmark) according to the manufacturer’s protocol. Reverse-transcribed material (1 
µL) was amplified with TaqMan Universal PCR Master Mix (Applied Biosystems, 
Stockholm, Sweden) using gene-specific primers. Locked nucleic acid (LNA) probes from the 
human Universal ProbeLibrary (Roche Applied Science, Hvidovre, Denmark), labeled with 
FAM fluorophore were used for detecting amplified LPT, PRL-R, BAX, CCND1, IGF1R, 
LTF, ANGPT2 and COX2 genes.  Power SYBR-Green PCR Master Mix (Applied 
Biosystems, California, USA)  was used for detection of the remaining genes: LPT-R, BCL2, 
IGF1, IGFBP3, IGFBP5, LALBA, VEGF, VEGF-R1, VEGF-R2, CA4, TBXAS, TGFB1, 
TGFB1-R1, TGFB1-R2, RTK, ANGPT1, COX1 and PTGIS. Melting curves showed no more 
than a single amplified product. The PCR amplification signal was detected using an ABI 
PRISM 7900 detection system (Applied Biosystems). Transcription of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), 18S ribosomal RNA I (18S RNR1) and beta-actin 
(ACTB) were quantified and their appropriateness as house keeping gene (HKG) were 
evaluated against the total RNA content. Transcription of target genes were normalized by the 
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mean transcription level of GAPDH as HKG, as suggested by Vandesompele et al. (2002) and 
described by Theil et al. (2006b). The oligonucleotide sequences for the genes were designed 
using the Primer Express software, version 2.0 (Applied Biosystems Inc, CA, USA) or 
Beacon Designer Version 7.00 software (Premier Biosoft International, CA, USA). No 
amplification was found in ribonuclease free water and in samples of genomic bovine DNA. 
For qRT-PCR, 40 cycles were used at 95°C for 15 s, and 60°C for 60 s. The response was 
quantified as the number of PCR cycles required to reach a certain threshold, and samples 
were analyzed in duplicates. The oligonucleotide sequences of forward primers, LNA probes 
(when used), and reverse primers for the genes are shown in table 2.  
Gene expression data were obtained as Ct values (the cycle number at which PCR cycles 
logarithmic plots cross a calculated threshold line) to evaluate mRNA quantities according to 
the manufacturer’s guidelines, and used to determine ∆Ct values: 
∆Ct = [Ct of the target gene] – [Ct of the reference gene (GAPDH)] 
Least square means of ∆Ct values of target genes were normalized to the level observed at d 1 
of MP glands, by calculating the ∆∆Ct values: 
∆∆Ct = [∆Ct observed at a given stage for PP or MP] – [∆Ct observed at d 1 for MP] 
The relative mRNA quantity was calculated as Q
-∆∆Ct
, where Q is 1 + PCR efficiency as 
determined by 10
-1/slope of standard curve
 -1 (Rasmussen, 2000). In cases with 100% PCR 
efficiency, this formula was simplified to the following:  
Relative mRNA quantity (100% efficiency) = 2
-∆∆Ct
 
All statistics were performed at the ∆Ct level (Theil et al., 2006b) to exclude potential bias 
because of averaging data that had been transformed through the equation 2
-∆∆Ct (Pfaffl, 
2001). Expression of both 18S rRNA and ACTB but not GAPDH were affected by parity. 
Therefore, GAPDH was selected to be used as housekeeping gene (HKG) for data 
normalization. 
 
Statistical Analysis 
Statistical evaluation of all data was performed using the Mixed procedure in SAS (v.9.1; 
SAS Institute, USA). Variables in the statistical models included the experimental year, 
treatment (parity, MP or PP), experiment day at which the biopsy sample has been taken and 
its interaction with treatment as fixed effects, the factor goat as random effect, and the factor 
gland within goat at each experiment day was listed in the repeated statement, as shown in the 
following model:  
[131] 
 
Y = µ + αi + βj + γk + βγjk + ρl + τklm  + εijklm, where 
Y= the dependent variables, µ= the overall means, αi= experimental year (i=1,2), βj= parity 
(j= MP and PP), γk= experiment day (k=1,10,60,180), βjk = interaction between parity and 
experiment day, ρl= random effect of goat (l=1, 2,..,9), τklm  = repeated statement of udder 
half within a goat at each experiment day (m= left, right), εijklm= random variation which was 
assumed to be normally distributed with a variance σ
2
 and a mean of zero. Before performing 
the final statistical analyses, data were checked for outliers based on residual plots. The data 
were additionally analyzed in two other ways; 1) including only the goats and glands that 
were PP in the first year and MP in the second year, and 2) using only PP and MP glands 
from the first experimental year (excluding year two). The P values differed only slightly 
compared to the model including the whole set of animals and glands in the two experimental 
years, and the significancy of the results were the same. Therefore, we decided to use the full 
model including observations from both years to obtain higher degree of freedom for the MP 
glands. In addition, contrast analyses were performed at each sampling stage. Furthermore, 
the data from poorly differentiated MEC as well as cell proliferating and apoptotic cells were 
arcsin transformed to meet statistical assumptions for normal distribution. However, back-
transformed data are presented in tables and graphs. Presented results are expressed as least 
squares means (LS-Means) with standard error of mean (SEM). The PDIFF option in SAS 
was used to generate comparisons between treatment means. The level of significance was set 
at P < 0.05. 
 
RESULTS 
The general patterns of changes in mammary morphological measures, mammary cell 
turnover and gene expression were the same in the two experimental years. But levels of 
alveolar number, proportion of MEC in different differentiation stages and expressions of 
ANGPT2, VEGF, BCL2, IGFBP3 and TGFB1-R2 differed between the two experimental 
years, and the reason for this year effect is not known.  
 
Mammary Morphology 
In the following, proportions will refer to the number of hits on a given cell or tissue structure 
compared to the total number of hits, and numbers refer to the total number of that structure 
observed as explained above. 
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Gross Morphological Changes. Micro-vessel proportion was neither affected by the stage of 
lactation nor by parity (results not shown). As shown in figure 1, MP compared to PP glands 
had higher alveoli number (3.1 versus 2.1) and interstitial tissue proportion (29% and 24%, 
respectively); but lower alveoli proportion (70% and 75%, respectively) across the whole 
lactation period. A very high alveoli proportion was observed at parturition (d1) in both MP 
(72%) and PP (76%) glands. Simultaneously, alveoli number was at its lowest at this time 
point in both MP (1.7) and PP (2.7) glands, and a very high lumen proportion was observed in 
PP glands (36%) at parturition, which was significantly higher than observed in the MP ones 
(26%). 
Within the first 10 days after parturition (d10), alveoli number increased in both MP and PP 
glands (to 3.4 and 2.5, respectively) due to a slight increase in MEC proportion (to 47%),  
whereas alveoli proportions remained at the same high (MP: 75% and PP: 78%) and 
interstitial tissue at the same low level (MP: 25% and PP: 21%) as at parturition. Lumen 
proportion decreased over the first 10 days of lactation in the PP glands to reach the same 
level as observed in MP glands (27%).  
From early into mid-late lactation, a decrease was observed in alveoli proportion (d60: 74% 
and d180: 65%). MEC proportion remained at the same level from early to mid lactation, but 
thereafter decreased to the lowest levels in late lactation (42%). From d10 to late lactation 
lumen proportion remained at the same level (26-27%), but decreased in MP glands to the 
lowest level (20%) in late lactation. Interstitial tissue proportion started to increase to its peak 
values, which were observed in late lactation (33%).  
Differentiation of MEC. As shown in figure 1, the proportion of poorly differentiated MEC 
was close to zero in PP glands and significantly lower than in MP glands (3%) during the 
whole period of lactation. The proportion of intermediate differentiated MEC was numerically 
(P = 0.13) higher in MP compared to PP glands (79% and 69%, respectively); while it was 
reverse (P = 0.11) for the proportion of fully differentiated MEC (16% and 26%, 
respectively). The proportion of intermediate differentiated MEC proportion was generally 
high at and a few days after parturition in both glands (79% at d1 and 77% at d10); while, the 
fully differentiated MEC proportion was low (16% at d1 and 18% at d10). Intermediate 
differentiated MEC proportion decreased in PP glands in mid and late lactation (60% and 
59%, respectively) and became significantly lower than in MP glands, in which proportion of 
intermediate differentiated MEC remained quite constant in mid late lactation (80%). For 
fully differentiated MEC proportion the reverse picture was seen, with increases in their 
proportion in PP glands in mid and late lactation (35% and 34%, respectively), and this 
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proportion became significantly higher than in MP glands (17% in mid and 13% in late 
lactation). 
 
Immunohistochemistry  
The highest rates of both Ki-67 staining and TUNEL staining were observed at the day of 
parturition (d1) in PP glands (4.44% and 0.31%, respectively), and those rates were 
significantly higher (P = 0.02 and P = 0.04, respectively) than in MP glands (0.84% and 
0.08%, respectively). Rates of proliferation and apoptosis were generally quite constant 
throughout the lactation period in MP glands (approximately 0.55% and 0.07%, respectively), 
but in PP glands rates of cell proliferation and apoptosis was high in early lactation (2.50% 
and 0.20%, respectively), and decreased to mid (1.04% and 0.06%, respectively) and late 
(0.80% and 0.01%, respectively) lactation stages. But as shown in figure 2, rates of cell 
proliferation were consistently higher in PP glands throughout the lactation period. 
 
Gene Expression 
Genes Related to Cell Turnover and Lactogenesis. IGF1 (P = 0.03), LPT (P = 0.004), LPTR 
(P = 0.04) were more, and BCL2 (P = 0.07) and IGFBP3 (P = 0.07) tended to be less 
expressed in PP compared to MP glands. As shown in figures 3A and 3B, BCL2, IGF1, 
IGFBP3, IGFBP5, TGFB1, TGFB1R2, PRLR, LALBA, LTF, LPT and LPTR were at a low 
or their lowest expression level at parturition time, and for BCL2 (P = 0.04), TGFB1 (P < 
0.01), PRLR (P = 0.01) and LALBA (P = 0.01) lower in PP than MP glands. BCL2 and 
IGFBP3 at d10 (P < 0.001 and P = 0.03, respectively) were lower expressed in PP than MP, 
but reached the same level in both glands at mid-late lactation. TGFB1, TGFB1R2, PRLR, 
LTF, LALBA and LPTR increased in PP glands at d10, made TGFB1R2 (P = 0.01) and 
PRLR (P = 0.01) higher in those than in MP glands. TGFB1 and LALBA at d10 and 
TGFB1R2 and PRLR at d60 reached the same level in both glands till late lactation. IGFBP5 
peaked in both glands in mid lactation. LTF was the same level in both glands, increased to 
peak in late lactation. IGF1, LPT and LPTR remained constant in MP. LPT and LPTR 
increased in PP glands, in a way similar to IGF1 and LPTR in mid lactation (P < 0.05 and P = 
0.04, respectively) and IGF1, LPT and LPTR in late lactation were higher in PP than in MP 
glands (P < 0.001, P < 0.01 and P < 0.001, respectively). There was neither effect of stage of 
lactation nor treatment on the expression of BAX, CCND1, IGF1R and TGFB1R1 (data not 
shown). 
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Genes Related to Vascular Function and Angiogenesis. As shown in figure 3B, in PP 
compared to MP glands, COX2 and PTGIS were higher and VEGF tended to be less (P < 
0.10) expressed. The expression of all other studied genes in this group were constant in MP 
glands, except for peaked expression of VEGF at d10 and for VEGFR1, ANGPT1 and RTK 
in mid lactation.  
The case in PP glands was different from that in MP glands as their expression at parturition 
was either low or at its lowest level, in a way that for TBXAS (P = 0.02), VEGFR1 (P = 0.01) 
and RTK (P = 0.04), was significantly lower than in MP glands. Expression of VEGF, 
VEGFR2, ANGPT1 and ANGPT2 was raised or peaked at d10, and became higher in PP than 
in MP (P = 0.03, P = 0.03, P < 0.01 and P = 0.03, respectively). From D10 onwards, 
expression of VEGF, VEGFR1, VEGFR2 and ANGPT2 and RTK remained at the same high 
level. COX1, COX2, PTGIS, TBXAS increased to peak in late lactation, made them higher in 
PP than in MP glands (P < 0.01, P < 0.01, P < 0.01 and P = 0.09, respectively). There was 
neither any effect of stage of lactation nor the treatment on the expression of CA4, although it 
was numerically lower in PP compared to MP glands. 
 
DISCUSSION 
It has been shown in dairy goats (Carnicella et al., 2008; Mioc et al., 2008) as well as dairy 
cows (Miller et al., 2006), that PP animals have a lower but more persistent milk production 
compared to MP animals. Unfortunately, the milk yield data in this experiment for the first 19 
weeks of lactation were lost, but in agreement with these previous reports, PP goats produced 
about 20% less milk than MP goats during lactation weeks 20 to 30 of lactation where the last 
samples were taken (results not shown). The difference became numerically smaller by the 
end of this period, but the data did not allow us to evaluate lactation persistency statistically.  
 
Impact of Parity Number on MEC Development During Lactation 
We observed a very low rate of cell proliferation and hardly any visible changes in this rate 
over the course of lactation in MP glands, in which renewal of cells mainly takes place prior 
to parturition (Caja et al., 2006). In contrast, cell renewal in PP glands was substantial after 
parturition. This continued growth in PP mammary gland has been previously reported in 
dairy goats (Anderson et al., 1981; Knight and Peaker, 1984) as well as in dairy cows (Miller 
et al., 2006). Furthermore, rates of apoptosis were high in both MP and PP glands right after 
parturition, but decreased to almost zero in PP glands over the course of lactation. The 
MEC:lumen ratio was substantially lower in PP (1.0:1) compared to MP glands (1.6:1) at the 
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time of parturition, but by d 60 of lactation the ratio in PP glands (1.8:1) had increased to the 
same level as in MP glands (1.7:1). This indicates that PP glands are less compositionally 
differentiated at parturition compared to MP glands. Thus it seems that MEC proliferation as 
well as differentiation continues further into lactation in PP compared to MP goats.  
There was a very low proportion of poorly and a high proportion of intermediately and fully 
differentiated MEC in both PP and MP glands during established lactation, which has also 
been previously reported in Holstein cows (Akers et al., 2006). In our study, the proportion of 
intermediately differentiated MEC decreased over the course of lactation in PP glands, whilst 
the proportion of fully differentiated MEC increased, especially from d10 and onwards. These 
changes most likely reflect that intermediately differentiated MEC progressively become 
differentiated into fully differentiated MEC in PP glands. As a consequence of lower rate of 
apoptosis from d10 and onwards in PP compared to MP glands, this would overall indicate 
that the MEC population in PP glands in addition to having new cells added during lactation, 
also were more persistent and hence capable of remaining lactating for a longer period of 
time.  
 
Impact of Parity Number on Key Regulatory Factors in MEC Turnover 
Parity significantly impacted expression of the majority of genes involved in regulation of cell 
turnover and lactogenesis (BCL2, IGF1, IGFBP3, IGFBP5, TGFB1, TGFB1R2, PRLR, 
LALBA, LPT and LPTR), but not BAX, CCND1, IGF1R, TGFB1R1 and LTF. In recent 
studies in MP cows (Norgaard et al., 2005), sheep (Norgaard et al., 2008a) and goats (Caja et 
al., 2006), it was found that the major part of mammary redevelopment occurs in late 
pregnancy. It was therefore not surprising that the level of expression of many of the genes 
involved in cell turnover was low at the time of parturition in our dairy goats, when lactation 
had been initiated.  
Expression of the antiapoptotic factor BCL2 (Reed, 1998) corresponded with high rates of 
apoptosis at parturition and higher apoptotic rates in PP compared to MP glands.  We were 
unable to relate differences in rates of apoptosis during the lactation period or between PP and 
MP glands to expression of BAX, which is an apoptotic factor (Reed, 1998). Although this 
suggests that the antiapoptotic factor BCL2 plays a greater role than BAX in regulation of 
apoptosis from parturition and during lactation, it can not be ruled out that BAX may be 
involved in this regulation as well. The present as well as previous gene expression studies 
have been conducted on biopsies of mammary tissue consisting of a variety of different 
tissues and cell types present in the mammary gland. Gene expression changes occurring in a 
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particular cell type may therefore be masked by the presence of other tissue structures. There 
is a  need in the future to conduct tissues specific expression studies, using new techniques 
like laser microdissection to separate individual cell types in order to shed more light on the 
coordinated regulation of mammary development and remodeling. 
Initiation of lactation in MP ruminants is associated with up-regulation of the PRLR in MEC 
and initiation of copious milk secretion including the whey protein LALBA, and in this study 
expression of these factors was at therefore at its highest at the time of parturition in MP 
goats. However, in PP goats both PRLR and LALBA expression increased from parturition to 
peak at d10, which is yet another indication that initiation of lactation and growth in the PP 
mammary gland continues further into early lactation and that initiation of lactation possibly 
is delayed or a prolonged process in PP glands of dairy goats. Prolactin and its receptor are 
involved in > 300 biological processes (Bole-Feysot et al., 1998). PRLR is a determinant for 
prolactin signaling, and stimulates cellular proliferation, differentiation and lactogenesis in 
MEC (Wall et al., 2006), and PRL/PRLR has been demonstrated to be important for milk 
removal and mammary function in dairy cows (Wall et al., 2006). Moreover, Theil et al. 
(2006a) showed that expression of PRLR in mammary glands of sows is crucial in order to 
ensure continued growth of the mammary gland at parturition and to onset lactation. The 
PRLR could therefore be one of the overall factors involved in coordinating mammary 
growth, function and angiogenesis in the periparturient dairy goat, and the delayed 
lactogenesis and continued development of the PP mammary gland into lactation could be a 
result of sustained expression of the PRLR. The underlying reason for this differential 
expression pattern in PP and MP goats’ mammary glands is not known. 
Insulin-like growth factor 1 has been reported to stimulate MEC growth, proliferation and cell 
survival (Knight, 2000) and LPT has been reported to be involved in regulation of MEC 
proliferation and/or differentiation prior to parturition (Chilliard et al., 2001). We found that 
expression of IGF1, LPT and LPTR were at similar levels in the MP and PP mammary gland 
at the time of parturition, but with progressing lactation, expression of these factors increased 
in PP glands, whereas expression levels remained constant or even diminished in the MP 
mammary glands. This coincided with the more pronounced shift from poorly over 
intermediately to fully differentiated MEC in PP compared to MP glands. It is therefore 
tempting to speculate that IGF-1 and LPT are important factors involved in regulating 
differentiation and cell survival during lactation in general, and also contributing to explain 
the different developmental patterns between PP and MP glands over the course of lactation. 
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The regulatory factors determining development and differentiation of MEC during the 
normal lactation in MP goats thus seem to be the same set of factors responsible for the 
differential pattern of development in the PP compared to the MP mammary gland. It would 
be valuable to gain insight into the underlying reason for the impact of parity on expression of 
this whole range of MEC genes, as this is a key to understanding aspects of lactation 
persistency. 
 
Impact of Parity Number on Vascular Development During Lactation and Key Regulatory 
Mechanisms  
In contrast to most other organs, where the angiogenic potential is only used in response to 
injury, the mammary parenchyma is persistently regulating its vasculature (Djonov et al., 
2001). There are a few studies available on the mammary vasculature in the normal mammary 
gland during the course of gestation and lactation (Akers, 2002), but to the best of our 
knowledge, no previous studies have looked into the regulatory mechanisms responsible for 
vascular remodeling and function during the normal course of lactation in ruminants. 
In the present study, the proportion of micro-vessels in mammary tissue was neither affected 
by stage of lactation nor by parity.  We performed an additional statistical analysis on our data 
to calculate the micro-vessel to interstitial tissue ratio in the interstitial tissue proportion only, 
i.e. the proportion of micro-vessels within the interstitial tissue rather than in the whole 
mammary tissue including MEC. The micro-vessel to interstitial tissue ratio was markedly 
higher (P < 0.0001) in PP (71%) than MP (41%) glands during the whole lactation period. 
This ratio decreased in parallel in PP and MP glands from early lactation and reached the 
lowest levels in late lactation in both PP and MP glands (59% and 31%, respectively). These 
overall lactation changes are equivalent to what has been previously reported in rats (Yasugi 
et al., 1989). The pattern of changes in the above ratio over the course of lactation reflects 
microvasculature regression. In the mouse, this has been shown to follow the alveolar 
degeneration (Matsumoto et al., 1992). Based on another study on vascular remodeling in the 
mouse mammary gland, Djonov et al. (2001) suggested that regression of the endothelium 
could be correlated to, or even be a consequence of, MEC involution. Whatever comes first, 
vascular or alveolar degeneration, it appears evident that the function and integrity of the 
MEC is dependent on and closely coordinated with the vascular system responsible for 
provision of nutrients and removal of waste products, essential to sustain MEC metabolism.  
This is the first report of quantitative gene expression analysis for factors involved in 
angiogenesis and vascular remodeling (VEGF, VEGFR1, VEGFR2, ANGPT1, ANGPT2 and 
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RTK) in the mammary gland in dairy goats during lactation. We are not aware of any such 
studies in the bovine, and only few studies in rodents have looked into the mammary 
vasculature and regulation of its remodeling (Djonov et al., 2001; Pepper et al., 2000). Parity 
appeared to influence the whole range of studied genes associated with vascular function and 
angiogenesis in our studied dairy goats. VEGFR1, VEGFR2, ANGPT1, ANGPT2 and RTK 
are all reported to be angiogenic factors (Shibuya, 2001; Thurston, 2003), and these genes as 
well as PRLR and LALBA were generally higher expressed in MP compared to PP at the time 
of parturition, but this had reversed by d10, where highest expression levels were found in PP 
glands. It has been suggested that the MEC is the main source of angiogenic factors in the 
mammary gland (Pepper et al., 2000), and as such it appears logical that expression of 
angiogenic factors would follow the developmental pattern of MEC described above during 
lactation and in mammary glands of different parity. Primiparous glands thus continue to 
develop also their vascular system post-partum to a greater extent than in MP goats. 
Furthermore, we observed that a number of other genes (COX1, COX2, PTGIS and TBXAS) 
encoding for factors regulating vascular tone and function (Nielsen et al., 1995) were higher 
expressed in PP than MP glands, especially in late lactation. These factors are synthesized 
within the capillary endothelial cells in addition to MEC. Cyclooxygenase (COX1 and COX2) 
are key enzymes involved in synthesis of a number of vaso-active substances (Simmons et al., 
2004), and the enzyme PTGIS specifically regulates the synthesis of prostacyclin (PGI2), 
which has been reported to be a potent vasodilator in the mammary gland (Nielsen et al., 
2004). Higher expression of genes encoding for potent vasodilators could likely be associated 
with improved blood perfusion in PP glands in more advanced stages of lactation, and would 
thus contribute to explain why lactation persistency may be higher in PP goats. The reason for 
higher expression of these genes encoding for factors with vasoactive action is not known.  It 
is noteworthy that IGF1, LPT and LPTR exhibited the same pattern of expression changes as 
the vasoactive factors COX1, COX2, PTGIS and TBXAS. This could suggest that the 
differential expression of the vascular function genes was linked to the differential 
development of the MEC in PP compared to MP glands, and in this way coupled to 
differential development also of the mammary vascular system. An important message is that 
the changes in vascular and MEC function appear to be regulated in a coordinated manner. 
Our study gives rise to the question whether the vascular system may be involved in 
determining lactation persistency, and this issue deserves to receive more attention in the 
future, as so little work has been carried out in this area so far. 
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CONCLUSION 
We have found that initiation of lactation and growth of the mammary gland continues further 
into early lactation in the PP compared to the MP dairy goats. This not only applies to MEC 
renewal, but also to development of vascular function (angiogenesis). This combined with 
improved MEC survival and maintenance of vascular competence, could explain the reported 
higher lactation persistency in PP compared to MP goats. There is an orchestrated change 
taking place to regulate the MEC and vascular function during normal lactation and to ensure 
coordination of function in these two important tissue components of the mammary gland. We 
have provided evidence that the set of genes regulating these orchestrated changes, are also 
basically the ones which can explain the different patterns of mammary development and 
performance during lactation between PP and MP goats, and hence the factors encoded for by 
these genes are likely to be important determinants of lactation persistency. We therefore 
suggest that development and function of the microvasculature may be just as essential for the 
overall integrity of the mammary gland and lactation persistency as the MEC. This issue 
should be addressed in future studies. The underlying reasons for the differential expression in 
PP compared to MP goats of genes responsible for regulation of MEC and vascular 
development remain to be established. 
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Figure legends 
 
Figure 1. Number of alveoli per picture, and the proportions (%) in mammary sections of 
alveoli, MEC, lumen, interstitial tissue, micro-vessels, and poorly, intermediate and fully 
differentiated MEC.  
PP and MP: primiparous (broken line) and multiparous (full line) glands, respectively. D: day 
of lactation. P values for stage of gestation-lactation (S), Parity (P) and their interaction are 
presented in the top or down right corner of each graph. 
Figure 2. Percentile of proliferative (Ki-67) and apoptotic (TUNEL) epithelial cells in 
mammary sections. 
PP and MP: primiparous (broken line) and multiparous (full line) glands, respectively. D: day 
of lactation. P values for stage of gestation-lactation (S), Parity (P) and their interaction are 
presented in the top or down right corner of each graph. 
Figure 3. Expression levels of genes related to A) cell turnover and lactogenesis, and B) 
vascular function and angiogenesis  
PP and MP: primiparous (broken line) and multiparous (full line) glands, respectively. D: day 
of lactation. Values are relative to d1 of MP glands and LSMeans, and 95% confidence limits. 
P values for stage of gestation-lactation (S), Parity (P) and their interaction are presented in 
the top or down right corner of each graph.  
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ABSTRACT 
The objectives of the present experiment were to study how mammary supply of essential 
amino acids versus energy yielding substrates in the form of acetate or glucose would affect 
mammary nutrient uptake and milk (protein) synthesis in early (EL) and late lactating (LL) 
dairy goats. Goats were fed a basal diet deficient in energy (90% of requirements) and protein 
(80% of requirements), and were randomly allocated to 4 treatments in a balanced 4 x 4 Latin 
Square design. The treatments consisted of 4-d continuous intravenous infusions of 
isoosmotic isoenergetic solutions of essential amino acids (EAA), sodium acetate (ACE) and 
glucose (GLU) with saline (SAL) as control. There was a 3-d rest period between each 
treatment. Simultaneous arterio-venous blood samplings over each udder half (gland) were 
performed every 4 h during the last 24 h of infusion. Blood acid-base parameters and plasma 
concentrations of glucose, non-esterified fatty acids, beta-hydroxy-butyrate, triacylglycerol 
and urea were determined. Milk production over the last 48 h of infusion was recorded, and 
milk fat and protein contents determined. Milk yield and energy corrected milk, milk fat and 
protein yields in g/last 48 hours were significantly higher in EL than LL. Gross milk yield 
was significantly higher on GLU and EAA treatments in EL compared to the SAL control 
treatment, and yield of ECM was increased on ACE relative to SAL. In LL, nutrient 
supplementations did not affect gross milk yield, but ECM was increased on EAA compared 
to other treatments. Protein percentage was lowest on GLU compared to other treatments, and 
protein yields were increased on EAA and ACE but not on GLU compared to SAL in EL. In 
LL, milk protein percentage was higher on EAA than GLU and milk protein yield was higher 
on EAA compared to ACE and GLU. Fat percentages were decreased by GLU and EAA 
compared to ACE and SAL in EL, and highest fat yield in EL was observed on ACE. In LL, 
GLU also lowered milk fat percentage, whereas EAA increased it in contrast to the effect in 
EL. We conclude that an insufficient amino acid supply to the mammary gland of dairy goats 
can be compensated in EL but perhaps not LL by increased mammary supply and uptake of 
an energy yielding substrate, provided this substrate specifically contributes to ATP 
generation in mammary epithelial cells. The mammary gland may thus be relatively less 
sensitive towards variations in amino acid supply in EL compared to LL. This suggests there 
might be scope for development of differential protein recommendations for ruminants in 
early and late lactation, and this issue should be pursued in future studies.  
Key words: mammary metabolism, mammary nutrient uptake, arterio-venous concentration 
difference, acid-base parameters 
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INTRODUCTION 
Consumers’ increased demand for protein has promoted the value of milk protein production 
over the last decades. Milk protein synthesis in dairy cows has been shown to be stimulated 
by increased amino acid supply either through dietary protein supplementation (Hanigan et 
al., 2001; Rulquin et al., 1993; Weekes et al., 2006) or by intravascular infusion of amino 
acids (Kim et al., 2000; Metcalf et al., 1996). However, increased mammary supply of a 
number of specific amino acids have not always had a positive impact on milk protein 
production (Seymour et al., 1990). Synthesis of protein in the mammary gland as well as in 
other body tissues relies not only on building blocks in form of amino acids, but also on 
availability of energy in the form of ATP. Raggio et al. (2006) therefore suggested that milk 
protein production could be improved by protein as well as energy supply to the mammary 
gland. Thus, intravascular infusion of energy yielding substrates like acetate (Chaiyabutr et 
al., 1998; Maas et al., 1995; Weekes et al., 2006) and glucose (Bobe et al., 2009; Schei et al., 
2007) has been shown to affect milk protein synthesis positively.  
Acetate and glucose are the major energy suppliers to the mammary gland. Acetate is utilized 
in oxidative phosphorylation of adenosine nucleosides, which results in the generation of ATP 
(Forsberg et al., 1984; Scott et al., 1976), whereas glucose is oxidized mainly through the 
pentose phosphate pathway to yield NADPH required for de novo fatty acid synthesis 
(lipogenesis) (Chaiyabutr et al., 1980; Chaiyabutr et al., 2008). If mammary energy supply is 
a main determinant for protein synthesis; it should theoretically be possible to substitute 
amino acids to some extent in the diet with an energy yielding susbstrate to provide extra ATP 
in the mammary gland and improve utilisation of the amino acids available.  
With progressing lactation, the milk production efficiency decline and the milk composition 
in dairy animals change as a result of declined number and activity of the secretory cells in the 
mammary tissue (Safayi et al., 2009; Wilde and Knight, 1989). Along with these changes, 
mammary nutritional requirements and uptake are also changed (Aganga et al., 2002; Nielsen 
et al., 2001). There are indications suggesting that this is associated with an altered sensitivity 
of the mammary gland towards variations in e.g. amino acid supply, since correlations 
between arterial concentrations and arterio-venous differences (efficiency of mammary 
uptake) for individual amino acids differed in early compared to late lactation in dairy goats 
fed different levels of lysine and methionine (Madsen et al., 2005). Therefore, it is also likely 
that there might be a prospect for differentiating protein recommendations for ruminants 
across the lactation period, and still maintain protein production by optimisation of the 
provision of energy yielding substrates relative to amino acids (Madsen et al., 2005).  
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We hypothesised that mammary supply of essential amino acids versus energy yielding 
substrates in the form of acetate or glucose would affect mammary nutrient uptake and milk 
(protein) synthesis in both early and late lactating dairy goats that were fed a basal diet 
deficient in energy (90% of requirements) and protein (80% of requirements). The more 
specific aims of the present project were to determine whether : 1) provision of energy (ATP) 
yielding substrates can compensate for an insufficient AA supply to the mammary gland and 
hence improve overall utilization of AA for milk protein synthesis, 2) acetate is more efficient 
than glucose in stimulating milk synthesis and particularly its milk protein content due to their 
contribution to mainly ATP and NADPH, respectively; and 3) milk synthesis is more 
sensitive towards changes in nutrient provision in early lactation (EL) compared with late 
lactation (LL). This issue is of major importance for the economy of dairy production by 
increasing our knowledge on how to maximize not only the milk protein yield but also the 
overall nitrogen utilization in dairy farming. 
The objectives were addressed in a study with goats conducted in both early and late lactation. 
The goats were fed a basal ration designed to meet approximately 90% and 80% of daily 
requirements for net energy and amino acids absorbable from the small intestine, respectively, 
and given intravenous infusions of isoosmotic solutions of essential amino acids (EAA), 
acetate (ACE), glucose (GLU) and saline (SAL) as control in a 4 x 4 Latin square design. 
 
MATERIALS AND METHODS 
Experimental design 
Four Danish Landrace dairy goats (parity ≥ 2) were used in this experiment. Goats were 
previously surgically prepared with exteriorized carotid arteries and milk veins, as described 
by Nielsen et al. (1995). The goats were randomly assigned to one of four treatments in a 
balanced 4 x 4 Latin square design, which was performed in both late lactation (LL) and the 
following early lactation (EL). Due to health reasons, one of the goats had to be replaced in 
the early lactation trial with her twin sister, which had a similar size, body weight and milk 
yield. At the start of each part of the experiment, early and late lactation, the goats were 21±1 
and 157±9 days postpartum, and live weights were 51±8 and 52±3 kg, respectively. 
Treatments consisted of continuous intravenous infusions of 4 isoosmotic solutions at pH 7.4 
(960 g/d for 4 days) containing either saline (SAL) as control, a mixture of essential amino 
acids (EAA) composed to match the relative proportion of EAA in milk protein determined in 
a previous experiment with this goat breed (Madsen et al., 2005), sodium acetate (ACE), or 
glucose (GLU). The chemical composition of the feed used in both early and late lactation as 
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well as an overview of the daily provision of energy and protein to the goats with the daily 
diet and infusion solutions are shown in tables 1 and 2. EAA, ACE and GLU infusions were 
composed to be isoenergetic based on the potential yield of ATP from oxidation of these 
nutrients in the body (33.6, 10 and 36 mol ATP/mol EAA mix, ACE and GLU, respectively). 
Each treatment period lasted one week, where the intravenous infusions were initiated at 
12:00 on day 1 (Monday) and concluded at 12:00 on day 5 (Friday), followed by a 3 day rest 
period in between. Samplings were performed during the last 24 hours of each infusion 
period. The goats were milked and fed the restricted basal diet in two daily meals (at 07:00 
and 17:00 h) during the first 3 days of each infusion period, and every 4 hours for the last 24 
hours during the sampling period. The diet (see Table 2) was consisted of artificially dried 
grass hay, barley, protected fat, urea, and a vitamin/mineral mix. It was designed to meet 
approximately 90% and 80% of daily requirements for energy and amino acids absorbable 
from the small intestine, respectively, based on the pre-trial body weight and milk yields in 
the early and late lactation period and according to Danish feeding standards (Strudsholm et 
al., 1999). The Danish standards are consistent with the nutrient requirements of dairy goats, 
as reported by Sauvant and Morand-Fehr (1989). 
The experiment was carried out at the experimental facilities at the Faculty of Life Sciences, 
University of Copenhagen, Denmark, and approved by the Danish Animal Experimentation 
Inspectorate, and complied with the Danish Ministry of Justice laws concerning animal 
experimentation and care for experimental animals. 
 
Sampling 
During each treatment period, the goats were placed in metabolic cages and the daily feed 
intake was determined. Feed refusals from the last 24 hours of each infusion period were 
collected. Milk yields were recorded at each milking. As described by Madsen et al. (2005), 
catheters were fitted in one carotid artery using local analgesic (20 mg/mL lidocain, 
AstraZeneca, Albertslund, Denmark) and in both milk veins. Blood samples from the carotid 
artery, and the milk veins (whilst manually clamping the vena pudenda externa) were 
withdrawn simultaneously seven times (every 4 hours) during the last 24 h period of each 
treatment starting at 12:00 on day 4 and ending at 12:00 on day 5. Blood samples were taken 
using 1 ml LiHep coated syringes (PICO50, Radiometer, Denmark) for immediate 
determination of acid-base parameters. Other blood samples were collected in 10 ml 
vacutainers coated with EDTA, and stored on ice till centrifugation (3000 gav at 4 °C for 12 
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min). Plasma was transferred to labeled cryo-tubes. Samples of the offered feed, feed refusals 
and milk (from each milking over the last 24 h) were collected and stored at -20 ºC. 
 
Analyses and Calculations 
Blood samples collected with 1 ml LiHep coated syringes, were immediately analyzed for 
acid-base parameters: pH, HCO3-, total O2 (TO2) and total CO2 (TCO2) (ABL700SERIES, 
USA and GEM OPL, USA). Stored plasma samples were analyzed for glucose (GLU), non-
esterified fatty acids (NEFA), beta-hydroxy-butyrate (BHB), triglycerol (TG) and urea. As 
described by Husted et al. (2008), all analyses were performed using an autoanalyzer, ADVIA 
1650® Chemistry System (Bayer Corporation, Tarrytwon, NY 10592, USA), at the Faculty of 
Agricultural Sciences, Aarhus University, Denmark. Plasma content of total long-chain fatty 
acids (LCFA) was calculated as concentration of NEFA + 3 x concentration of TG. Plasma 
concentration of IGF-1 was determined in the first arterial sample on every sampling day, as 
described by Tygesen et al. (2008). A commercial spectrophotometric kit was used for 
determination of plasma concentration of acetate (ACE) (AnzyPlus Rasio Diagnostic A/S, 
Italy). Milk protein and fat content was analyzed and calculated as described by Nielsen and 
Jakobsen (1993). Mammary extraction (E) rate for metabolites was calculated as mammary 
arterial-milk vein concentration difference (AVD) divided by arterial concentration. 
Respiratory quotient (RQ) values for each mammary gland was calculated as mammary CO2 
release divided by mammary O2 uptake = (TCO2 (mM) x mammary blood flow) / (TO2 
(mM) x mammary blood flow) = TCO2 AVD / TO2 AVD. Energy corrected milk yield 
(ECM) was calculated as milk yield (g/last 48 hours) x ((0.383 x fat% + 0.242 x protein% + 
0.7832) / 3.14), where 1 g of ECM equals 3.14 kJ (Sjaunja et al., 1991). 
 
Statistical Analysis 
Statistical evaluation of all data was performed using the Mixed procedure in SAS (v.9.1; 
SAS Institute, USA). Variables in the statistical models included treatment, experiment week 
and the time at which the samples were taken, the experimental stage and its interaction with 
treatment as fixed effects, and the factor gland within goat was considered as random effect, 
as shown in the following model: 
Y = µ + αi + βj + γk + λl + ηil + ρm + τn  + εijklmn, where 
Y = the dependent variables, µ = the overall means, αI = treatment (I = ACE, EAA, GLU or 
SAL), βj = experimental week (j = 1, 2, 3 or 4), γk = sampling time (k= 1, 2, 3, 4, 5, 6 or 7), λl 
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= lactation stage (l = EL or LL), ηil = interaction between treatment and lactation stage, ρm = 
random effect of goat (m =1, 2, 3 or 4), τn  = random effect of gland (n = left or right) and 
εijklm = random variation which was assumed to be normally distributed with a variance σ
2
 and 
a mean of zero. In addition, statistical analyses were performed separately for each individual 
stage of lactation for milk yield data to compare the treatment effects within each stage more 
precisely. Before performing the final statistical analyses, data were checked for outliers 
based on residual plots. Presented results are expressed as least squares means (LS-Means) 
with standard error of mean (SEM). One goat went off her feed in the last experimental week 
in LL on the ACE treatment and showed extreme values for most of the blood parameters. 
Her data for that week was taken out of the final statistical analyses. The PDIFF option in 
SAS was used to generate comparisons between treatment means. The level of significance 
was set at P < 0.05.  
 
RESULTS 
Milk Yield and Composition 
In the following the changes in EL and LL in milk yield, energy corrected milk (ECM), 
percentages and yields of both milk fat and protein will be presented for the three different 
nutrient infusions compared to SAL as control infusion. Statistical analyses were performed 
separately for each stage of lactation. All the results are shown in Table 3.  
Milk yield. Gross milk yield tended to be affected by treatment in EL (P = 0.06). GLU had a 
stimulating effect on milk yield compared to the control treatment (P = 0.01),  and this also 
tended to be the case for EAA (P = 0.06) but not for ACE (P = 0.11). There was no effect of 
treatment on milk yield in LL. ECM was not affected by treatment in EL (P = 0.19), although 
ECM yields on ACE tended to be higher compared to SAL (P = 0.06). In LL, however, ECM 
was affected by treatment (P=0.03), and the highest ECM yield was observed in response to 
EAA infusion compared to GLU (P = 0.01), ACE (P = 0.09) and SAL (P = 0.06). Both milk 
yield and ECM were significantly higher in EL than LL. 
Milk protein. Milk protein percentage was generally lower but total protein yield higher in EL 
compared to LL, for all treatments except ACE, where milk protein percentage was the same 
in EL and LL (P = 0.18). In EL, milk protein percentage was significantly lower on GLU 
compared to other treatments including the control group (P = 0.03). Milk protein yield was 
increased by provision of EAA (P = 0.03) compared to the SAL control, and provision of 
ACE (P = 0.08) also tended to raise milk protein yield above that on the control treatment. In 
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LL, milk protein percentage was significantly higher on EAA compared to GLU (P = 0.03), 
and milk protein yield was higher on EAA compare to GLU (P < 0.01) and tended to be 
higher compared to ACE (P = 0.06). 
Milk fat. In EL, milk fat percentages were similar on ACE and SAL treatments and 
significantly higher compared to EAA and GLU, and fat yield on ACE tended to be higher 
than on EAA (P = 0.07). In LL the picture was slightly different. Fat percentage was still 
lowest on GLU but not significantly different from SAL (P = 0.17), whereas highest fat 
percentages were found on ACE and also EAA compare to GLU and SAL treatments. 
Compared with SAL, fat yield was increased by EAA and decreased by GLU in LL (P = 0.06 
and P = 0.01, respectively). Milk fat percentage was at the same level in EL as in LL, but fat 
yield was higher in EL for all treatments. 
Arterial Concentrations (A), Arterial-Milk Vein Concentration Differences (AVD), and 
Mammary Extraction Rates (E) of Plasma Metabolites 
In the following the changes in A, AVD and E of plasma metabolites across the mammary 
gland will be presented for the three different nutrient infusions compared to SAL as control 
infusion in both EL and LL. All the results are shown in Table 4.  
Glucose: A was highest on GLU compared to other treatments in both EL and LL. In EL, 
glucose E was lower on GLU compared to EAA treatment, and glucose AVD was higher on 
EAA compared to ACE. In LL, the lowest GLU E and AVD was observed on GLU compared 
to all other treatments. AVD and E rates for glucose were higher in EL compared to LL for all 
treatments except SAL. 
Acetate: A and AVD was either numerically or significantly higher on ACE treatment 
compared to other treatments in both EL and LL. AVD changed in proportion to A, so that 
acetate E remained constant across treatments in both EL and LL. However, acetate E was 
affected by stage of lactation, being higher in EL compared to LL across all treatments (EAA: 
P <0.01, GLU:P < 0.001, SAL: P= 0.07) except ACE (P = 0.41).  
BHB: A, AVD in EL and LL as well as its E rate in LL were lowest on GLU compared to all 
other treatments and lower for EAA and ACE compared to SAL. Although the A 
concentrations for all treatments were lower in EL than LL, the E rates were higher. 
NEFA: A and AVD in EL were lower on GLU compared to other treatments, and lower for 
EAA and ACE compare to SAL. In LL, both A and AVD was highest on EAA compared to 
all other treatments. E rates were not affected by treatment in neither EL nor LL. A, AVD and 
E rates for NEFA were, however, significantly higher in EL than LL except for A and AVD 
on EAA treatment. 
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TG and LCFA: A and AVD were unaffected by any of the treatments in EL, but E ratios were 
significantly lower on SAL control compared to all other treatments. In LL, A was highest on 
SAL and AVD and E were lowest on GLU compared to the other treatments. In EL compared 
to LL, A for TG and LCFA were generally higher (all treatments), AVD lower (on ACE and 
SAL treatments) and E also lower (all treatments except for SAL).   
Urea: A was highest on ACE compared to other treatments in EL, but highest on EAA 
compared to other treatments in LL.AVD as well as E rates were not significantly different 
from zero and are not shown.  
IGF1 and insulin: A concentrations were neither affected by treatment nor by stage of 
lactation. 
Arterial Concentrations (A), Arterial-Milk Vein Concentration Differences (AVD), and 
Mammary Extraction Rates (E) of Acid-Base Parameters 
In the following the changes in A, AVD and E for blood acid-base parameters will be 
presented for the three different nutrient infusions compared to the SAL control infusion in 
both EL and LL. All the results are shown in Table 5.  
TO2: In EL, A was unaffected by treatment, but AVD and E were highest on EAA compared 
to other treatments, and E was higher on ACE compare to GLU. In LL, A, AVD and E were 
lower on EAA, ACE and GLU treatments compared to SAL. A AVD and E for TO2 were not 
affected by stage of lactation, except on SAL where the lowest values were observed in EL. 
EAA and E for ACE were higher. 
TCO2 and HCO3: These two parameters changes in parallel. A was highest and E least 
negative on ACE, and AVD least negative on GLU compared to the other treatments in both 
EL and LL. A and E rate on GLU treatment was higher than on EAA and  SAL in EL.  In EL 
compare to LL, A was lower on EAA but higher on ACE, while its AVD and E rates were 
higher on ACE and SAL. 
RQ: across the mammary gland was unaffected by treatment, but tended (P = 0.09) to be 
lower in EL compare to LL on all treatments. 
pH: The highest arteral pH was found on ACE compared to other treatments in both EL and 
LL, whereas the lowest pH was found on EAA in EL and on EL and SAL in LL. Lactation 
stage effect was only seen on SAL, where pH was higher in EL compared to LL. 
There was a week effect for many of the blood parameters, which probably reflects the 
changes in metabolic state goats would normally be experiencing during early lactation. There 
was also an effect of sampling time during the day of sampling for some acid-base parameters 
as well as metabolites. However, changes were not in any way systematically related to times 
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of feeding or milking, and were therefore considers to be random without biological 
significance in this context. 
 
DISCUSSION 
The general condition and behavior of the goats used in this experiment were normal on  
different treatments in both EL and LL, except the week they were getting ACE infusion. 
ACE was infused at constant pH (7.4), but during oxidation in the body, the infused acetate 
anions would associate with protons (H+) resulting in loss of acid from the body resulting in a 
more alkalotic state. Thus, on the ACE treatment arterial blood pH, total CO2 and HCO3- 
increased, reflecting a shift to the left in the carbonic acid buffering system in blood: H+ +  
HCO3- ↔ H2CO3 ↔ CO2 + H2O. The goats did not seem to be affected by this, judged from 
their overall behavior, except for one goat (who was in her final experimental week), and she 
was subsequently taken out of the experiment as previously described.  
Substitution of essential amino acid supply to the mammary gland by energy yielding 
substrates and the effect on milk synthesis and composition  
Continuous intraruminal infusion of acetate in different stages of lactation in dairy cows 
(Rook and Balch, 1961) and dairy goats (Lough et al., 1983) have been reported to increase 
milk fat yields, without any effect on neither milk volume nor protein yield. In the present 
study, milk fat percentage and yield were highest on ACE treatment in EL. This was expected 
since ACE contributes to milk fat synthesis as a substrate in de novo fatty acid synthesis 
(Bickerstaffe et al., 1974). Increased mammary uptake of acetate in response to increased 
supply can drive up milk fat, consisting of more short and medium chained fatty acids 
(Bauman and Griinari, 2003). Acetate is commonly believed to be taken up by the mammary 
gland in proportion to the concentration gradient across the mammary epithelial cell 
membrane, ie. in proportion to concentrations in arterial blood. AVD across the mammary 
gland for acetate was therefore increased to the highest levels during ACE treatment, when 
also A levels of acetate for obvious reasons increased. The additional mammary uptake of 
acetate on the ACE treatment did apparently not induce changes in the use of other fat 
precursors like BHB and LCFA, which agrees with previous findings (Purdie et al., 2008). 
Mammary E for acetate remained constant across the different treatments. However, E was 
higher in EL compared to LL, suggesting either that a higher mammary metabolic activity in 
EL can drive a higher uptake of acetate through lowering of intracellular acetate 
concentrations (pull effect) or that a higher proportion of mammary blood flow is directed 
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through arterio-venous shunts as lactation progresses, and not contributing to capillary 
(nutritive) perfusion (Fleet and Mepham, 1983).  
A milk protein reduction with intravascular GLU infusion has previously been reported in 
dairy cows by Cant et al. (2002), and Hurtaud et al. (1998; 2000) reported in dairy cows that 
intra-duodenal infusion of GLU did not lead to an increase in milk protein yield. The decrease 
in protein and fat percentages in EL on GLU treatment could most probably be ascribed to a 
dilution effect explained by increased lactose synthesis in response to the provision of glucose 
(Cant et al., 2002; Rook, 1979). There was a significant increase in gross milk yield and a 
numerical increase in ECM in EL but not in LL in response to GLU infusion. This would be 
in agreement with the mammary gland being capable of increasing glucose uptake to some 
extent in EL in response to increased supply, but not as efficiently in LL where the synthetic 
capacity of the mammary gland is presumed to be the most limiting factor for glucose uptake 
(Nielsen et al., 2001). Infusion of GLU in LL did therefore presumably not lead to increased 
mammary uptake, but rather increased uptake of nutrients in non-mammary tissues, and this 
could have been associated with a general diversion of nutrients towards non-mammary 
metabolism, as indicated by the reduction in milk fat content and yield during GLU treatment 
in LL. However, insulin and IGF-1 plasma levels were surprisingly not significantly affected 
by GLU treatments in neither EL nor LL despite elevation of plasma glucose levels. The 
highest NEFA levels, however, were observed on the SAL treatment in EL, indicating that 
experimental animals in EL would have been in the most negative energy balance on this 
treatment, when fed the protein and energy deficient basal diet without any additional 
supplementation. This may in turn explain why fat percentage in milk in EL on the SAL 
treatment was as high as on the ACE treatment. 
Compared to the SAL control treatment, milk protein yield was increased by provision of 
EAA and an energy yielding substrate in the form of ACE in EL. But in LL, insufficient 
mammary EAA supply could apparently not be compensated as efficiently by provision of 
more energy-yielding substrates. Acetate and glucose are both substrates contributing to 
oxidative metabolism in the mammary epithelial cell, but acetate is quantitatively the most 
important of the two in both dairy goats and cows (Bickerstaffe et al., 1974). Glucose, has a 
reported entry rate in the order of 52-70 % of that of acetate (Bickerstaffe et al., 1974). 
Oxidation of acetate is coupled to oxidative phosphorylation of adenosine nucleosides, which 
results in the generation of ATP (Forsberg et al., 1984; Scott et al., 1976), whereas glucose in 
the mammary gland is oxidized mainly through the pentose phosphate pathway to generate 
NADPH required for de novo fatty acid synthesis (lipogenesis) (Chaiyabutr et al., 1980; 
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Chaiyabutr et al., 2008). Milk protein synthesis is a highly energy consuming process, and 5 
ATP are consumed for every peptide bond formed (Hanigan and Baldwin, 1994; Lobley, 
1990). Our results showed that it is possible in EL to sustain milk protein synthesis whilst 
reducing amino acid supply to the mammary gland provided: 1) that the mammary supply and 
uptake of energy yielding substrates are increased, and 2) that this additional energy supply is 
in the form of a nutrient (acetate) that contributes predominantly to ATP generation in the 
mammary epithelial cells. But when the energy supply is given in the form of glucose, protein 
synthesis and milk protein content can not be sustained, neither in EL nor in LL. This 
illustrates the importance of ATP for sustenance of milk protein synthesis. 
Impact of stage of lactation on sensitivity of milk synthesis towards changes in nutrient 
provision 
In EL, the synthetic capacity of the mammary gland is at its maximum and feed intake 
capacity normally not sufficient to cover the nutritional requirements for milk production. It is 
therefore generally anticipated that nutrient supply to the mammary gland is the main limiting 
factor for milk production in EL, whereas synthetic capacity becomes limiting later in 
lactation, when mammary epithelial cells die and feed intake increases to the extent where 
nutrient supply no longer limits nutrient uptake in the mammary gland (Madsen et al., 2005; 
Wilde and Knight, 1989). With progressing lactation, it therefore appears logical to assume 
that milk synthesis within the mammary gland should become less sensitive to changes in 
supply of nutrients. In LL, additional supply of acetate did indeed fail to drive up milk fat 
synthesis, although AVD for acetate increased on ACE compared to all other treatments. This 
indicates that mammary gland synthetic capacity was the main limiting factor for de novo 
fatty acid synthesis at this stage of lactation and not substrate supply. Milk TG synthesis may 
however not be limited by changes in synthetic capacity to the same extent as de novo fatty 
acid synthesis in LL,  since a very high positive correlation (R2 <0.01) was found between 
milk fat yield and AVD for NEFA in LL. 
In LL, the population of transporters in the MEC for both glucose (Shennan and Peaker, 
2000) and amino acids (Sharma and Kansal, 2000) decrease compared to EL. The same has 
been reported for activity of the capillary enzyme lipoprotein lipase involved in mammary 
uptake of plasma TG (Neville and Picciano, 1997). Hence more nutrients provided by the 
blood will escape mammary uptake. Consequently AVD and E were significantly lower in LL 
compared to EL, reflecting the decreased synthetic capacity and metabolic activity in the 
organ, with a decreasing capability to extract nutrients from whatever volume of blood that 
flows through it. Even for nutrients where concentration gradients are believed to be the 
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driving force for mammary uptake (acetate, BOHB and NEFA), efficiency of mammary 
uptake decreased as lactation progressed, showing that extraction of such nutrients is 
determined not only by arterial concentrations, but probably also by the intracellular 
concentration and hence metabolic activity in the mammary epithelial cells.  
Quantitative nutrient uptake in the mammary gland is determined by AVD as well as the rate 
of MBF. According to Cant et al. (2003), amino acids are not directly involved in regulation 
of vascular tone and hence MBF. The majority of published studies have shown a positive or 
no effect of increasing amino acid supply to the mammary gland on MBF. Thus MBF was 
neither in early nor in late lactating dairy goats affected by dietary supplementation with 
protected Lys and Met (Madsen et al., 2005). In dairy cows, close-arterial infusion into the 
mammary gland of a mix of 18 AA excluding Leu was reported to increase MBF (Bequette et 
al., 1996), and it was suggested by Cant et al (2003) that MBF and net extraction of deficient 
amino acids are elevated during a single amino acid deficiency, by which mammary blood 
flow increases. But in one study (Guinard and Rulquin, 1995), duodenal infusions of DL-Met 
in increasing doses has been reported to have a negative impact on MBF. Rulquin et al. 
(2004) reported that intra-duodenal infusion of glucose in dairy cows increased MBF. In other 
studies in dairy cows a negative impact of glucose infusion on illiac plasma flow has been 
found (Cant et al., 2002; Purdie et al., 2008), but to what extent the decreased iliac flow could 
be ascribed to decreased MBF or decreased blood supply to the hind leg is unknown. We did 
not measure mammary blood flow in this experiment, but it seems from previous studies that 
mammary blood flow would most likely have been unaffected or if anything increased on 
EAA and GLU treatments. Yet, there was no indication of a positive milk yield response on 
ACE treatment in LL. Only supplementation of additional EAA to the basal energy and 
protein deficient diet could drive up synthesis of ECM, milk protein as well as fat in LL. This 
milk yield response was associated with increased uptake of NEFA (high AVD across the 
mammary gland) due to increased arterial levels of NEFA, and urea levels were also increased 
in LL. We have no explanation why the EAA treatment apparently induced a more catabolic 
state in the animals compared to the SAL control. 
In a previous goat experiment we showed that AVD for lysine and methionine across the 
mammary gland increased linearly with A in both EL and LL in response to increased dietary 
supply. But it required higher arterial concentrations to drive a given uptake (AVD) in LL 
(Madsen et al., 2005). It has been shown by (Sharma and Kansal, 2000) in the rabbit that the 
relative abundance of different amino acid transporters in the mammary epithelial cell 
membrane changes during lactation. This observation along with our results, suggest that the 
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mammary gland in EL may in fact be more robust towards changes in amino acid supply, 
capable of maintaining amino acid uptake even at rather low arterial concentrations. And this 
may explain why an insufficient amino acid supply in EL could be compensated by a larger 
energy (ATP) supply, whereas this was not possible in LL.  
 
CONCLUSION 
Milk protein synthesis requires presence in the mammary epithelial cell of building blocks in 
the form of amino acids as well as energy in the form of ATP. An insufficient supply of 
amino acids to the mammary gland of dairy goats can be compensated in EL but perhaps not 
LL by increased energy supply to the mammary gland, provided that this increased energy 
supply is in the form of nutrients like acetate, which are metabolized predominantly in 
pathways resulting in generation of ATP. The mammary gland may thus be relatively less 
sensitive towards variations in amino acid supply in EL compared to LL, but the underlying 
reason for this altered sensitivity during lactation remains to be established. The present study 
thus indicate that there could be scope for development of differential protein 
recommendations for ruminants in early and late lactation, and this issue should be pursued in 
future studies.  
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Table 1- The chemical composition of the feed used in both early and late lactation.  
Nutrient  SFU1 AAT2 PBV3 Fatty acids Sugar Starch Ca P Mg 
  DM (%) SFU/kg DM g/SFU g/SFU g/SFU g/SFU g/SFU g/SFU g/SFU g/SFU 
Barley 85 1.13 84 -36 25 18 517 0.6 3.6 1.1 
Hay 93 0.61 135 18 17 112 0 5.0 2.0 2.0 
Urea 100 1 0 2880 0 0 0 0 0 0 
Protected fat 99 2.35 0 0 310 0 0 30 0 0 
1One Scandinavian Feed Unit (SFU) = 7890 KJ of net energy/kg of DM, 2Amino acids absorbed from the small intestine (AAT), 3Protein 
balance in rumen (Strudsholm et al., 1999). 
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Table 2- An overview of the daily provision of energy and protein to the goats by the diet and 
with infusion solutions for a goat with a body weight of 50 kg and a milk yield of 3 and 1.5 kg 
per day in early and late lactation, respectively.  
* 
*Omsolarity of infusion solutions were 2.25 in EL and 1.69 in LL 
 
 
 
 
 
 
 
 
 
Daily dietary provision 
(g/d except otherwise stated) 
EL 
Body weight = 50 kg 
milk yield = 3 kg/d 
LL 
Body weight = 50 kg 
milk yield = 1.5 kg/d 
AAT 181.11 136.11 
Hay 400 400 
Barley 1420 970 
Protected fat 70 80 
Urea 16 10 
Vit/Min 20 10 
Dietary NE (MJ/d) 13.93 10.71 
Daily provision via infusion  
(g/d unless otherwise stated) 
        
EAA ACE GLU SAL EAA ACE GLU SAL 
kJ NE/d 560.9 560.9 560.9 0 421.5 421.5 421.5 0 
Osmoles /d* 2.16 2.16 2.16 2.16 1.62 1.62 1.62 1.62 
EAA in total 45.28    34.01    
Ile 4.78    3.59    
Leu 8.77    6.59    
Met 2.12    1.59    
Phe 4.18    3.14    
Thr 4.50    3.39    
Trp 1.76    1.31    
Val 6.67    5.01    
Arg 2.72    2.04    
His 2.52    1.90    
Lys 7.26    5.45    
Glucose   53.93    40.53  
Acetic acid (100%)  64.77    48.68   
NaCl 46.35  54.28 63.03 33.33  40.80 47.38 
mol ATP/d 10.8 10.8 10.8 0 8.1 8.1 8.1 0 
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Table 3- Milk yield and its fat and protein contents in early and late lactating dairy goats fed a 
restricted diet supplemented by intravascular infusion of nutrients. 
   Treatment   P-value 
  EAA ACE GLU SAL SEM T 
Milk yield (g/last 48h)      
EL  4821ab 4765ab 5140a 4237b 547 0.06 
LL  2888 2732 2787 2861 606 0.71 
ECM (g/last 48h)       
EL  5188  5761 5393 4959 602 0.19 
LL  3547a  3040ab 2775b 3118ab 602 0.03 
Protein (%)       
EL  3.48a 3.46a 3.06b 3.38a 0.15 0.03 
LL  3.98a 3.76ab 3.52b 3.74ab 0.14 0.13 
Protein yield (g/last 48h)       
EL  166a 163ab 157ab 139b 14 0.11 
LL  114a 100ab 98b 106ab 14 0.09 
Fat (%)        
EL  4.49a 5.81b 4.61a 5.44b 0.33 0.01 
LL  5.51a 5.50a 3.86b 4.51ab 0.32 0.02 
Fat yield (g/last 48h)       
EL  222 272 238 232 31 0.26 
LL  160a 130a 108b 130a 31 0.04 
EAA: essential amino acids, ACE: acetate, GLU: glucose, Sal: saline, T: Treatment, S: Stage of lactation, EL: early lactation, LL: late 
lactation. Different letters within a row indicate significant difference between treatments. 
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Table 4- Arterial concentrations (A), arterial -milk vein concentration differences (AVD), and 
mammary extraction rates (E) for plasma metabolites, IGF-1 and insulin in early and late 
lactating dairy goats fed a restricted diet supplemented by intravascular infusion of nutrients. 
   Treatment    P-value  
  EAA ACE GLU SAL SEM T S T x S 
GLU          
EL          
 A (mM) 4.00ac 3.95a 4.60b 4.22c 0.14 <0.001 0.02 <0.06 
 AVD (mM) 1.27a 1.18b 1.24ab 1.21ab 0.16 <0.01 <0.001 <0.01 
 E ratio 0.32a 0.30ab 0.28b 0.29b 0.04 <0.001 <0.001 <0.001 
LL          
 A (mM) 4.00a 3.99a 4.24b 3.97a 0.15    
 AVD (mM) 1.12a 1.04a 0.88b 1.16a 0.16    
 E ratio 0.27a 0.26a 0.20b 0.29a 0.04    
ACE          
EL          
 A (mM) 0.78a 0.93ab 0.59c 0.64ac 0.08 0.01 0.65 0.54 
 AVD (mM) 0.64a 0.75b 0.48c 0.52 c 0.05 <0.001 0.22 0.04 
 E ratio 0.81 0.79 0.82 0.80 0.02 0.98 <0.001 0.07 
LL          
 A (mM) 0.73a 0.91ab 0.61ac 0.79a 0.08    
 AVD (mM) 0.53a 0.72b 0.42c 0.60a 0.05    
 E ratio 0.75a 0.78ab 0.74ac 0.77a 0.02    
BHB          
EL          
 A (mM) 0.41a 0.33b 0.25c 0.48d 0.04 <0.001 <0.001 0.46 
 AVD (mM) 0.28a 0.21b 0.17c 0.32d 0.03 <0.001 0.51 <0.01 
 E ratio 0.68a 0.64b 0.67ab 0.66ab 0.04 0.01 <0.001 <0.001 
LL          
 A (mM) 0.48a 0.47a 0.36b 0.56c 0.04    
 AVD (mM) 0.23a 0.26a 0.15b 0.32c 0.03    
 E ratio 0.51a 0.53ac 0.45b 0.54c 0.04    
NEFA          
EL          
 A (µEq) 392a 454a 309b 544c 35 <0.001 <0.001 <0.001 
 AVD (µEq) 157a 155a 111b 238c 18 <0.001 <0.001 <0.001 
 E ratio 0.31 0.30 0.30 0.38 0.06 0.17 <0.001 0.66 
LL          
 A (µEq) 375a 266b 236b 279b 36    
 AVD (µEq) 126a 57b 72b 81b 19    
 E ratio 0.17 0.15 0.08 0.17 0.06    
TG          
EL          
 A (mM) 0.16 0.16 0.16 0.15 0.02 0.18 <0.001 0.01 
 AVD (mM) 0.10 0.10 0.10 0.09 0.02 <0.01 <0.001 <0.001 
 E ratio 0.62a 0.64a 0.63a 0.51b 0.04 <0.01 <0.001 <0.001 
LL          
 A (mM) 0.23a 0.23a 0.20a 0.27c 0.02    
 AVD (mM) 0.11a 0.13ac 0.09b 0.14c 0.02    
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   Treatment    P-value  
  EAA ACE GLU SAL SEM T S T x S 
 E ratio 0.50a 0.55a 0.42b 0.51a 0.04    
LCFA          
EL          
 A (µEq) 487 481 483 465 66 0.18 <0.001 0.06 
 AVD (µEq) 307 309 305 268 58 <0.01 <0.001 <0.001 
 E ratio 0.62a 0.64a 0.63a 0.51b 0.04 <0.01 <0.001 <0.001 
LL          
 A (µEq) 680a 688a 617a 817b 67    
 AVD (µEq) 330a 376a 262b 412a 59    
 E ratio 0.50a 0.55a 0.42b 0.51a 0.04    
Urea          
EL A (mM) 2.65a 3.36b 2.34a 2.60a 0.50 <0.01 <0.001 0.20 
LL A (mM) 4.70a 4.54ab 4.01b 3.97b 0.50    
IGF1       0.64 0.74 0.98 
EL A (nM) 55.0 46.9 53.3 46.9 8.3    
LL A (nM) 53.3 49.2 56.2 49.7 8.3    
Insulin       0.30 0.55 0.66 
EL A (µg/l) 0.60 0.43 0.40 0.43 0.12    
LL A (µg/l) 0.59 0.40 0.58 0.45 0.12    
T: Treatment, S: Stage of lactation, EL: early lactation, LL: late lactation, EAA: essential amino acids, ACE: acetate, GLU: glucose, Sal: 
saline, BHB: beta hydroxyl butyrate, NEFA: non-esterified fatty acids, TG: triglyceride, LCFA: long chain fatty acids, IGF1: insulin growth 
factor 1, A: arterial concentration, AVD: arterial-milk vein difference, E ratio: extraction rate. Different letters within a row indicate 
significant difference between treatments. 
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Table 5- Arterial concentrations (A), arterial -milk vein concentration differences (AVD), and 
mammary extraction rates (E) for blood acid-base parameters in early and late lactating dairy 
goats fed a restricted diet supplemented by intravascular infusion of nutrients. 
   Treatment    P-value  
  EAA ACE GLU SAL SEM T S T x S 
TO2          
EL          
 A (mM) 5.38 5.52 5.39 5.33 0.22 0.64 0.02 0.26 
 AVD (mM) 2.77a 2.57ac 2.25bc 2.37c 0.17 <0.001 0.19 <0.001 
 E ratio 0.52a 0.47b 0.42c 0.44bc 0.03 <0.001 0.47 <0.001 
LL          
 A (mM) 5.53a 5.57ab 5.52a 5.83b 0.22    
 AVD (mM) 2.53a 2.41ab 2.24b 3.09c 0.18    
 E ratio 0.46a 0.43ab 0.40b 0.54c 0.03    
TCO2          
EL          
 A (mM) 24.0a 39.6b 25.9c 23.9a 0.98 <0.001 0.31 0.03 
 AVD (mM) -2.41a -2.27a -1.87b -2.47a 0.30 <0.001 <0.001 0.20 
 E ratio -0.10a -0.05b -0.08c -0.11a 0.01 <0.001 <0.01 0.17 
LL          
 A (mM) 26.0a 37.7b 26.7ac 25.0ad 0.99    
 AVD (mM) -2.62a -2.91b -2.17c -3.22ab 0.31    
 E ratio -0.10a -0.08b -0.08b -0.13c 0.01    
Mammary RQ       0.50 0.09 0.79 
EL  0.87 0.93 0.90 0.94 0.09    
LL  0.97 1.17 0.96 0.99 0.09    
HCO3          
EL          
 A (mM) 22.9a 38.3b 24.8c 22.8a 0.95 <0.001 0.36 0.03 
 AVD (mM) -2.19a -2.14a -1.67b -2.33a 0.29 <0.001 <0.001 0.40 
 E ratio -0.10a -0.05b -0.07c -0.11a 0.01 <0.001 <0.01 0.38 
LL          
 A (mM) 24.8a 36.3b 25.5ac 23.8ad 0.97    
 AVD (mM) -2.39ac -2.71a -1.96b -2.94ad 0.30    
 E ratio -0.10a -0.07b -0.08b -0.13c 0.01    
pH          
EL A 7.41a 7.53b 7.45c 7.44c 0.01 <0.001 <0.01 0.06 
LL A 7.41a 7.51b 7.43c 7.41a 0.01    
T: Treatment, S: Stage of lactation, EL: early lactation, LL: late lactation, EAA: essential amino acids, ACE: acetate, GLU: glucose, Sal: 
saline, TCO2: total CO2, TO2: total O2, RQ: respiratory quote, A: arterial concentration, AVD: arterial-milk vein difference, E ratio: 
extraction rate. Different letters within a row indicate significant difference between treatments. 
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Activities in relation to PhD education  
(since September 2004) 
 
Papers and presentations 
- Safayi, S., and M. O. Nielsen. Intravenous Supplementation of Acetate, Glucose or 
Essential Amino Acids to an Energy and Protein Deficient Diet in Early and Late 
Lactating Dairy Goats: Effects on Milk Production and Mammary Nutrient Extraction. 
(to be submitted to J. Dairy Sci.) 
- Safayi, S., P. K. Theil, V. S. Elbrønd, L. Hou, M. Engbaek, J. V. Norgaard, K. 
Sejrsen, and M. O. Nielsen. 2009. Mammary Remodelling in Primiparous and 
Multiparous Dairy Goats During Lactation. J. Dairy Sci. (Accepted; JDS-09-2422.R2) 
- Safayi, S., P. K. Theil, L. Hou, M. Engbaek, J. V. Norgaard, K. Sejrsen, and M. O. 
Nielsen. 2009. Continuous Lactation Effects on Mammary Remodelling During Late 
Gestation and Lactation in Dairy Goats. J. Dairy Sci. (In press; doi:10.3168/jds.2009-
2507) 
- Safayi, S., and M. O. Nielsen. 2009. Continuous lactation effects on mammary 
extraction rates of nutrients in dairy goats. Pages 652-653 in The XIth International 
Symposium on Ruminant Physiology (ISRP). Vol. Clermont-Ferrand, France. Y. 
Chilliard, F. Glasser, Y. Faulconnier, F. Bocquier, I. Veissier, and M. Doreau, eds. 
Wageningen Academic Publishers, Wageningen, The Netherlands. 
- Nørgaard J. V., M. O. Nielsen, P. K. Theil, M. T. Sørensen, S. Safayi, and K. Sejrsen. 
2008. Development of mammary gland of fat sheep submitted to restricted feeding 
during late pregnancy. Small Ruminant Research. 76:155-165. 
- Safayi, S., P. K. Theil, V. S. Elbrønd, L. Hou, M. Engbaek, and M. O. Nielsen. 2008. 
Mammary development and remodelling in primiparous and multiparous dairy goats 
during lactation, CRU Symposium on 'Lactation in Mammals and Humans', Uppsala, 
Sweden. (Oral presentation) 
- Safayi, S., P. K. Theil, V. S. Elbrønd, L. Hou, M. Engbaek, and M. O. Nielsen. 2008. 
Effect of continuous lactation in dairy goats on mammary histology, cell turnover and 
expression of angiogenic factors, The 5th European Gordon Research Conference on 
Mammary Gland Biology, Lucca (Barga), Italy. (Poster presentation) 
- Safayi, S., P. K. Theil, and M. O. Nielsen. 2007. Effect of parity and continuous 
lactation on expression of angiogenic factors during different stages of lactation in the 
mammary gland of dairy goats, The 1st SHARE (Synergy in Human and Animal 
Research) Symposium, Copenhagen, Denmark. (Poster presentation) 
 
Other publications 
- Bolliger A. M., Muguerza N. B., Grossi A., Safayi S. 2006. The PhD Students’ 
Network at KVL –Is It Dying Out?. Det Levende Universitet (KVL’s Magazine), 
1:22-23. 
- Gjerstad R. T., Nielsen D., Andren M., Holso K., Lindberg H., Solli M., Babigumira 
R., Bjonnes I., Brydolf S., Areskog M., Horn I., Jor E., Lundberg D., Vuorinen A., 
Safayi S. 2005. The Students’ Perspective: NOVA Student Forum, in book “10 Years 
NOVA-UN 1995-2005”. 118:119. 
- Safayi S. 2005. KVL – An International University, Det Levende Universitet (KVL’s 
Magazine), 6:7. 
 
 
 
[174] 
 
Research projects 
2009 Participant in project on “Role of Prostaglandin E2 (PGE2) on Growth and 
Differentiation of Bovine Mammary Epithelial Cells” (with University of 
Arizona, AZ, USA) 
2007-2009 Participant in project on “Continuous lactation in dairy cows” (with Swedish 
Agricultural University, Sweden) 
2006-2009 PhD student in project on “Continuous lactation and dry period feeding: 
Impact on pre- partum mammary redevelopment and milk production potential 
in ruminants” 
2006 Participant in project on “Starch for dairy cows” (with Aarhus University, 
Denmark) 
2004-2006 PhD student in project on “Role of mammary epithelial cell turnover and 
nutrient supply in regulation of milk production in small ruminants” 
 
PhD courses (60.5 ECTS + 1 audit course) 
2009 ¨Medical Scientific English¨ (2.5 ECTS), Faculty of Health Sciences, University 
of Aarhus, Denmark 
2007-2008 ¨Applies Statistics¨, Faculty of Life Sciences, University of Copenhagen, 
Denmark (audit course) 
2007 ¨Write Publishable Research: An Interactive Process¨ (2.5 ECTS), Copenhagen 
Business School, Denmark 
 ¨Stereology: Sampling and Measurement of 3D Structures¨ (3 ECTS), Faculty 
of Life Sciences, University of Copenhagen, Denmark 
 ¨Image Analysis¨ (7.5 ECTS), Faculty of Life Sciences, University of 
Copenhagen, Denmark 
 ¨Real Time RT-PCR Advanced¨ (4 ECTS), Faculty of Science, University of 
Copenhagen, Denmark 
 ¨Genome & Cell Biology¨ (12 ECTS), Faculty of Life Sciences, University of 
Copenhagen, Denmark 
2005 ¨Real Time PCR¨ (2.5 ECTS), TATAA Biocenter, Dept. of Molecular 
Biotechnology, Chalmers University of Technology, Gothenburg, Sweden 
 ¨Laboratory Animal Science¨ Category C (9 ECTS), Faculty of Life Sciences, 
University of Copenhagen, Denmark 
 ¨The R System for Computational Data Analysis¨ (2 ECTS), Danish Informatics 
Network in the Agricultural Sciences (DINA) Research School, Denmark 
 ¨Statistics for Veterinarians¨ (9 ECTS), Faculty of Life Sciences, University of 
Copenhagen, Denmark 
2004 ¨Immunodiagnostic Methods for Veterinarians¨ (6 ECTS), Faculty of Life 
Sciences, University of Copenhagen, Denmark 
 
Teaching experiences 
2007-2008 Co-supervising two MSc thesis’ projects on “Lactation Physiology”, Faculty of 
Life Sciences, University of Copenhagen, Denmark 
2005-2008 ¨Experimental animal nutrition and physiology¨ postgraduate courses 
(theoretical and practical parts), Faculty of Life Sciences, University of 
Copenhagen, Denmark 
2007 ¨Veterinary physiology¨ undergraduate course, Faculty of Life Sciences, 
University of Copenhagen, Denmark 
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Workshops 
 2005 II International ¨COST B20 Action¨ Workshop on ¨Mammary Gland 
Development, Function and Cancer: Proteins and signaling pathways 
controlling mammary epithelial cell function¨, Institute for Biochemical 
Research, Georg-Speyer-Haus, Frankfurt, Germany 
 ¨Scientific Information Sources and Information Management¨ Workshop, 
Faculty of Life Sciences, University of Copenhagen, Denmark 
 ¨Databases and Web Programming¨ Workshop, Danish Informatics Network in 
the Agricultural Sciences (DINA), Tune Landboskole, Roskilde, Denmark 
 
Board memberships 
2006- 2008 PhD Study Committee, Graduate School, Faculty of Life Sciences, University 
of Copenhagen, Denmark 
2005-2007 The Students’ Forum Board (NSF) and Local NOVA-UN Team, The Nordic 
Forestry, Veterinary and Agricultural University Network (NOVA-UN), Nordic 
Countries 
2004-2007 PhD Network, Faculty of Life Sciences, University of Copenhagen, Denmark 
2004-2006 Iranian Academic Society in Denmark (IASD), Denmark 
 
 
 
 
